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Samenvatting
Dit doctoraatsonderzoek focust op de ontwikkeling en validatie vannieuweme-
thoden en toestellen ter bepaling van arteriële stijfheid en golfreecties, twee
indicatoren met voorspellende waarde voor de ontwikkeling van hoge bloed-
druk (hypertensie) en de hiermee geassocieerde hart- en vaatziekten.
De tekst bestaat uit vijf onderdelen. Het eerste deel bevat algemene achter-
grondinformatie, terwijl de voornaamste conclusies worden samengevat in het
laatste deel. Het eigenlijke onderzoek is gegroepeerd in de drie middelste de-
len: delen II en III bundelen een aantal studies over de validatie en ontwikke-
ling van nieuwe methoden en toestellen ter bepaling van arteriële stijfheid en
golfreecties. In het vierde deel wordt gefocust op de studie van de arteriële
eigenschappen van zwarten. Elk deel wordt hierna kort samengevat.
Deel I: Achtergrond
In hoofdstuk 1 worden de basisprincipes van de cardiovasculaire anatomie, fy-
siologie en pathofysiologie geïntroduceerd, met bijzondere aandacht voor ar-
teriële wandmechanica en hemodynamica. Hypertensie speelt een cruciale rol
als zowel een vorm van hart- en vaatziekte op zichzelf als een risicofactor voor
de ontwikkeling van andere types hart- en vaatziekten. Om een beter begrip te
krijgen van de verschillende factoren die de ontwikkeling beïnvloeden van hy-
pertensie in het bijzonder en van de eigenschappen van de arteriële circulatie
in het algemeen, worden de twee grote klassen van modellen van de arteriële
circulatie besproken. In het windketelmodel worden de verschillende eigen-
schappen van de arteriële boom voorgesteld door een beperkt aantal ’lumped’
parameters zoals weerstand, compliantie (of zijn inverse, stijfheid) en inertie.
In het tweede soort modellen wordt de arteriële circulatie als een golfsysteem
bekeken, waarbij de druk- en snelheidsgolven samengesteld zijn uit voorwaarts
lopende golven die zich weg van het hart bewegen en terugwaartse golven die
naar het hart toe bewegen na reectie op uiteenlopende plaatsen in de arte-
riële boom. Uit deze modellen komen arteriële stijfheid en golfreecties naar
voor als de belangrijkste determinanten van een toename in systolische druk
en pulsdruk.
xv
Samenvatting
Hoofdstuk 2 gaat dieper in op de verschillende methoden om arteriële stijf-
heid en golfreecties te bepalen. Stijfheid kan bepaald worden op een globaal,
regionaal of lokaal niveau. Hoewel elke aanpak zijn voor- en nadelen hee, is
de meting van aortastijfheid door middel van de carotis-femoralis golfsnelheid
(pulse wave velocity, PWV)momenteel de klinische referentietechniek. Arteri-
ële golfreecties kunnen gekwanticeerd worden op basis van de vorm van de
drukgolf (golfvormanalyse) of op basis van een wiskundige opsplitsing van de
druk- en snelheidsgolf in voorwaartse en terugwaartse golven, hetzij in het fre-
quentiedomein (impedantie-analyse) of in het tijdsdomein (intensiteitsanalyse).
Deel II: Validatie en ontwikkeling van nieuwe methoden
De analyse van golfreecties en arteriële stijfheid hee zich de laatste 15 à 20
jaar sterk ontwikkeld en is nu in de overgangsfase tussen klinisch onderzoek en
klinische praktijk, zoals geïllustreerd wordt door de inclusie van PWV als een
maat voor subklinische orgaanschade in de ESC/ESH1 richtlijnen sinds 2007.
Met het oog op deze overgang naar de klinische praktijk verschui de focus
in de bepaling van arteriële stijfheid en golfreecties van een complete, accurate
karakterisatie zoals gebruikt (zou moeten worden) in klinisch onderzoek naar
een meer pragmatisch compromis tussen nauwkeurigheid en tijds- en kosten-
eciëntie van de meettechniek. Gebruik makend van de concepten die in deel
I werden aangebracht, valideerden en ontwikkelden we een aantal nieuwe me-
thoden ter bepaling van arteriële stijfheid en golfreecties.
Hoofdstuk 4beschrij de resultaten van een validatiestudiewaarin eennieuwe
methode van golfseparatie op basis van een gemeten drukgolf en een geschatte
(driehoekige) snelheidsgolfwordt vergelekenmet demeer traditionelemethode
van golfseparatie op basis van gemeten druk- en snelheidsgolven. Hoewel deze
nieuwe methode benaderend is, hee ze het voordeel dat de vaak dure en tijds-
intensieve meting van de snelheidsgolfvorm vermeden wordt. Deze aanpak
werd geïntroduceerd door Westerhof et al. voor de bepaling van de reec-
tiemagnitude (RM), met veelbelovende resultaten in een kleine dataset. Later
gebruikten Qasem et al. dezelfde methode om transittijden (TT) en golfsnel-
heid in de aorta te bepalen aan de hand van een centrale drukgolf, de drukgolf
ter hoogte van de aorta. De nauwkeurigheid van deze benaderingstechnieken
voor de bepaling van RM en TT werd nagegaan door gebruik te maken van
beschikbare drukgolven in de carotis en snelheidsgolven in de aorta die op niet-
invasieve wijze werden gemeten tijdens de Asklepios studie. Daarnaast werd
ook de nauwkeurigheid onderzocht van een meer fysiologische snelheidsgolf-
vorm als benadering voor de echte, gemeten golfvorm. Hiervoor werd gebruik
1ESC: European Society of Cardiology; ESH: European Society of Hypertension
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gemaakt van een gemiddelde golfvorm die genormaliseerd en persoonspeciek
in de tijd geschaald werd.
De driehoekige snelheidsgolfvorm, in de tijd geschaald op basis van tijdsin-
formatie van de gemeten snelheidsgolfvorm, leverde een matige overeenstem-
ming tussen de referentie en de geschatte RM en TT. Zowel voor de RM als
voor de TT verslechterde deze overeenstemming nog wanneer de tijdsinforma-
tie van de drukgolf in plaats van die van de snelheidsgolf werd gebruikt. Deze
overeenstemming tussen schatting en referentie verbeterde aanzienlijkwanneer
de snelheidsgolf benaderd werd door demeer fysiologische golfvorm, al blijven
sommige individuele verschillen groot. Het is daarom niet vanzelfsprekend om
deze benaderende technieken toe te passen in de klinische praktijk. Besluitend
kunnenwe stellen dat, in de Asklepios populatie, de benaderendemethoden ter
bepaling van RM en TT waarden opleveren die grondig verschillen van de re-
ferentiewaarden die worden verkregen wanneer zowel gemeten druk- als snel-
heidsgolfvormen gebruikt worden.
Hoofdstuk 5 is gewijd aan de niet-invasieve bepaling van drukgolven in de
halsslagader of carotis. Calibratie van een tonometriecurve opde carotis gebeurt
aan de hand van de diastole en gemiddelde bloeddruk gemeten op de boven-
armof brachialis. Deze gemiddelde bloeddrukwordt in het ideale geval bepaald
als het rekenkundig gemiddelde van de brachiale drukgolfvorm. Dit impliceert
dat voor een correcte niet-invasieve bepaling van de carotisdruk de drukgolf
op zowel de brachialis als de carotis moet gemeten worden. Omdat het vaak
moeilijk is om goede tonometriecurven te verkrijgen bij zwaarlijvige mensen,
kan het gebruik van gecalibreerde distensiecurven een breder toepasbaar alter-
natief vormen voor tonometrie. Deze aanpak kan in het bijzonder van nut zijn
op de brachialis, waar de haalbaarheid van een betrouwbare tonometriemeting
in het verleden meermaals in vraag werd gesteld.
Voor deze studie werd gebruik gemaakt van distensie- en tonometrieme-
tingen op de brachialis en carotis van 148 personen. De pulsdruk ter hoogte van
de carotis, verkregen op basis van geschaalde distensiemetingen, werd vergele-
kenmet de klassieke (referentie-)calibratiewijze op basis van tonometriecurves,
alsookmet de recent voorgestelde combinatie van een brachiale tonometriecurve
en een lineair of exponentieel geschaalde distensiecurve op de carotis. Het ver-
schil tussen de referentie pulsdruk en de pulsdruk verkregen via geschaalde dis-
tensiemetingen was kleiner dan het verschil tussen de referentie pulsdruk en
demethodes op basis van één tonometriecurve en één distensiecurve. Omwille
hiervan raden we aan om de bloeddruk ter hoogte van de carotis te bepalen
aan de hand van twee metingenmet dezelfde techniek, hetzij tonometrie, hetzij
distensie.
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Centrale bloeddruk kan ook geschat worden uit drukgolven gemeten op de
voorarmslagaders (radialis) door middel van een zogenaamde transferfunctie.
Dit betekent dat de verkregen centrale bloeddrukwaarde zal afhangen van de
calibratie van de radiale drukgolf. In hoofdstuk 6 worden drie calibratiemetho-
den, toegepast op radiale en carotis tonometriecurven, gemeten in de Asklepios
studie: calibratie op basis van brachiale diastole bloeddruk en (i) brachiale sys-
tole bloeddruk, (ii) gemiddelde bloeddruk verkregen als één derde van de bra-
chiale pulsdruk (de zogenaamde één-derde regel), (iii) gemiddelde bloeddruk
verkregen als 40% van de brachiale pulsdruk. Uit deze vergelijking blijkt dat
zowel de systole bloeddruk ter hoogte van de carotis als deze ter hoogte van
de aorta, verkregen via een transferfunctie, sterk afhankelijk zijn van de cali-
bratie van carotis en radiale drukgolven. Onze data suggereren dat de één-derde
regel voor de berekening van de gemiddelde bloeddruk (die wordt beschreven
in standaard handboeken)moet vermedenworden, zeker indien de gemiddelde
bloeddrukwordt gebruikt voor verdere berekening van aortadruk via een trans-
ferfunctie. Het gebruik van 40% van de brachiale pulsdruk als benadering voor
de gemiddelde bloeddruk is nauwkeuriger en wordt daarom aanbevolen.
In hoofdstuk 7 worden de determinanten van een nieuwe stijfheidsindex,
deAmbulatory Arterial Stiness Index (AASI), onderzocht aan de hand van een
numeriek model van de arteriële circulatie. Op basis van 24-uurs ambulante
bloeddrukmetingen kan de AASI berekend worden als één min de helling van
de lineaire regressielijn tussen de systole en diastole bloeddruk, en vereist dus
geen meting van druk-, snelheids- noch distensiegolfvorm. Hoewel de een-
voud van deze methode aanspreekt, zijn 24-uurs bloeddrukmetingen vereist en
is er controverse in hoeverre de AASI een maat is voor arteriële stijfheid en
niet beïnvloed wordt door andere hemodynamische parameters. Wij onder-
zochten de invloed van vijf parameters (arteriële distensibiliteit, perifere weer-
stand, hartritme, cardiale contractiliteit en veneuze vullingsdruk) op de AASI
door elke parameter te variëren van 80% tot 120% van zijn initiële waarde in
stappen van 10% om de dagelijkse uctuaties na te bootsen in een theoretische,
normotensieve persoon. Om na te gaan in welke mate de AASI verandert bij
grote veranderingen in stijfheid, werden twee bijkomende theoretische perso-
nen gesimuleerd met een gemiddelde distensibiliteit van respectievelijk 50% en
25% van de distensibiliteit van de eerste theoretische persoon. Uit deze simu-
laties is duidelijk dat arteriële distensibiliteit, perifere weerstand en vooral hart-
ritme de belangrijkste determinanten van de AASI zijn. De verstorende invloed
van hartritme en perifere weerstand op de AASI betekent een aanzienlijke be-
perking van de bruikbaarheid van de AASI als maat voor arteriële stijfheid.
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Deel III: Validatie en ontwikkeling van nieuwe toestellen
Tesamen met de verhoogde interesse voor de rol van de grote arteriën in de
ontwikkeling van hypertensie en in het bijzonder sinds de inclusie van PWV
in de ESC/ESH richtlijnen voor de behandeling van hypertensie, is het aantal
toestellen om golfreecties en arteriële stijfheid temeten sterk toegenomen. Dit
derde deel beschrij de validatiestudies die werden ondernomen op twee re-
latief nieuwe toestellen, alsook de ontwikkeling van een goedkoper toestel voor
gebruik in ontwikkelingslanden.
Hoofdstuk 9 bespreekt de resultaten van een numerieke validatie van het
werkingsprincipe van de Arteriograph (Tensiomed, Boedapest, Hongarije), een
toestel dat beweert de golfsnelheid in de aorta te meten door middel van een
eenvoudige manchet ter hoogte van de brachialis. Terwijl de manchet opge-
blazen wordt tot boven de systole bloeddruk, wordt een drukcurve opgemeten
die twee duidelijke pieken vertoont. De eerste piek is de systole piek, terwijl
de tweede piek door de uitvinders wordt toegeschreven aan een reectie ter
hoogte van de splitsing van de aorta in de liesslagaders. De PWV wordt dan
berekend als de verhouding van tweemaal de afstand tussen het borstbeen en
het schaambeen tot het tijdsverschil tussen de twee pieken in de drukgolfvorm.
Om de geldigheid van dit werkingsprincipe te testen maakten we gebruik van
een numeriek model van de arteriële circulatie om bloeddrukken en snelheids-
golven te simuleren in de normale conguratie en in een conguratie waarbij
de brachialis afgekneld is. Deze laatste conguratie leverde inderdaad een dui-
delijke tweede piek op in de brachiale drukgolfvorm, maar de timing van deze
piek was enkel gerelateerd aan de brachiale en axillaire stijfheid en niet aan de
stijfheid van de aorta. Dit wijst er op dat de voorgestelde methode golfreec-
ties oppikt die zich beperken tot de brachialis en de axillaris, en dat de aldus
bekomen PWV-waarden eerder een maat zijn voor de brachiale en axillaire
stijfheid dan voor de beoogde aortastijfheid. Onze simulaties stellen als dus-
danig het werkingsprincipe van de Arteriograph ernstig in vraag.
In hoofdstuk 10 worden de resultaten besproken van vergelijkende metin-
gen van de centrale systole bloeddruk (cSBP) tussen de Omron HEM-9000AI
(Omron Healthcare, Kyoto, Japan) en de SphygmoCor (Atcor Medical, Syd-
ney, Australië). Centrale bloeddrukwordt beschouwd als een sterkere predictor
van cardiovasculaire problemen dan de conventionele brachiale bloeddruk. De
Omron HEM-9000AI is de eerste automatische tonometer die de bepaling van
cSBP toelaat. Een eerdere studie rapporteerde echter grote verschillen tussen de
cSBP-waarde van Omron HEM-9000AI en deze van SphygmoCor, zonder een
duidelijke verklaring te geven. Onze studie gaat op zoek naar de oorzaken van
het verschil tussen beide centrale bloeddrukschattingen en gee een indicatie
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welke schatting het dichtste bij de werkelijkheid ligt. Hiervoor werd gebruik
gemaakt van de aortadruk afgeleid uit de carotisdruk als toestel- en algoritme-
onafhankelijke referentie.
143 zwarte Zuid-Afrikanen werden bemeten met zowel een Omron HEM-
9000AI (tonometrie op radialis) als een SphgymoCor toestel (tonometrie op ra-
dialis, brachialis en carotis). Hoewel de vorm van demet beide toestellen geme-
ten radiale drukcurves vergelijkbaar was en de cSBP-waarden goed correleer-
den, was deOmron-schatting gemiddeld 18.8mmHghoger dande SphygmoCor-
schatting. De aortadruk lag tussen beide schattingen in. De resultaten van
deze studie tonen aan dat het aanzienlijke verschil tussen de centrale bloed-
drukschattingen van Omron HEM-9000AI en SphygmoCor te wijten is aan
verschillen in algoritme, en suggereert dat de overschatting doorOmronHEM-
9000AI groter is dan de onderschatting door SphygmoCor.
De beschikbare toestellen ter bepaling van arteriële stijfheid en golfreec-
ties zijn duur, wat een obstakel kan vormen voor onderzoek in ontwikkelings-
landen. Daarom ontwikkelden wij een goedkoper toestel om snelheids- en
drukgolven en aldus PWV en lokale bloeddruk te meten. De ontwikkeling
en validatie van de hardware en soware van dit Tono-Doppler toestel wor-
den beschreven in hoofdstuk 11. De hardware is samengesteld uit commer-
cieel beschikbare componenten: snelheidsgolven, gemeten viamobieleDoppler
toestellen (Huntleigh Healthcare, Cardi, UK), en tonometriecurves, gemeten
via een micro-tip transducer (Millar Instruments, Texas, USA), worden gedigi-
taliseerd aan 100 Hz in een data-acquisitie module (NI-9219, National Instru-
ments, Texas, USA). Een ECG-signaal kan mee opgenomen worden door een
éénkanaals ECG-module (EG01000,MedlabGmbH,Karlsruhe, Duitsland). Het
toestel hee geen aparte elektrische voeding nodig maar wordt gevoed via de
USB-verbinding met een PC of laptop. Specieke acquisitie- en verwerkings-
soware werden ontwikkeld in Matlab (MathWorks, Natick, Massachusetts,
USA) op basis van bestaande code en algoritmes ontwikkeld in het kader van
de Asklepios studie. Hard- en soware werden afzonderlijk gevalideerd in een
validatiestudie op 11 gezonde vrijwilligers. De totale kostprijs van het Tono-
Doppler toestel ligt beneden de 4000e.
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Deel IV: Arteriële eigenschappen bij zwarten
Het vierde deel van deze tekst focust op de arteriële eigenschappen bij zwarten,
wiens cardiovasculair risicoproel duidelijk verschilt van dat van blanken.
Hoofdstuk 13 gaat dieper in op deze verschillen in risicoproel en de moge-
lijke mechanismen die aan de oorzaak ervan liggen. De literatuur rond arteri-
ële eigenschappen bij zwarten wordt besproken, met specieke aandacht voor
de ethnische verschillen in de mechanische eigenschappen van de grote arte-
riën. De stijfheid van de grote elastische arteriën zoals de aorta en de carotis
blijkt hoger in zwarten dan in blanken, terwijl er geen verschil in stijfheid wordt
gerapporteerd voor de meer musculaire arteriën zoals de brachialis, noch voor
elastische of musculaire arteriën in diabetici en hemodialysepatiënten.
Uit deze literatuurstudie wordt duidelijk dat het overgrote deel van het on-
derzoek naar ethnische verschillen tussen zwarten en blankenwordt uitgevoerd
op zwarten die in Westerse landen leven, zoals de Verenigde Staten en het Ver-
enigd Koninkrijk. Gezien hart- en vaatziekten ook in sub-Saharisch Afrika aan
een snelle opmars bezig zijn, is meer onderzoek op zwarten in sub-Saharisch
Afrika dringendnodig als een objectieve basis voor beleids- en behandelingsstrate-
gieën.
Tegen deze achtergrond werden twee studies ondernomen in Nigeria, het
dichtstbevolkte land in sub-Saharisch Afrika. Hoofdstuk 14 beschrij de re-
sultaten van een vergelijkende studie van de arteriële stijfheid en golfreec-
ties in 184 jonge Nigeriaanse vrouwen en 92 Belgische vrouwen van dezelfde
leeijd. De determinanten van arteriële stijfheid en de gemiddeldewaarden van
stijfheid en golfreecties werden vergeleken tussen beide ethnische groepen.
We stelden geen verschillen vast in PWV en cSBP, maar de radiale SBP en de
centrale augmentatie index waren lager in Nigeriaanse vrouwen. Bovendien
was het verschil tussen de carotisdruk en de centrale druk verkregen via een
transferfunctie duidelijk groter bij de Nigeriaanse vrouwen dan bij de Belgis-
che vrouwen. Dit vraagt om een specieke validatie van de transferfunctie in
zwarten.
In een tweede studie beschreven in hoofdstuk 15 werd de aortastijfheid van
264 Nigeriaanse baby’s gemeten bij de geboorte, na 3 maanden en opnieuw na
12 maanden, in een poging om de vroegste veranderingen in arteriële disten-
sibiliteit te meten. Omdat het aantal baby’s met kwaliteitsvolle metingen sterk
varieerde tussen de verschillende follow-up periodes, worden de data voorge-
steld als een vergelijking tussen cross-sectionele metingen op drie momenten
en als drie subsets van longitudinale data. Uit zowel de cross-sectionele als de
longitudinale data blijkt dat de PWV signicant toeneemt van de geboorte tot
de leeijd van 3 of 12maand. Daarentegenwerd tussen de opeenvolgende PWV-
metingen op dezelfde baby’s geen correlatie vastgesteld.
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Summary
On the interface between engineering and medicine, this PhD focuses on the
development and validation of newmethods and devices to assess arterial sti-
ness and wave reections, two emergingmarkers predictive of the development
of high blood pressure (hypertension) and concomitant cardiovascular disease
(CVD), the leading cause of death worldwide.
e manuscript is subdivided into ve parts.e rst part provides a gen-
eral background to the dierent studies performed during my PhD, while the
last part summarizes the most important conclusions. e actual research is
grouped in the three middle parts: parts II and III bundle a number of studies
on the validation and development of new methods and devices to quantify ar-
terial stiness andwave reections. In the fourth part, this knowledge is applied
to study the arterial properties in people of African descent. Each part is briey
summarized in the following sections.
Part I: Background
Chapter 1 introduces the basics of cardiovascular anatomy, physiology andpatho-
physiology, with particular focus on arterial wall mechanics and hemodynam-
ics. Hypertension plays a crucial role, both as a type of CVD as well as a risk
factor for the development of other types of CVD. In order to gain a better un-
derstanding of the dierent factors inuencing the development of hyperten-
sion in particular and the characteristics of the arterial circulation in general,
the two main classes of models of the arterial circulation are discussed. In a
Windkessel model, the dierent properties of the arterial tree are represented
by a number of discrete, lumped parameters, such as resistance, compliance
(stiness) and inertance. Alternatively, the arterial tree can be viewed as a wave
systemwhere the pressure and owwaves are composed of forward waves trav-
elling away from the heart and backward waves travelling towards the heart,
reected at dierent sites along the arterial tree. From these models, arterial
stiness and wave reections emerge as the most important determinants of
increasing systolic and pulse pressures.
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Chapter 2 focuses on arterial stiness and wave reections and summarizes
the various methods that have emerged to quantify both parameters. Arterial
stiness can be assessed at a global, regional or local level. ough each ap-
proach has its pros and cons, the measurement of carotid-femoral pulse wave
velocity (PWV) as a means of regional arterial stiness has gained the status of
clinical gold-standard technique. Arterial wave reections can be quantied on
the shape of the pressure wave (wave shape analysis) or frommathematical wave
separation in forward and backward waves, either in the frequency (impedance
analysis) or time domain (wave intensity analysis).
Part II: Validation and development of new methods
e analysis of wave reections and arterial stiness has increasingly gained
attention over the last 15-20 years and is now in the transition between clinical
research and clinical practice, as illustrated by the inclusion of PWVas amarker
of subclinical organ damage in the 2007 ESC/ESH2 guidelines.
With regard to this (anticipated) introduction in clinical practice, the focus
in assessing arterial stiness and wave reections has shied from an accurate,
complete characterisation as (should be) used in clinical research to a more
pragmatic compromise between accuracy and time- and cost-eectiveness of
the measuring technique, applicable in clinical practice. Using the concepts in-
troduced in part I, we validated and developed a number of new methods to
quantify arterial stiness or wave reections.
Chapter 4 details the results of a validation study inwhich a new approach of
wave separation based on ameasured pressure waveform and an estimated (tri-
angular) ow waveform is compared to the more traditional approach of wave
separation using a measured pressure and ow waveform. ough approxi-
mative, this new approach has the advantage of bypassing the oen expensive
and time-consuming assessment of an aortic owwaveform.e approach was
rst introduced byWesterhof et al. to estimate reectionmagnitude (RM), with
promising results in a small dataset. Later, Qasem et al. used the same approach
to derive pulse transit time (TT) and aortic PWV from a central pressure wave-
form. We veried these approximation techniques for RMandTTusing carotid
pressure and aortic ow waveforms measured non-invasively in the Asklepios
study and explored the accuracy of approximating the ow waveform by using
a person-specic time-scaled normalized average ow waveform.
A triangular ow approximation using timing information from the mea-
sured aortic owwaveform yieldedmoderate agreement between reference and
estimated RM and TT. For both RM and TT, agreement between reference and
2ESC: European Society of Cardiology; ESH: European Society of Hypertension
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approximated values further decreased when the approximated ow waveform
was obtained using timing information from the pressure waveform. Approxi-
mating the ow by amore physiological waveform signicantly improved these
results. We conclude that, in our Asklepios population, results from pressure-
based approximative methods to derive RM or aortic pulse TT dier substan-
tially from the values obtained when using both measured pressure and ow
information.
Chapter 5 relates to the non-invasive assessment of carotid artery pressure
waveforms. Calibration of the carotid tonometric curve is based on brachial
diastolic blood pressure (DBP) and mean arterial blood pressure (MAP), the
latter ideally obtained as the arithmetic average of the brachial pressure wave-
form. erefore, proper non-invasive assessment of carotid artery pressure
ideally requires waveforms recorded at two anatomical locations: the brachial
and the carotid artery. As tonometry recordings are dicult to obtain in obese
patients, the use of calibrated diameter distension waveforms could provide a
more widely applicable alternative for local arterial pressure assessment than
applanation tonometry.is approachmight be of particular use at the brachial
artery, where the feasibility of a reliable tonometricmeasurement has been ques-
tioned.e aim of this study was to evaluate an approach based on distension
waveforms obtained at the brachial and carotid arteries.
Using local brachial and carotid diameter distension and tonometry wave-
forms recorded in 148 subjects, this approach is compared to traditional pulse
pressures obtained through tonometry at both the carotid and brachial arter-
ies (used as a reference) and the more recently proposed approach of combin-
ing tonometric readings at the brachial artery with linearly or exponentially
calibrated distension curves at the carotid artery. e dierence between the
reference carotid pulse pressure (PP) and the PP obtained from brachial and
carotid distension waveforms was smaller than the dierence between the ref-
erence carotid PP and the estimates obtained using a tonometric and a disten-
sion waveform. We therefore recommend to stick to one technique on both the
brachial and the carotid artery, either tonometry or distension, when assessing
carotid blood pressure non-invasively.
Central blood pressure can be estimated from radial artery pressure wave-
forms using a generalized transfer function. However, the obtained central
pressure waveform depends on the calibration of the radial waveform. In chap-
ter 6, three calibrationmethods are compared using the radial and carotid tono-
metric waveforms acquired on 1873 individuals in the Asklepios study: calibra-
tion using brachial arteryDBP and (i) brachial systolic pressure (SBP), (ii)MAP
estimated with the one-third rule and (iii) MAP estimated as 40% of brachial
artery pulse pressure. Both carotid artery SBP and central SBP obtained via a
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transfer function are highly sensitive to the calibration of the respective carotid
artery and radial artery pressure waveforms. Our data suggest that the one-
third rule to calculate MAP from brachial cu BP, which is advocated in stan-
dard clinical textbooks, should be avoided, especially when used to calibrate ra-
dial artery pressure waveforms for subsequent application of a pressure transfer
function. Until more precise estimation methods become available, it is advis-
able to use 40% of brachial pulse pressure instead of 33% to assess MAP.
In chapter 7, the determinants of a newly proposed stiness index, the Am-
bulatory Arterial Stiness Index (AASI) are explored using a numerical model
of the arterial circulation. Based on 24-hour ambulatory blood pressure record-
ings, the AASI is calculated as one minus the slope of the linear regression
line between systolic and diastolic blood pressure values and thus does not re-
quire the recording of a pressure, ow or diameter distension waveform. Al-
though appealing because of its simplicity, it does require 24-hour blood pres-
sure recordings and there is controversy as to which extent AASI reects arte-
rial stiness or is aected by other cardiovascular parameters. We assessed the
relative importance of ve parameters (arterial distensibility, peripheral resis-
tance, heart rate, cardiac contractility and venous lling pressure) on the AASI
by varying each parameter from 80 to 120% of its initial value in steps of 10%
to mimick the daily uctuations in one theoretical, normotensive subject. To
assess the ability of AASI to detect large changes in stiness, two additional
subjects were simulated with a distensibility of 50% and 25% of the default dis-
tensibility, respectively. From these simulations, it becomes clear that arterial
distensibility, vascular resistance and especially heart rate are the main deter-
minants of the AASI.e confounding eects of vascular resistance and heart
rate seriously limit the use of the AASI as a marker of stiness.
Part III: Validation and development of new devices
Along with the increased attention for the role of the large arteries in the de-
velopment of hypertension and concomitant cardiovascular diseases and es-
pecially since the ESC/ESH guidelines include the measurement of PWV for
the management of patients with hypertensive disease, the number of devices
to measure wave reections and arterial stiness has boosted. is third part
describes the validation studies that were performed on two relatively new de-
vices, as well as the development of a low-cost device for use in African settings.
Chapter 9 details the results of a numerical validation of the working princi-
ple of theArteriograph (Tensiomed, Budapest, Hungary), a device that claims to
assess aortic PWVbymeans of a simple brachial cu. Brachial blood pressure is
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measured during supra-systolic pressure ination of the cu, yielding pressure
waveforms with pronounced rst and secondary peaks. e secondary peak
is ascribed to a reection from the aortic bifurcation, and PWV is calculated
as the ratio of twice the jugulum-symphysis distance (∼ aortic root - bifurca-
tion) and the time dierence between the two peaks. To test the validity of this
working principle we used a numerical model of the arterial tree to simulate
pressures and ows in the normal conguration and in a conguration with an
occluded brachial artery. A pronounced secondary peak was indeed found in
the brachial pressure signal of the occluded model, but its timing was only re-
lated to brachial-axillary stiness and not to aortic stiness. Our data indicate
that the method picks up wave reection phenomena conned to the brachial
and axillary arteries, and derived values of PWV rather reect the stiness of
the brachial and axillary arteries than the intended aortic stiness. As such, our
simulations question the working principle of the Arteriograph.
Chapter 10 reports on the comparative measurements between the Omron
HEM-9000AI (Omron Healthcare, Kyoto, Japan) and SphygmoCor systems in
an attempt to validate the central systolic pressure (cSBP) estimate provided by
OmronHEM-9000AI.eOmronHEM-9000AI is the rst automated tonom-
eter to provide an estimate of cSBP, which is considered to bemore predictive of
cardiovascular events than the conventional brachial pressure. However, con-
siderable dierences between the cSBP-estimate of Omron and that of Sphyg-
moCor have been reported, but not explained.is study assesses the sources of
the dierences between both cSBP-estimates and provides a handle on which
estimate is closest to reality. For this purpose, aortic cSBP derived from cali-
brated carotid SBP was used as device- and algorithm-independent reference.
A total number of 143 black South Africans were measured with an Omron
HEM-9000AI (radial tonometry) and a SphygmoCor device (radial, brachial
and carotid tonometry). Each subject was measured with an Omron HEM-
9000AI and a SphygmoCor.ough the shape of the recorded radial pressure
waves was similar in both devices and the corresponding cSBP-estimates cor-
related strongly, the Omron-estimate was on average 18.8 mmHg higher than
the SphygmoCor-estimate. Aortic SBP was in between both estimates.e re-
sults from this study demonstrate that the considerable dierence between the
central pressure estimates of Omron HEM-9000AI and SphygmoCor is due to
algorithm dierences, and suggest that the overestimation by Omron HEM-
9000AI is larger than the underestimation by SphygmoCor.
e available devices to assess arterial stiness and wave reections are ex-
pensive, which may pose an obstacle for research in developing countries such
as most countries in sub-Saharan Africa. We therefore developed a low-cost
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device to acquire ow and pressure waveforms and hence derive PWV and lo-
cal blood pressure. e development and validation of the hardware and so-
ware of this Tono-Doppler device is outlined in chapter 11. e hardware is
assembled from commercially available components: ow recordings from two
handheld Doppler devices (Huntleigh Healthcare, Cardi, UK) and tonome-
try recordings from a micro-tip transducer (Millar Instruments, Texas, USA)
are digitized at 100Hz in a data-acquisition module (NI-9219, National Instru-
ments, Texas, USA). An ECG can be co-registered by a one-channel ECGmod-
ule (EG01000, Medlab GmbH, Karlsruhe, Germany).e device does not need
to be connected to the mains but is powered from a PC or laptop through USB-
connection. Based on existing code and algorithms developed in the frame-
work of the Asklepios study, a dedicated acquisition and processing interface
were developed in Matlab (MathWorks, Natick, Massachusetts, USA). Hard-
and soware were validated separately in a validation study on 11 healthy vol-
unteers.e total price of the Tono-Doppler device is <4000e.
Part IV: Arterial properties in people of African descent
e fourth part of thismanuscript focuses on the arterial properties of people of
African descent, who display a clearly dierent cardiovascular risk prole than
Caucasians.
Chapter 13 elaborates on this dierence in risk prole and the potential
mechanisms that may be at the origin of it. e literature on arterial proper-
ties of Africans is reviewed, with particular focus on the ethnic dierences in
mechanical properties of the large arteries.e stiness of the large elastic ar-
teries such as the aorta and carotid artery was consistently found to be higher in
African origin than in people of Caucasian origin. No such dierence has been
observed for more muscular arteries like the brachial artery, nor for elastic or
muscular arteries in subjects with type-2 diabetes or patients on hemodialysis.
From the literature review, it is apparent that most of the research on ethnic
dierences between Africans and Caucasians is performed on Africans living
inWestern countries such as the United States and the United Kingdom. Given
the increasing rates of cardiovascular disease in sub-Saharan Africa, more re-
search on Africans living in sub-Saharan Africa as a basis for policy and treat-
ment strategies is urgently needed.
Against this background, two studies were undertaken in Nigeria, the most
populous country in sub-Saharan Africa. Chapter 14 details the results of com-
parative study on the aortic stiness and arterial wave reections in 184 young
Nigerian women and 92 age-matched Belgian women. Mean levels as well as
determinants of PWV, augmentation index (AIx) and local pressure were com-
pared across ethnicity. No ethnic dierences in PWV and cSBP in young and
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middle aged womenwere observed, but we did nd a lower radial SBP and cen-
tral AIx in Nigerian as compared to Belgian women. e observed dierence
between carotid SBP and aortic SBP derived via the radial-to-aortic transfer
function in Nigerian women warrants the need for a specic validation of the
transfer function in people of African descent.
In a second study described in chapter 15, the aortic stiness of 264Nigerian
babies was asessed at the age of 0, 3 and 12 months in an attempt to track early
changes in arterial distensibility. As the number of babies measured at each
timepoint varied greatly, data are presented as a comparison of cross-sectional
measurements at the three timepoints and as three subsets of longitudinal data.
Both the cross-sectional and the longitudinal data report a signicant increase
in PWV from 0 to 3 months or 12 months. However, no correlation between
longitudinal PWV-data was found. Malaria episodes during pregnancy ap-
peared not to inuence the PWV during the rst year of life.
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Introduction
Relevance
Cardiovascular diseases (CVDs) are the leading cause of death inWestern coun-
tries.ere are dierent types ofCVDs, such as cerebrovascular disease (stroke),
coronary heart disease, elevated blood pressure (hypertension) and heart fail-
ure. Of these, hypertension plays a crucial role as it is both a type of CVD and
a major risk factor for the development of other types of CVDs.
It is now clear that the elasticity of the large, central arteries plays an im-
portant role in the development of hypertension.ese vessels form an elastic
buer, in which the blood volume is stored. e stier the large arteries, the
lesser the pulse pressure is damped. It is well established that a high pulse pres-
sure is directly related to an increased risk of CVD.erefore, the assessment
of arterial function and structure by means of the arterial stiness and wave
reections is of paramount importance in hypertension research.
InWestern countries, there is increasing evidence from large-scale epidemi-
ological studies that the assessment of arterial stiness has a strong predictive
value in predicting cardiovascular events, over and beyond traditional risk fac-
tors such as blood pressure, smoking, cholesterol and obesitas. erefore, the
assessment of arterial stiness and wave reections is now on the verge of being
introduced into clinical practice.
In developing countries, especially in sub-Saharan Africa, the prevalence
of CVDs is rapidly increasing and CVDs are expected to surpass infectious dis-
eases such as malaria and AIDS as the leading cause of death in the near fu-
ture. Furthermore, the cardiovascular risk prole of people of African descent
is clearly dierent from that of people of European descent. Although many
dierent hypotheses have been proposed, the reason for this dierence remains
largely unknown. Given the role of arterial stiness in the development of hy-
pertension and concomitant CVD, large artery research onAfricans is of partic-
ular interest as it may contribute to our understanding of the ethnic dierence
in cardiovascular risk prole.
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Aim
e aim of this thesis is twofold:
• to critically evaluate a number of newly emerged methods and devices
for the assessment of arterial stiness and wave reections.
• to facilitate large artery research in people of African descent and to per-
form a number of pilot studies in sub-Saharan Africa.
Structure
is dissertation is divided in ve main parts.
e rst part provides a general background on arterial physiology and
pathophysiology, as well as on the dierent methods to assess arterial stiness
and wave reections.e actual research is grouped in the three middle parts:
parts II and III bundle a number of studies on the validation anddevelopment of
new methods and devices to quantify arterial stiness and wave reections. In
the fourth part, this knowledge is applied to study the arterial properties in peo-
ple of African descent. Each part starts with a short outline, summarizing and
linking the dierent studies together. In the h part, the major conclusions
per study are restated and some perspectives for future research are discussed.
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Arterial physiology and
pathophysiology
1.1 The cardiovascular system
e cardiovascular system is a closed circulatory system comprised of the heart
and blood vessels.e heart consists of two atria (le and right) and two ven-
tricles (le and right) and can be viewed functionally as two pumps with the
pulmonary and systemic circulations situated in between (Figure 1.1). While
the pulmonary circulation carries blood to the lungs and back to the heart, the
systemic circulation provides all other parts of the human body with blood.
Contraction of the right ventricle pumps the blood into the pulmonary circu-
lation where oxygen and carbon dioxide are exchanged within the lung alveoli.
Oxygenated blood from the lungs enters into the le atrium, then into the le
ventricle, which pumps the blood into the aorta for distribution to the organs
via large distributing arteries. Smaller blood vessels within the organs and tis-
sues (primarily capillaries) serve as the primary site of nutrient exchange. Blood
leaves the organs and returns to the heart via the venous circulation.
e focus of this PhD dissertation is on the arteries of the systemic cir-
culation. e following references served as a basis for writing this chapter:
Anatomy of the Human Body[3], McDonald’s blood ow in arteries [4], Princi-
ples of vascular physiology [5] and Snapshots of Hemodynamics [6].
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Figure 1.1: Functional view of the cardiovascular system indicating the distribution of the car-
diac output in an average resting individual. [1, 2]
1.2 Arterial anatomy
During systole, the contracting le ventricle ejects blood into the aorta, the
largest artery of the human body. e aorta forms the trunk of the strongly
branched arterial tree. Upon its root, the aorta is about 3 cm in diameter. It
ascends for a short distance, arches backwards and to the le side to further
descend at the le side of the vertebral column. At around the fourth lumbar
vertebra, the aorta, only around 1.75 cm in diameter, ends by dividing into the
le and right common iliac arteries [3].
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Figure 1.2: Large arteries in the thorax, abdomen and upper limb [7].
Figure 1.3: Large arteries in the neck [8].
Figure 1.2 gives a simplied overview of the numerous large arteries that
branch from the aorta. Two coronary arteries branch from the ascending aorta
to supply the heart. ree larger arteries branch from the aortic arch: the in-
nominate, the le carotid and le subclavian artery.e largest of these three is
the innominate artery, which divides into the right common carotid and right
subclavian artery aer 4 to 5 cm. Figure 1.3 shows a detailed view of the le
and right common carotid arteries, supplying the head and the brain, and the
subclavian arteries, supplying the upper extremities. e subclavian artery is
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named axillary artery between the outer border of the rst rib and the armpit
(axilla), and further termed brachial artery between the armpit and the elbow.
Here the trunk ends by dividing into two branches: the radial and ulnar artery.
e descending aorta can be divided into a thoracic and abdominal part,
correspondingwith the two great cavities the aorta traverses. While the branches
from the thoracic aorta are rather small, supplying the bronchial tubes, the
oesophagus and the spinal column, the abdominal aorta has markedly larger
branches, the most important being the celiac artery, supplying the stomach,
pancreas and liver, the superior mesenteric artery, supplying the duodenum,
and the renal arteries, supplying the kidneys. From the aortic arch towards
the peripheral arteries, the vessel diameter decreases gradually, a phenomenon
called geometric tapering. Arteries with a diameter below 0.4 mm are called
arterioles, whereas capillaries are the smallest type of arteries with a diameter
of around 5 µm. Table 1.1 displays a number of structural characteristics for the
dierent types of arteries, such as the internal diameter, the wall thickness and
the total cross-sectional area.
Table 1.1: Structural characteristics of the vascular system[1]
Aorta Large arteries Arterioles Capillaries
Internal diameter 2.5 cm 0.4mm 30µm 5 µm
Wall thickness 2.0 mm 1.0 mm 20 µm 1 µm
Amount 1 160 5⋅107 1010
Total cross-sectional area 4.6 cm2 20 cm2 400 cm2 4500 cm2
ough the wall thickness and the relative content can dier among dier-
ent types of arteries, all arteries have a three-layered structure (gure 1.4):
• e tunica intima is the innermost layer and consists of three sublayers:
one single layer of endothelial cells, a subendothelial layer of supporting
connective tissue (collagen) and an elastic or fenestrated layer consisting
of a membrane of longitudinally oriented bers, the elastic lamina.
• e tunicamedia ormiddle layer consists of smoothmuscle cells (SMCs),
nerves and elastic tissue, arranged in lamellae in concentric circles around
the vessel wall.is layer accounts for most of the arterial wall thickness.
• e tunica adventitia or tunica externa is the outermost layer, mainly
composed of collagen and supported by external elastic lamina.e col-
lagen serves to anchor the blood vessel to nearby organs, giving it stabil-
ity.
A distinction is made between elastic and muscular large arteries. Elas-
tic arteries are the largest arteries close to the heart, such as the aorta and the
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Figure 1.4: Le: three-layered wall structure; Right: relative content of endothelium, elastic and
brous tissues and smooth muscle in dierent types of arteries, modied from [9].
carotid arteries. ey have a thick, highly developed medial layer composed
mainly of elastic lamellae, allowing them to distend maximally during systole
and thus act as a buer, temporarily storing blood which is brought into cir-
culation again when the arteries return to their original size. e eect of this
recoil is to maintain the pressure during the diastolic phase and to force the
blood pumped out of the le ventricle away from the heart, into the systemic
vascular system.e large elastic arteries gradually evolve into more muscular
arteries which have a media almost entirely composed of SMCs, making them
highly contractile.eir degree of contraction or relaxation is controlled by the
autonomic nervous system as well as by endothelium-derived vasoactive sub-
stances.
1.3 Arterial wall mechanics
1.3.1 Properties of arterial tissue
Due to their three-layered structure and the variety of proteins and cells in-
volved in the arterial wall, arteries behave as incompressible, anisotropic and
viscoelastic materials. At low strain levels, elastin dominates the composite
behavior, while at high strain levels, collagen becomes increasingly important.
is implies that themechanicalwall properties of an artery are pressure-dependent.
e stiness of a material can be expressed by Young’s modulus of elasticity (E),
7
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dened as the ratio of stress (σ) and strain (ε): E=σ/ε. For linear elastic mate-
rials, this relation is straight and a single Young modulus characterizes the ma-
terial.e stress-strain curve for arteries, however, as for most other biological
tissues, exhibits a curved shape, with its slope, the incremental elastic modulus
(Einc), increasing with strain.is indicates a progressive stiening of the arte-
rial wall with increasing stress and strain, and limits the strain at high stresses,
thus protecting against overstretch and damage. A typical value for the incre-
mental elastic modulus of arteries in the normal human is about 500 kPa [6].
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Figure 1.5: Stress-strain relation in the thoracic and abdominal aorta and denition of incre-
mental elastic modulus E inc [10]
Apart from the described non-linear elastic behavior, arterial tissue also
exhibits some viscoelastic characteristics when undergoing deformation. One
of these characteristics is the hysteresis curve that can be seen when record-
ing stress-strain curves in vivo.roughout the cardiac cycle, strain lags stress,
which leads to dissipation of mechanical energy. Altogether, the eects of vis-
coelasticity are small and are oen neglected in practice.
1.3.2 Forces acting on the arterial wall
ere are three types of stress acting on the arterial wall:
• Tensile, tangential or circumferential wall stress (σ) is the load on the ar-
terial wall caused by the transmural pressure gradient (p). Assuming the
ratio of the wall thickness (h) and the lumen radius (r) is small, tensile
stress can be calculated using Laplace’s law as pr/h. It is apparent that
this load increases with decreasing wall thickness and increasing radius,
which explains the danger of vascular dilatations such as aneurysms. In-
creased tensile stress can be compensated by wall thickening.
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• Shear stress is the frictional stress exerted by the blood ow on the wall.
It is determined by the magnitude and the shape of the velocity prole
near the wall as well as by the blood viscosity. Shear stress is about 10
000 times smaller than tensile wall stress, but its importance lies in its
eect on the endothelium, where it acts as a biomechanical stimulus.
• Arterial pressure causes a radial wall stress. e pressure uctuates be-
tween systolic (maximal) and diastolic (minimal) pressure and induces
ltration of uid through the vessel wall.
1.3.3 Vascular remodeling
Upon a change in the mechanical forces acting on the vessel (eg. due to hyper-
tension or a pressure gradient due to stenosis), the vessel wall has the ability to
re-establish an equilibrium, a process called vascular remodeling. Blood ves-
sels have hormonal mechanisms that enable them to remodel by modulation
of the vascular smooth muscle cells or endothelial cells to produce structural
modications. A distinction can be made between pressure- and ow-induced
remodeling.
Adaptation to changes in pressure. An increase in blood pressure causes the
tensile stress to rise, which is compensated by hypertrophy or thickening of the
arterial wall.
Adaptation to changes in ow. A change in blood ow (Q) has implications for
the endothelium, the thin cell layer at the interface of lumen and vessel wall, by
means of a change in shear stress. Because shear stress is proportional to Q/r3,
with r the vessel radius, an increase in ow can be compensated by a much
smaller increase in vessel radius (vasodilation). us, acute changes in blood
ow lead to vasodilation or vasoconstriction. Chronic or long term changes in
blood ow lead to structural remodeling of the vessel wall, by reorganization of
cellular and extracellular wall components [6].
Remodeling is fundamental for normal vessel growth and adaptation, as
it allows the vessel to maintain an optimal environment. However, when the
vascular environment changes drastically and/or permanently, the remodeling
process may contribute to disease progression.
9
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Pressure Flow
Figure 1.6: Pressure-induced (le) and ow-induced (right) remodeling [6] .
1.4 Arterial hemodynamics
1.4.1 Resistance
Figure 1.7: Factors inuencing blood ow through a tube [2].
When blood ows through an artery, there is a pressure drop along that
artery caused by the resistance of the artery to the ow as illustrated in gure
1.7. In the specic case of a circular, sti tube with a parabolic velocity prole,
the law of Hagen-Poiseuille describes the relation between pressure drop (∆P)
and blood ow (Q) under steady ow conditions as:
Q = ∆P r4
8ηl
(1.1)
with
r: inner radius of the tube [m]
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l : tube length [m]
η: dynamic viscosity [Pa.s]
In analogy to the electrical law of Ohm, where resistance equals voltage
drop over current, the resistance (R) of an arterial segment can be expressed
as the ratio of the pressure drop along that segment and the ow through the
segment under steady ow conditions:
R = ∆P
Q
(1.2)
Combining equations 1.1 and 1.2, the resistance for the uniform tube can be
calculated as
R = 8ηl
r4
(1.3)
Although this formula is not exactly applicable in the human body as not all
underlying conditions are met, it serves to illustrate the strong dependency of
resistance on arterial wall radius, and, to a lesser degree, the inuence of the
vessel length and blood viscosity. Equation 1.2, also called Ohm’s law, is more
general and can be used in practice. Application of Ohm’s law to the arterial tree
allows to deduce which type of arteries has the largest resistance, as elegantly
explained by Westerhof [6]:
"Again using the electrical analogy, the total resistance (Rtot) of two vessels (R1
and R2) in parallel is 11/R1+1/R2 , while two resistances in series result in a total re-
sistance equal to the sum of the resistances. Using equation (1.3), the resistance
of an arteriole can be compared to that of the aorta. Assuming an aortic radius
of 15 mm and an arteriole with a radius of 7.5 µm and a length of 1 mm, the re-
sistance of a single arteriole is 3.2 ⋅ 1010 larger than that of a 50 cm long aorta.
However, there is only one aorta and there are about 3 ⋅ 108 arterioles, which can
be considered as parallel to each other. erefore, the total arteriolar resistance
is 3.2⋅10103⋅108 ≈ 100 times larger than the aortic resistance. Capillaries have diameters
of the same order as arterioles, but there are approximately 4 to 5 capillaries per
arteriole, reducing their total resistance with a factor 4 to 5."
Figure 1.8 also illustrates that the vascular resistance is almost exclusively
determined by the small arteries and arterioles. ese are muscular arteries
that can regulate the resistance within a wide range by limited changes in di-
ameter. Compared to the resistance of the arterioles, the resistance of the aorta
and other large arteries is so low that the mean arterial pressure is practically
the same along the large arteries.e large arteries can therefore be interpreted
as a supply reservoir with the peripheral resistances (arterioles) adjusting them-
selves so that the demand of ow to the tissue is met.
11
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Figure 1.8:e upper panel displays the change in mean pressure and in pulsatile pressure be-
tween the ascending aorta and venous circulation. Mean and pulse pressure fall over a short
length in the smallest arteries and in the arterioles as a result of the high resistance to blood ow
that these vessels present, as illustrated in the lower panel. [11].
When equation 1.2 is applied over the entire systemic circulation, we get:
Pa = Rperiph ⋅ CO + Pv (1.4)
with
• Pa the mean arterial pressure [Pa]
• Rperiph the total peripheral resistance [Pa ⋅s/m3]
• CO the cardiac output [m3/s]
• Pv the mean venous pressure [Pa]
Since venous pressure is close to zero, the mean arterial pressure is determined
by two main factors: the total peripheral resistance and the cardiac output.
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1.4.2 Compliance
When the pressure increases, the artery distends.e change in volume (V ) is
related to the change in pressure (P) by means of the arterial compliance (C).
For arteries, the pressure-volume relation is not straight, as can be seen in gure
1.9. For a small change (∆) around a chosen working point, compliance can be
determined as the local slope of the curve:
C = ∆V
∆P
. (1.5)
e inverse of compliance is the elastance: E = ∆P/∆V .
Compliance strongly depends on the chosen working point. us, when
reporting compliance data one should report the pressure at which the compli-
ance was determined. When comparing arteries of a dierent size, compliance
should be normalised with respect to the arterial volume: C/V = (∆V/V)/∆P,
called distensibility.
It is important to note that compliance is a structural property depending
on the arterial geometry, as opposed to material properties such as the Young
modulus. is is illustrated by the fact that an artery and a vein of about the
same size have a similar Young modulus, as venous and arterial walls are com-
posed of the same materials, yet a large dierence in compliance is observed.
Veins have a far smaller wall thickness making them more compliant than ar-
teries [6].
1.4.3 Inertance
As illustrated in gure 1.10, during the early ejection phase, the le ventricular
pressure is higher than the aortic pressure and the blood is accelerated into the
aorta. In the late ejection phase, the aortic pressure becomes higher than the
ventricular pressure, causing a deceleration of blood.
In this acceleration/deceleration process, the bloodmass and the aortic geome-
try play a role.is is represented by the inertance (L), which can be calculated
as
L = ρl
A
, (1.6)
with
• ρ the blood density [1015 kg/m3]
• l the vessel length [m]
• A the cross-sectional vessel area [m2].
13
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Figure 1.9: Denition of compliance (C) and elastance (E).
Figure 1.10: Inertance plays a role in accelerating and decelerating the blood: in early systole,
when le ventricular pressure is higher than aortic pressure, the blood accelerates and the ow
increases; in late systole, aortic pressure is higher than ventricular pressure and the blood velocity
decreases. [6].
Inertance links the oscillatory pressure dropwith the rate of change of blood
ow:
∆P = LdQ
dt
(1.7)
e dependence on 1/r2 (via 1/A) implies that inertance plays a larger role than
resistance (∼ 1/r4) in the large arteries, while the opposite holds for smaller
arteries and arterioles.
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1.4.4 Impedance
Vascular impedance (Z) can be considered a more general hemodynamic pa-
rameter, integrating resistance, compliance and inertance.
Assuming the arterial system to be linear and in steady state oscillation, the
pressure and ow wave can be decomposed into a series of sinusoidal signals
(harmonics) using Fourier analysis.e zeroth harmonic represents the steady
state pressure (ow), while the frequency of the n-th harmonic is n times the
heart rate frequency. Impedance is dened in the frequency domain as the ratio
of pulsatile pressure and ow:
Z = P
Q
(1.8)
and is expressed as a modulus and a phase per harmonic.
e three basic hemodynamic elements, resistance, compliance and iner-
tance, can also be represented in the frequency domain as impedances with a
modulus and a phase.e relation between the pressure drop over the element
and the ow through the element determines its impedance. For resistance, the
pressure drop and ow are in phase and their amplitude ratio gives the value
of the resistance. For compliance, the ow wave precedes the pressure drop,
whereas the opposite holds for the inertance, as illustrated in gure 1.11 [6]. To-
gether, these three basic elements can describe all pressure-ow relations of the
arterial system when placed in parallel or series combination (see 1.5.1).
When impedance is measured at the aortic root, it is called ’input’ imped-
ance (Zin) and fully characterizes the systemic arterial circulation. Figure 1.12
gives a typical example of a systemic input impedance and the information that
can be drawn from it. e total vascular resistance appears as the modulus of
the zeroth harmonic. Indeed, total vascular resistance is dened as the ratio of
steady state pressure and ow.e contribution of the compliant large arteries
is dominant in the rst harmonics, causing a decrease in modulus and phase of
Zin. For higher harmonics, themodulus oscillates around a constant value, also
called the characteristic impedance (Zc). Zc can be interpreted as the imped-
ance in the absence of wave reections and becomes a real number for higher
harmonics, which can be obtained as:
Zc = ρcA (1.9)
with c the wave speed [m/s] and ρ and A the blood density and cross-sectional
vessel area as previously dened. In practice, Zc is estimated as the average
modulus of the high frequency harmonics, typically from the 4th to the 10th
harmonic.
15
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Figure 1.11: Frequency domain representation of vascular resistance, compliance and inertance
[6].
1.5 Models of the arterial circulation
A good model approximates and simplies reality by identifying those factors
that are most relevant, and omitting the less relevant factors. Models of the ar-
terial circulation allow us to simulate the eect of a given physiologic change on
the arterial system and thus aid in gaining a better understanding of its behav-
ior.ere are two main, well established types of models of the arterial system:
(i) lumped parameter ’Windkessel’ models in which a number of discrete ele-
ments model the dierent properties of the arterial tree and (ii) transmission
line/propagative models in which the arterial tree is viewed as a wave system
where forward waves travel away from the heart and backward waves reect at
dierent reection sites along the arterial tree.
1.5.1 Windkessel models
Derived from the German word for air chamber, Windkessel models originate
from the analogy between the buering function of the large arteries and the
working principle of a re engine, in which a windkessel blunts the intermittent
ow of the pump to provide a more steady outow of water at the re hose.
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Figure 1.12:e input impedance fully characterizes the systemic arterial circulation [6].
Figure 1.13 gives an overview of the dierent Windkessel models, which can be
expressed in hydraulic and electric representations.
In its simplest form, a Windkessel model contains two elements: the total
arterial resistance and the total arterial compliance [12]. As described earlier
(1.4.1), the total arterial resistance is mainly determined by the smaller arter-
ies and arterioles, while the total arterial compliance is mainly determined by
the large elastic arteries. During diastole, the pressure drop follows an expo-
nential decay: P(t) = Poe−1/RC . When comparing the input impedance of the
2-element Windkessel model with the input impedance of the arterial system
(gure 1.14), it is clear that the model still diers substantially from the in vivo
circulation, especially at higher frequencies. To improve the high-frequency be-
havior, a 3-element Windkessel model was introduced by Westerhof by adding
the characteristic impedance of the aorta in series to the 2-element Windkessel
model [13]. Although this model mimics the in vivo input impedance quite
well, it overestimates Zin in the lower frequencies.erefore, Stergiopulos et al.
[14] proposed the four-elementWindkessel model with an inertance (L) in par-
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Figure 1.13: Hydraulic and electric representations of the two-element (top), three-element
(middle), and four-element (bottom) Windkessel models. R: total peripheral resistance, C: to-
tal arterial compliance, Zc : aortic characteristic impedance, L: arterial inertance P(t): potential
dierence (pressure) generated by the heart, I: current (ow) [2].
allel with the characteristic impedance. For lower frequencies, Zc is bypassed
through this inertance.
1.5.2 Propagative models
In a propagative or transmission line model of the arterial tree, the observed
pressure and ow waveforms are viewed as the resultant of forward and back-
ward travelling waves. Upon contraction of the le ventricle, pressure and ow
waves are generated travelling away from the heart into the arterial tree. At ev-
ery change in impedance, reections occur, causing backward waves propagat-
ing towards the heart.e shape of the resulting pressure and ow waveforms
at any location in the arterial tree is determined by the magnitude and the tim-
ing of the forward and backward travelling waves.e time at which reections
arrive at a location depends on the distance to the reection sites and the wave
speed.is wave speed, the pulse wave velocity (PWV), is considerably higher
(5-15 m/s) than the blood ow velocity (≈ 1 m/s) and is directly related to the
18
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Chapter 6
of the two-element Windkessel. Wetterer17 even showed the quantitative diEerence between 
measured and predicted pressure in systole, but he did not suggest what the determinant of 
this pressure diEerence is.
With measurement of aortic Fow together with the developments in computing capabili-
ties that allowed for Fourier analysis of the pressure and Fow signals, the calculation of input 
impedance became possible.14,18-20 From the input impedance, the shortcomings of the two-ele-
ment Windkessel also became clear, because for high frequencies its modulus reduces to neg-
ligible values and its phase angle reaches minus 90 degrees, while the aortic input impedance 
derived in mammals showed that the impedance modulus decreases to a plateau value and the 
phase angle hovers around zero for high frequencies (Figure 6.4). <e rather constant level of 
the input impedance modulus at higher frequencies was found to be equal to the characteristic 
impedance of the proximal aorta. <is information led to the addition of aortic characteristic 
impedance to the two-element Windkessel (Figure 6.5). <e characteristic impedance in the 
three-element Windkessel,2,6 can be seen as a link between the lumped Windkessel model and 
wave travel aspects of the arterial system since characteristic impedance equals wave speed 
times blood density divided by (aortic) cr ss-sectional area. 
<e oscillations seen on the impedance modulus and phase are not represented by the three-
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Figure 6.3 The decay of aortic pressure in diastole can be approximated by an exponential curve, characterized by the 
product of peripheral resistance R and total arterial compliance C: the RC-time. The RC-time is a characterisation of 
the arterial system, the heart period T is a characterisation of the heart. 
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Figure 6.4 An example of measured aortic input impedance plotted together with impedances predicted by the two-, 
three- and the four-element Windkessel. (Adapted from Westerhof et al.20) Figure 1.14: Aortic input impedance plotted with impedance predicted from a two-, three- and
four-element Windkessel model [15].
elasticity of the vessels via the Moens-Korteweg equation:
PWV = ¿ÁÁÀhEinc
ρD
(1.10)
with
• h the wall thickness
• Einc the incremental elastic modulus
• ρ the blood density
• D the lumen diameter
eBramwell-Hill equation relates pulsewave velocity to compliance (dV/dP)
or the area distensibility (DA = dA/A/dP):
PWV = ¿ÁÁÀVdP
ρdV
= ¿ÁÁÀAdP
ρdA
= √ 1
ρDA
. (1.11)
e location of the wave reections has been a point of debate for a long
time. Several researchers tried to identify one or more distinct reection points
[16–18]. Locations such as the aorta-iliac bifurcation, a major discontinuity,
19
1. Arterial physiology and pathophysiology
and the arteriolar bed, with a multitude of bifurcations over a short distance,
certainly form major zones of reections. However, as wave reections occur
at each change of impedance, the continuous change in diameter (geometric
tapering) and elastic properties of the arterial tree causes continuous wave re-
ections, making it practically impossible to identify all the dierent reection
sites.
To quantify the amount of wave reection, the complex phenomenon of
scattered wave reection is simplied. Westerhof et al. proposed to consider
the arterial system as a single viscoelastic tube, in which the pressure and ow
wave are seen as the superposition of a single forward and a single backward
wave[19]. e forward and backward waves are the integrated representation
of all incident and reected travelling waves.is approach is called wave sep-
aration analysis and is performed in the frequency domain. As an alternative
approach, Parker and Jones introduced the wave intensity analysis, in which
wave reections are studied in the time domain. Both approaches are discussed
in further detail in section 2.4.
Time
Pr
es
su
re
Figure 1.15: Separation of ameasured pressure (black) into its forward (blue) and backward (red)
components [2].
e propagative model is able to explain some phenomena that can not be
explained based on theWindkessel models, such as the shape dierences in the
pressure waveform at dierent locations. When comparing the pressure wave-
form at the ascending aorta with the pressure waveform at the femoral artery as
displayed in gure 1.16 for a young subject, it is clear that the femoral waveform
is more peaked and has a higher systolic pressure than the pressure waveform
at the ascending aorta.is can be explained by noting that the femoral artery
is closer to the main reection sites than the ascending aorta. Whereas the re-
ected waves arrive at the femoral artery during the systolic phase, thus boost-
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ing systolic pressure, the reections at the ascending aorta arrive later, gener-
ally during the diastolic phase. In general, wave reections cause the pressure
waveform to be increasingly peaked when moving away from the heart. is
phenomenon is called pulse pressure amplication.
Pressure amplification in the arterial tree 
Liang et al. Biomechanical characterization of ventricular–arterial coupling during aging:A 
multi-scale model study. J Biomechanics 2009 
Simulation - 25 year old Simulation - 85 year old 
Figure 1.16: Snapshots of pressure wave variation along the arterial tree at the age of 25, obtained
from a numerical model of the cardiovascular system. [20].
Since blood pressure is usually assessed at the brachial artery, it is important
to keep in mind that brachial systolic (SBP) and diastolic blood pressure (DBP)
dier from aortic SBP andDBP as a result of the pressure amplication between
the aorta and the brachial artery. Ideally, the reected waves arrive at the heart
just as the aortic valve closes. Such timing ensures that the reected wave does
not add to the le ventricular pressure load, but boosts pressure during dias-
tole to enhance coronary perfusion. However, in general, the aortic stiness
increases with age, leading to a higher wave speed (via 1.11) and an earlier re-
turn of the reected wave, causing a boost in systolic aortic pressure and le
ventricular aerload and a decrease in pulse pressure amplication.
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1.6 Pathophysiology
1.6.1 Cardiovascular disease
Cardiovascular diseases (CVDs) are themain cause of deathworldwide, with an
estimated 17.1 million worldwide deaths in 2004, representing 29% of all global
deaths [21]. A distinction is made between coronary heart disease (myocardial
infarction), cerebrovascular disease (stroke), elevated blood pressure (hyper-
tension), peripheral artery disease, rheumatic heart disease, congenital heart
disease and heart failure. Of these, coronary heart disease and stroke are the
most frequent pathologies, with an estimated 7.2 million and 5.7 million deaths
per year, respectively. Apart from the congenital pathologies, the underlying
cause of most types of cardiovascular disease is atherosclerosis, a gradually de-
veloping process in which cholesterol, fat and brous tissue build up in the ar-
terial wall.e pathogenesis of atherosclerosis will be discussed in more detail
in section 1.6.3.
1.6.2 Risk factors
Based on the outcome of large-scale population studies, a number of risk factors
for the development of CVD have been identied [21, 22]. Approximately 75%
of all CVD can be attributed to these risk factors [23], which are classied into
modiable and non-modiable factors.
e most important non-modiable risk factors are:
• Age - A vast majority of people suering from CVDs is 65 years or older.
erefore, age is recognized as an important risk factor for the devel-
opment of cardiovascular disease.roughout life, the blood vessels un-
dergo drastic structural changes.is process is called vascular aging and
is described in more detail in 1.6.4. Together with normal vascular aging,
a number of gradually evolving long-term processes such as atheroscle-
rosis (see 1.6.3) are at the root of the excess burden of CVDs at older age.
• Gender - In general, women are considered to be more protected from
CVD until reaching menopause [23]. Although the overall mortality and
morbidity of men and women is comparable, specic dierences exist
in the disease prole per gender. Men have a higher risk of myocardial
infarction than women [22, 23], while stroke is markedly more common
in women [24].
• Heredity - Children of parents with a history of CVD are at higher risk to
develop CVD themselves [23].is also holds for non-congenital CVD.
Apart from a family history of CVD, ethnicity also aects the cardio-
vascular risk prole. African Americans for example have more severe
hypertension than Caucasians and a higher risk of heart disease [22].
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Among the keymodiable risk factors are:
• Cholesterol -Mainly produced in the liver, cholesterol is an essential struc-
tural component of cell membranes which plays a role in the production
of bile acids, steroid hormones, and vitaminD. Cholesterol is transported
via the blood by lipoproteins. Two main types of lipoproteins can be
discriminated: high-density (HDL) and low-density (LDL) lipoproteins.
While HDL is responsible for the transport of excess cholesterol from
the cells to the liver and acts anti-atherogenic, LDL is partially ingested
by macrophages and foam cells in the vessel wall, potentially leading to
atherosclerosis.erefore, high concentrations of LDL and an imbalance
between LDL and HDL are risk factors for the development of CVD. A
total cholesterol/HDL-cholesterol ratio more than 5 indicates increased
risk [25].
• Tobacco - Smoking promotes the development of CVD through a num-
ber of mechanisms. It damages the endothelium, increases fatty deposits
in the arteries, increases clotting, raises LDL-cholesterol, reduces HDL-
cholesterol and promotes coronary artery spasm. Nicotine, the addictive
component of tobacco, accelerates the heart rate and raises blood pres-
sure. Smokers have a two- to fourfold risk of developing coronary heart
disease compared to non-smokers. Smoking is a powerful independent
risk factor for sudden cardiac death in patients with coronary heart dis-
ease [8, 22].
• Hypertension - Hypertension is the single most important risk factor for
stroke [26] andmarkedly increases the risk ofmyocardial infarction, kid-
ney failure and congestive heart failure.e number of people suering
from hypertension worldwide is estimated at more than 970million [27].
e role of hypertension is special in the sense that it is considered both
a type of CVD and a risk factor for the development of other CVD types.
e pathogenesis and classication of hypertension are discussed in 1.6.5.
• Physical inactivity - Physical activity, at any age, protects against a multi-
tude of chronic health problems including all types of CVD. Evenmoder-
ate levels of daily exercise are benecial for the blood pressure, blood lipid
levels, blood glucose levels, blood clotting factors and the level of vascu-
lar stiness. However, the increasing degree of urbanization and mecha-
nization worldwide has reduced our levels of physical activity.eWorld
Health Organization estimates that more than 60% of the global popu-
lation is not suciently active, exposing those without sucient daily
physical activity to an increased risk of coronary heart disease and stroke
of up to 50% [23].
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• Obesity - People with excess body fat - especially at the waist - are more
likely to develop heart disease and stroke even in the absence of other
risk factors. Excess weight increases the cardiac load and promotes the
development of diabetes. It also raises blood pressure and triglyceride
levels, and lowers HDL-cholesterol levels.
• Diabetes mellitus - Diabetes mellitus is a metabolic disease characterized
by high blood sugar levels which can be classied into twomajor groups.
Type-1 diabetes is characterized by a reduction or total absence of en-
dogenous insulin production, whereas type-2 diabetes is mainly caused
by insulin resistance, which causes the cells not to respond to the pro-
duced insulin. People with diabetes develop atherosclerosis at a younger
age and more severely than people without diabetes. In type-1 diabetics,
a two- to three-fold increase in risk of developing CVD is reported.is
risk is almost entirely conned to those patients that develop renal dis-
ease [28]. In type-2 diabetes, all patients are at increased CVD risk, with
women at markedly higher risk than men [25]. About three-quarters of
people with diabetes die of CVD [22].
Although dierent risk factors can be interrelated, the risk of developing
CVD increases with a subject’s number of risk factors. In an attempt to quan-
tify the overall risk of CVD, several integrated risk scores have been proposed.
Categorisation of total CVD risk as low, moderate, high or very high has the
merit of simplicity and can therefore be recommended [26]. Based on 12 Eu-
ropean cohort studies, the European Society of Cardiology introduced a risk
chart called SCORE (Systematic COronary Risk Evaluation) which allows an
estimation of the risk of cardiovascular death within a period of 10 years [25].
A distinction is made between countries with high CVD risk (including most
Eastern-European countries) and countries with low CVD risk, including Bel-
gium.e 2007 SCORE chart for countries with low CVD risk is shown in g-
ure 1.17. Another commonly used index is the Framingham risk score, which
expresses the risk of developing coronary heart disease within the next 10 years.
It is derived from the Framingham Heart Study, a long ongoing cardiovascular
study in the US with over 5000 subjects which now includes the third genera-
tion of participants.
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Figure 1.17: Score chart: 10-year risk of fatal cardiovascular disease in populations at low CVD
risk based on age, gender, smoking, systolic blood pressure and total cholesterol/HDL cholesterol
ratio. CVD: cardiovascular disease, HDL: high-density lipoprotein. [25].
1.6.3 Atherosclerosis
Atherosclerosis is a complex and slowly developing process that starts early in
life [29, 30] and gradually develops, as illustrated in gure 1.18. Over time, the
endothelial function deteriorates, allowing cholesterol rich low-density lipopro-
teins (LDLs) to enter the arterial intimal layer from the blood stream. is
causes a chronic inammatory reaction in the arterial wall, which in some loca-
tions leads to the formation of a plaque: a large core of necrotic and lipid tissue,
covered by a brous cap.
In a vast majority of cases, the brous cap is strong enough to withstand
the stress. In these cases, the plaque remains asymptomatic and stable, and
hencemost oen unnoticed. Vulnerable plaques, however, are prone to rupture,
which can be a life-threatening event if it is followed by thrombosis [30]. In
mechanical terms, plaque rupture occurswhen the imposed stress on the plaque
exceeds its strength.
For the coronary arteries, a vast majority of the sudden deaths results from
plaque rupture followed by thrombosis. In a minority of cases, fatal thrombosis
25
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Figure 1.18: Pathogenesis of atherosclerosis.
results from a supercial erosion of the endothelial layer overlying the plaque.
Plaque erosion is more common in young victims, in smokers and in women
[31–33].
Extensive data conrm that most of the acute infarcts are associated with
non-stenotic lesions [33–37]. In this regard, it is important to highlight the role
of arterial wall remodeling: the artery responds to plaque growth by increasing
its cross-sectional area while retaining suciently large lumen dimensions [38,
39]. An immediate consequence is that these plaques do not cause chest pain
and can therefore be regarded as silent killers.
1.6.4 Aging
It is debatable whether aging should be considered a pathologic process. Al-
though oen associated with atherosclerosis, the increase in stiness as noted
in normal aging is a clearly dierent process than atherosclerosis. Atheroscle-
rosis is predominantly a disease of the arterial intima and is localized to specic
sites in the large arteries. Arterial changes observed in normal aging are diuse
and predominantly aect the arterial media [4]. It is important to note that ar-
terial aging does not simply develop in the elderly but is a gradually developing
long-term process starting at young age.
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roughout the course of life, the systemic large arteries undergo pronounced
structural changes. Arterial aging phenomena include intimal hyperplasia, cal-
cium deposition, increased collagen content, and, most importantly, progres-
sive thinning and disorganization of the media, with loss of the structural ar-
rangement of elastin bers and laminae. A logical explanation for this arterial
degeneration arises from the application of the principle of material fatigue to
the arterial wall. Aer long-term exposure to cyclic stretch, the elastin can-
not be re-synthesized quickly enough, and is gradually replaced with collagen
[4]. As a consequence, arteries progressively stien with age.e higher pulse
pressure caused by this increase in stiness may in turn cause extra wear of the
vessel wall resulting in more breakdown of elastin.
Comparison between seated and supine hemodynamics.
Values for seated AIx and PP amplification were signifi-
cantly higher than supine values (AIx, 8  14% vs. 7 
16%, p  0.001; PP amplification, 1.59  0.21 vs. 1.55 
0.21; p  0.001). These differences disappeared, however,
when the data were corrected for the postural-induced
changes in MAP and HR (p  0.32, and p  0.19,
respectively).
DISCUSSION
Although age is one of the most important determinants of
cardiovascular risk, large artery stiffness is also a key inde-
pendent predictor of cardiovascular mortality (4–8). A
number of indexes, including aortic PWV and AIx, can now
be easily assessed non-invasively and have been included in
several outcome studies. The aim of the current study was to
determine the effect of aging on these indexes in a large
cohort of healthy, normotensive individuals. Our main
novel findings were that the age-related changes in central
AIx and aortic PWV follow different patterns. Changes in
AIx were more prominent in younger individuals (50
years), whereas the changes in aortic PWV were more
marked in older individuals (50 years). In addition, we
confirmed previous observations of a widening of peripheral
PP after the age of 50 years, but extended this to show for
the first time that central PP rises linearly with age. Overall,
these data suggest that central AIx might be a more sensitive
marker of arterial aging in younger individuals, and aortic
PWV more sensitive in those over 50 years of age.
Several previous studies have highlighted the positive
association between age and central AIx, which is often
considered to be linear (22). Mitchell et al. (12) recently
questioned this view, reporting that AIx changes less with
age in older individuals and actually declines after the age of
60 years. In the present study, the relationship between age
and AIx was clearly non-linear, with a greater age-related
effect in younger individuals, supporting the findings of
Mitchell et al. (12) and suggesting that AIx might be a more
sensitive marker of arterial aging in younger individuals.
Indeed, previous data demonstrate that low birth weight is
associated with increased AIx in adolescents (23); however,
we found no evidence of a decline after the age of 60, rather,
Figure 1. Blood pressure averaged for deciles of age for males (left) and females (right). Symbols represent peripheral systolic (closed triangles), central
systolic (open triangles), and diastolic (closed squares) blood pressures.
Figure 2. Regression curves representing the effect of age on parameters of
arterial stiffness and wave reflection for males (circles, solid lines) and
females (squares, dashed lines). Panel A represents augmentation pressure
(open circles/open squares) and augmentation index (closed circles/
closed squares). Panel B represents aortic pulse wave velocity. Data points
are the group means for each decile of age. The estimated functions for
these relationships appear in Table 2.
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Figure 1.19: Evolution of brachial systolic blood pressure (closed triangles), brachial diastolic
blood pressure (closed squares) and central systolic blood pressure (open triangles) with age.
Mean value ± standard deviation are shown for each decile of age. [40].
Figure 1.19 shows the evolution of brachial SBP and DBP with age in the
general population. While SBP rises steadilywith age, theDBP reaches a plateau
level between the h and the sixth decade anddecreases progressively at higher
age.e increase in pulse pressure (PP) can be explained by an increase in ar-
terial stiness. During a lifetime, aortic wave speed increases by about a factor
two, equalling a decrease in aortic complianc by a factor four (via quation
1.11). Apart from stiening, the a rta and the central elastic r eries also di-
late and become tortuous. Inter stingly, these structural ch ges are virtually
conned to the aorta nd the central elastic arteries. Unlike the large elastic
arteries, no gradual decrease was reported in the distensibility [41, 42] or the
PWV [43, 44] of the fe oral, radial or brachial arteries with age.
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1.6.5 Hypertension
Hypertension mostly occurs as a result of an increase in peripheral resistance
and/or an increased level of central arterial stiness. e inital cause of this
increase in either resistance or stiness is oen unclear, as illustrated by the
fact that essential hypertension, or hypertension of unknown cause, represents
90% of all cases of hypertension [45].ere is, however, a multitude of factors
that have been shown to contribute to the pathogenesis of hypertension. Some
of these factors are long-term high sodium intake, diabetes mellitus, increased
sympathetic nervous system activity and obesity, but also structural and func-
tional factors such as endothelial dysfunction, increased oxidative stress and
vascular remodeling.
Whereas an isolated increase in peripheral resistance causes SBP and DBP
to rise equally, elevated stiness is associated with an increase in pulse pressure
and SBP. Given the progressive stiening of arteries at higher pressure, hyper-
tension automatically leads to higher levels of stiness.e increase in stiness
implies an increase in PWV and aortic impedance, which causes the amplitude
of the incident wave to increase and the reected pressure wave to arrive earlier,
thus boosting systolic pressure and aggravating the level of hypertension. Note
that an alternative reasoning, based on the windkessel model, leads to a similar
conclusion.
When hypertension is sustained, the cardiac load and the stress on the large
arteries are increased and cardiovascular degeneration is accelerated. ere-
fore, the eect of hypertension on the arterial system has many similarities to
the aging process and can be regarded as a type of accelerated aging.e eects
of hypertension on the more muscular arteries dier from those on the elas-
tic arteries and include intimal hyperplasia, accelerated atherosclerosis [46, 47]
and impaired endothelial function [48–50].
Although hypertension itself is recognised as a type of CVD, it also leads to
a variety of other cardiovascular events, such as stroke [51] and le ventricular
hypertrophy [52]. erefore, strict follow-up of the blood pressure of those at
risk is of paramount importance. e crucial role of hypertension in the esti-
mation of a subject’s cardiovascular risk is illustrated in the latest guidelines of
the European Society of Hypertension (ESH), where blood pressure gures as
a separate marker, while all other risk factors are pooled, as illustrated in gure
1.20). Because clinical evidence shows a continuous relationship between blood
pressure and cardiovascular risk, any denition of hypertension is largely arbi-
trary [53]. In todays clinical practice, hypertension is dened based on brachial
blood pressure values. According to the current guidelines [26], a subject is
hypertensive if the brachial SBP exceeds 140 mmHg or the brachial DBP ex-
ceeds 90 mmHg. Hypertension is further classied in three categories (grades
1, 2 and 3), while the blood pressure of normotensives can be normal or high
normal (see gure 1.20).
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individual. This is further illustrated in section 2.3 and in
Fig. 1.
2.3 Total cardiovascular risk (Box 1)
2.3.1 Concept
For a long time, hypertension guidelines focused on
blood pressure values as the only or main variables
determining the need and the type of treatment.
Although this approach was maintained in the 2003
JNC 7 Guidelines [30], the 2003 ESH-ESC Guidelines
[3] emphasized that diagnosis and management of
hypertension should be related to quantification of total
(or global) cardiovascular risk. This concept is based on
the fact that only a small fraction of the hypertensive
population has an elevation of blood pressure alone, with
the great majority exhibiting additional cardiovascular
risk factors [35–39], with a relationship between the
severity of the blood pressure elevation and that of
alterations in glucose and lipid metabolism [40]. Further-
more, when concomitantly present, blood pressure and
metabolic risk factors potentiate each other, leading to a
total cardiovascular risk which is greater than the sum of
its individual components [35,41,42]. Finally, evidence is
available that in high risk individuals thresholds and goals
for antihypertensive treatment, as well as other treatment
strategies, should be different from those to be imple-
mented in lower risk individuals [3]. In order to maximize
cost-efficacy of the management of hypertension the
intensity of the therapeutic approach should be graded
as a function of total cardiovascular risk [43,44].
2.3.2 Assessment
Estimation of total cardiovascular risk is simple in
particular subgroups of patients such as those with 1) a
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Box 1 Position statement: Total cardiovascular
risk
# Dysmetabolic risk factors and subclinical organ
damage are common in hypertensive patients.
# All patients should be classified not only in relation
to the grades of hypertension but also in terms of
the total cardiovascular risk resulting from the
coexistence of different risk factors, organ damage
and disease.
# Decisions on treatment strategies (initiation of
drug treatment, BP threshold and target for treat-
ment, use of combination treatment, need of a
statin and other non-antihypertensive drugs) all
importantly depend on the initial level of risk.
# There are several methods by which total cardio-
vascular risk can be assessed, all with advantages
and limitations. Categorization of total risk as low,
moderate, high, and very high added risk has the
merit of simplicity and can therefore be recom-
mended. The term ‘added risk’ refers to the risk
additional to the average one.
# Total risk is usually expressed as the absolute risk of
having a cardiovascular event within 10 years.
Because of its heavy dependence on age, in young
patients absolute total cardiovascular risk canbe low
even in the presence of high BPwith additional risk
factors. If insufficiently treated, however, this con-
dition may lead to a partly irreversible high risk
condition years later. In younger subjects treatment
decisions should better be guided by quantification
of relative risk, i.e. the increase in risk in relation to
average risk in the population.
Figure 1.20: Stratication of CV risk according to the 2007 ESC/ESH guidelines. SBP: systolic
blood pressure, DBP: diastolic blood pressure, CV: cardiovascular, HT: hypertension. OD: sub-
clinical organ damage, MS: metabolic syndrome. Low, moderate, high, and very high risk refer
to 10 year risk of a CV fatal or non-fatal event. e term ‘added’ indicates that in all categories
risk is greater than average.e dashed line indicates how the denition of hypertension may be
variable, depending on the level of total CV risk [26].
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Non-invasive assessment of wave
reflection and arterial stiffness:
overview of existingmethods,
devices and associated parameters
2.1 Introduction
Research on hypertension, the most important risk factor for CVD, has been
extensive for many decades. Until about 15 years ago, the focus of research and
treatment was on peripheral resistance as the main cause of hypertension [10].
More recently, increased emphasis has been given to elevated systolic and pulse
pressure, considered to be primarily caused by an increase in arterial stiness
and wave reections [54]. As a result, arterial stiness and wave reections are
being increasingly used in the clinical assessment of patients with hyperten-
sion and various CV risk factors [55]. e aim of this chapter is to summarize
the various methods that have emerged to quantify arterial stiness and wave
reections. As most of these methods rely on a pressure, ow or diameter dis-
tension waveform, the chapter starts with a description of the assessment of
these three types of waveforms.
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2.2 Waveform acquisition
2.2.1 Pressure waveform
While the use of a cu-sphygmomanometer allows easy and relatively accurate
assessment of the brachial systolic and diastolic pressure, arterial pressurewave-
forms can be measured non-invasively using either photoplethysmography or
applanation tonometry.
Figure 2.1: Nexn photoplethysmograph (BMEYE, Amsterdam,e Netherlands).
A photoplethysmograph measures the volume change of an organ by illu-
minating the skin and recording the changes in light absorption. Finger ar-
terial pressure can be assessed by using the volume-clamp or Penaz method.
With this method, the nger arteries are clamped at the unloaded diameter, the
point at which nger cu pressure and intra-arterial pressure are equal, thus at
which the transmural pressure across the nger arterial walls is zero. A high-
speed feedback mechanism allows to keep the artery at this unloaded diameter
throughout the cardiac cycle by varying the pressure of the nger cu.e cu
pressure then equals the intra-arterial nger pressure waveform. Commercial
photoplethysmographs include Finometer, PortaPress (FMS, Amsterdam,e
Netherlands) and Nexn (BMEYE, Amsterdam, e Netherlands), as shown
in gure 2.1. Although nger pressure waveforms correspond well with radial
pressure waveforms in young, healthy subjects, signicant dierences arise un-
der several (patho)physiologic conditions, due to wave reections and the pres-
sure gradient in the small nger arteries [56].
Applanation tonometry makes use of a high-delity strain micromanome-
ter that records arterial pressure waves when applied on the skin at constant
pressure (gure 2.2). It can be applied to various supercial large arteries, pro-
vided there is a bone or hard structure under the artery for proper applanation.
While it is generally accepted that radial, carotid and femoral artery pressure
waveforms can be accurately assessed using applanation tonometry, no consen-
sus exists for brachial artery tonometry. Although the brachial artery lies su-
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applanated artery
skin
tonometer
strain sensor
bone
Figure 2.2: Applanation tonometry: working principle (le) and application on the radial artery
(right).
percially, it can be dicult to obtain adequate tonometric waveforms in obese
individuals or in people with large biceps muscles.
e recorded tonometric waveforms need to be calibrated. At the brachial
artery, this can easily be done by using the systolic and diastolic pressures ob-
tained via sphygmomanometry. For the calibration of pressure waveforms at
other arterial locations, a more complicated calibration procedure is followed
(gure 2.3). Kelly and Fitchett [57] demonstrated that the dierence between
diastolic and mean arterial pressure remains constant throughout the large ar-
teries. By additionally assuming that also the absolute values of DBP and mean
arterial pressure (MAP) remain constant throughout the large arteries [58, 59],
the brachial DBP and MAP can be used to calibrate tonometric curves at all
other large arteries. Ideally, brachial MAP is obtained as the arithmetic average
of a calibrated brachial pressure waveform, and thus requires brachial tonom-
etry. Alternatively, brachial MAP can be approximated by adding 40% of the
pulse pressure to the diastolic pressure [60].
Although clinically the most relevant location, the aortic pressure wave-
form cannot directly be obtained non-invasively. However, based on invasive
radial and aortic pressure waves, population-based generalized transfer func-
tions have been constructed to transfer a radial pressure waveform to a synthe-
sized aortic wave.ese transfer functions are applied in the time or frequency
domain and can be regarded as sophisticated low pass lters since the aortic
pressure wave contains fewer higher harmonics than the radial wave. e use
of less complicated lters, such as an n-point moving average lter with n one-
quarter of the sampling frequency, was recently shown to be capable of accu-
rately predicting central aortic systolic pressure [62].
ere are a number of commercially available applanation tonometry sys-
tems. e most widespread device is the SphygmoCor (Atcor Medical, Aus-
tralia), using a pen-type tonometer tomanually applanate the artery.e Sphyg-
moCor soware has a built-in radial-to-aortic transfer function. For the acqui-
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Figure 2.3: Calibration method for carotid artery tonometry waveforms [61].e same calibra-
tion scheme can be used to calibrate waveforms of other supercial large arteries.
sition of radial pressure waves, there are more complex, automated tonome-
ters which, once attached to the wrist by a strap, automatically locate and ap-
planate the artery, such as the BP-508 (ColinMedical Instrumentation, Komaki,
Japan) and, more recently, the Omron HEM-9000AI (Omron Healthcare, Ky-
oto, Japan).
2.2.2 Flow waveform
Flow is obtained as the product of velocity and cross-sectional area. Both ve-
locity and cross-sectional area can bemeasured non-invasively with ultrasound
techniques. An acoustic ultrasound wave, typically at a frequency of between
7 and 12 MHz, propagates in the tissue and reects on interfaces with a dis-
continuity in acoustic impedance, such as the wall-lumen interface [63]. When
a set of waves is emitted and reected, a so called B-mode image can be cre-
ated from the radio frequency (RF) data. By holding the vascular ultrasound
probe perpendicular to the axis of the vessel of interest, the cross-sectional area
becomes visible and its dimensions can be measured.e velocity waveform is
measuredwithDoppler ultrasound. Adistinction can bemade between pulsed-
wave or continuous-wave Doppler. Continuous-wave Doppler is the simplest
mode, whereby ow information is received from all of the moving reectors
in the path of the beam. In pulsed-wave mode, a transducer sends a series
of short sound pulses into the body, with pauses between each pulse to allow
for the detection of the returning sounds that are echoing back from the red
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blood cells. Doppler ultrasound is by default available on vascular ultrasound
scanners. Relatively inexpensive handheld Doppler ultrasound systems are also
available which employ continuous-wave probes to give Doppler output with-
out the addition of B-mode images. Flow can bemeasured at the le ventricular
outow tract to provide aortic inow (gure 2.4), but it can also be measured
in any supercial artery, as illustrated in gure 2.5.
Figure 2.4: Aortic ow waveform at the le ventricular outow tract (LVOT) assessed with
Doppler ultrasound. LVOT diameter (top right) is imaged using B-mode ulstrasound.
50
50
cm/s
0
B-mode
Carotid artery
Doppler flow
Radial artery
0
50
100
cm/s
cm/s
0
Femoral artery
Figure 2.5: Examples of carotid, radial and femoral artery owwaveforms assessedwithDoppler
ultrasound.
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2.2.3 Diameter distension waveform
Diameter distension of supercial large arteries can be accurately measured
with non-invasive vascular ultrasound.e clear reections at the lumen-intima
and media-adventitia interface allow detection of the posterior and anterior
wall, as illustrated in gure 2.6. To optimize accuracy, automated "wall tracking"
algorithms have been developed using the RF data to track the displacement of
both walls in time. e hence obtained distension waves have an accuracy of
less than 5 µm. However, it is worth noting that the arterial distension at the
inner wall is about 25% (for relative distension ∆D/D) higher than that at the
outer wall [64]. is can be explained by simple geometrical considerations:
during systole, the distended vessel wall is thinner than in diastole, because of
conservation of wall volume.is leads to a smaller increase in diameter of the
outer compared to the inner wall. Because dierent ultrasound scanners might
track another point in the vessel wall, special care should be taken when com-
paring diameter distensions. In the near future, evolutions in other imaging
techniques like CT andMRI may enable the assessment of distension of deeper
arteries such as the aorta [63].
precedes the maximal diameter (A-type wave as ob-
served in old subjects), D1 ¼ Dinfl and D2 ¼ Dsys and
AIx . 100%. When the inflection point follows maximal
diameter (C-type wave as measured in young healthy
subjects), D1 ¼ Dsys and D2 ¼ Dinfl and AIx , 100%.
To further quantify morphological differences between
the different curves, tracings were normalized (ampli-
tude 1, offset correction) and the total area between
two tracings was calculated and normalized for the area
under inner (WTS versus inner wall tracing) or outer
wall prototype tracing (WTS versus prototype outer
wall tracing; prototype inner versus outer wall tracing)
and expressed as percentage value (%TA). In addition,
the net area between the curves was calculated to
account for tracing crossovers, and again expressed as
percentage of the area under WTS or outer wall
prototype tracing (%NA).
Prototype data from the inner and outer wall and WTS
data were compared using correlation and linear regres-
sion analysis, paired t-tests and Bland–Altman [20]
analysis (Sigmastat 2.0; Jandel Scientific, SPSS Inc,
Chicago, Illinois, USA). For the prototype system, we
calculated the difference between the intima–lumen
and media–adventitia displacement for both the ante-
rior and posterior wall, yielding the temporal variation
of the intima–media thickness (IMT). We considered
their average value as an estimate of the anterior
(IMTant) and posterior (IMTpost) IMT. For all parameters,
we also studied the relation with age.
Repeatability study
To assess the repeatability of the prototype system and
WTS, we performed an intra-observer intersession
repeatability study in a subgroup of 10 healthy volun-
teers. All subjects were examined at day 1 and the
following day at the same period of the day. Repeat-
ability was calculated as the average of the coefficients
of variation for each individual subject. In addition, the
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
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Fig. 1
With the Wall Track System (WTS) (left panels), the displacement of the anterior and posterior vessel wall is tracked (top), and the diameter change
over the cardiac cycle is derived. For the prototype system (right panels), a radio frequency (RF)-beam within the RF region of interest (ROI) is
selected in the B-mode cineloop, and displayed as an RF M-mode. An upscaled B-mode image around the beam allows careful selection of the
lumen–intima (inner wall tracking) and media–adventitia boundaries (outer wall tracking) on the anterior and posterior wall (clear lines in RF M-mode
image) and, subsequently, calculation of the diameter waveform. The data in the bottom figures are diameter curves measured with both systems in
the same subject.
Heterogeneity of vessel wall distension Segers et al. 975
Figure 2.6: A selected region of interest (ROI) in a B-mode image is followed over time and
displayed as an M-mode image (upper right). By tracking the displacement of the anterior and
post rior wall (upper le), the diameter change over the cardiac cycle can be derived (lower le).
Depending on whether the inner or outer wall is tracked, dierent diameter distension curves
are obtained [64].
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2.3 Arterial stiffness
Arterial stiness can be assessed at a local, regional or global level. Each ap-
proach has its advantages and disadvantages and is described below in more
detail.
2.3.1 Local arterial stiness
Denition
Arterial compliance, the inverse of stiness, is the ratio of volume change for
a given change in pressure. In practice, the volume of a vessel is dicult to
measure and is oen replaced by cross-sectional vessel area or diameter. When
pressure and diameter aremeasured continuously over a large pressure interval,
S-shaped pressure-area loops can be constructed such as the ones obtained by
Langewouters from ex-vivo aortic tissue, shown in gure 2.7.
Figure 2.7: Le: aortic pressure (p) and external diameter (de) during stepwise in- and deation.
Right: area-pressure relation base measurements during ination (dots) and tted data (solid
line) [65].
In clinical practice, compliance is calculated over a smaller pressure range,
hereby neglecting the nonlinear behavior of the vessel wall within the pressure
interval.is approximation yields the compliance coecient (CC) which rep-
resents the buering capacity of the artery:
CC = ∆A
∆P
= pi/42D ⋅ ∆D + ∆D2
∆P
(2.1)
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with
• D the diastolic diameter
• ∆D the dierence between maximum and minimum diameter
• ∆P the dierence between maximum and minimum pressure
e compliance coecient, however, is highly dependent on the vessel caliber,
and therefore the distensibility coecient (DC) is a better representation of the
elasticity of the artery:
DC = ∆A/A
∆P
= 2D ⋅ ∆D + ∆D2
D2∆P
(2.2)
In practice, both DC and CC are oen calculated over the operating pressure
range interval, so ∆P becomes PP and ∆D the wall distension between diastole
and systole.
A related parameter is the β-stiness index, expressing the ratio of loga-
rithm of systolic and diastolic pressures to the relative change in diameter:
β = ln(SBP/DBP)(Ds − Dd)/Dd (2.3)
with Ds and Dd the systolic and diastolic diameter, respectively.
Measurement
Assessing the distension and compliance coecients requires pressure and di-
ameter distension waveforms, measured at the same location and time. Since
DC and CC strongly depend on the pressure interval over which they are calcu-
lated, it is important, when comparing dierent subjects, to dene a common
pressure window over which ‘isobaric’ distension and compliance coecients
can be calculated.
Clinical application
Local stiness is regularly assessed in clinical studies. Most literature exists for
carotid stiness, since the carotid artery is an easily accessible large elastic artery
prone to plaque formation. Carotid stiness has been shown to be associated
with increased CV risk [66] as well as with major CV risk factors such as age
[67], hypertension [68], smoking [69] and obesity [70]. When local stiness is
assessed at two locations, conicting results can be observed: Spek et al. found
carotid distensibility to decreasewith age, while brachial distensibility remained
constant for men and even increased for women[67]. is suggests that mus-
cular arteries are able to adapt to the altered conditions [63].
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2.3.2 Regional arterial stiness
Denition
Regional arterial stiness is typically assessed via the pulse wave velocity (PWV),
the wave speed at an arterial segment connecting two locations. Although the
stiness of dierent arterial regions can be of clinical interest, the most rele-
vant region is the aorta. It represents the largest part of the arterial buering
function and, together with its rst branches, is ’seen’ rst by the le ventricle,
and as such is responsible for most of the pathophysiological eects of an in-
crease in arterial stiness [55]. Aortic PWV is most commonly measured over
the carotid-femoral pathway, as these are two supercial arteries which can eas-
ily be measured non-invasively (gure 2.8). A less frequently used alternative
methodmeasures PWVbetween the subclavian artery and the abdominal aorta
at the position of the umbilicus [71]. Since 2007, PWV is listed in the ESC/ESH
guidelines as an establishedmarker of subclinical organ damage.is has given
rise to a multitude of devices and methods to assess PWV.
PWV =
∆L
∆T ∆L
Carotid artery
∆T
Femoral artery
Figure 2.8: Carotid-femoral pulse wave velocity (PWV) [55]
Measurement
Pulse wave velocity is calculated as the ratio of travel distance and travel time.
e travel time is the time needed for the wave to travel from the carotid to
the femoral artery, and is measured as the time delay (∆T) between the feet of
the carotid and the femoral waveforms, the so-called foot-to-foot method. It
is assumed that the early part of the wave is little aected by wave reections
and thus reects the true wave speed. Since pressure, distension and veloc-
ity changes at the measuring site are all due to the same perturbation travel-
ing through the arteries, travel time can be assessed from either of these three
waves.
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identical to that of the thoracic aorta, which is close in
reality. It is a problem also for pathway measurement.
Different ways to measure distance are represented in
Fig. 3. The simplest way to measure pathway is to measure
transcutaneously using a tape meter or a caliper. If the
measurement is made between the two measurement sites,
it leads to a systematic overestimation of PWV by an amount
close to 30%. It is possible to correct this by subtracting the
distance between the carotid site and the sternal notch from
the overall distance. This method provides values closer to
invasive measurements, but is more complicated, and is
a source of errors. Moreover, the direct (carotid to femoral)
distance was used in nearly all epidemiological studies.4 A
European project conducted by a consortium of expert
centers will provide reference values for arterial stiffness,
together with conversion factors for converting measures
obtained with one method to the other.25 The measurement
of aortic pulse wave velocity using Doppler probes posi-
tioned at the suprasternal notch and close to the umbilicus
bypasses such difficulties,7,26 because it measures a more
homogeneous vessel with no bifurcation. This advantage is
tempered by more imprecision on the precise site of flow
signal acquisition.
Relative value of different pulse wave velocity
Carotid to femoral PWV is the most widely used index of
arterial stiffness, and has demonstrated its predictive
value, independent and above classical risk factors in more
Algorithms for identifying the foot of the wave
Intersecting tangents
10% upstroke Maximum upstroke of the second derivative 
2nd derivative
1st derivative
A
B
C
Figure 2 Different algorithms used to identify specific part of the pulse signal (here distension waveform of the carotid artery).
Panel A: intersecting tangents; Panel B: maximum upstroke of the second derivative; Panel C: percentage of the full amplitude of
the cycle.
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Figure 3 Different ways to measure path length.
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Figure 2.9: Overview of dierent approaches for dening the path length for PWV calculation
[2]
e travel distance is usually measured on the body surface and is therefore
only an approximation of the true distance travelled by the waves. As illustrated
in gure 2.9, dierent methods exist: the direct distance simply measures the
distance over the skin between the two recording sites. Alternatively, the sub-
tracted distance is calculated as the distance between the (supra)sternal notch
and the femoral measurement site minus the distance between (supra)sternal
notch and carotid measurement location.is method takes into account that
the direction of the blood ow in the carotid artery is opposite to that in the
femoral artery. Since the blood ow in the carotid and femoral arteries origi-
nates from the heart, the dierence in path length between the heart and the
femoral artery minus the path length between the heart and the carotid artery
is the true travelled distance.e position of the heart is approximated on the
body surface by the suprasternal notch. Both distance methods co-exist, so one
must be cautious when comparing dierent PWVs as the distance method in-
uences the absolute value of PWV. Recently, the use of 0.8 times the direct
distance was introduced as a third method [72]. is method proved to yield
the smallest error and a high correlation when compared to the true travelled
pathlength measured with MRI [73, 74].
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Clinical application
e measurement of carotid-femoral PWV is generally accepted as the most
robust and reproducible method to determine arterial stiness [55]. ere is
a large body of evidence demonstrating its association with incident CV dis-
ease (CVD), independent of traditional risk factors and in various populations
[71, 75–77]. Recently, Vlachopoulos et al [78] demonstrated that PWV is a
strong predictor of future cardiovascular events and all-cause mortality in a
meta-analysis including 15,877 follow-up patients. To facilitate the introduc-
tion of PWV in routine clinical practice, a set of normal and reference values
per blood pressure and age-category was proposed based on data from 13 cen-
tres across Europe [72] (see gure 2.10).
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Figure 2.10: Geographic distribution of the centers participating in the reference value project
2.3.3 Global arterial stiness
Denition
Assessing the global arterial stiness implies integrating the stiness of the en-
tire arterial circulation into a single parameter. As a fast approximation, the ra-
tio of stroke volume and pulse pressure (SV/PP) can be used. Although this cor-
responds with the general understanding of arterial compliance, SV/PP overes-
timates the true arterial compliance, as it assumes the entire stroke volume to be
stored in the large elastic arteries and neglects peripheral outow [79]. More ac-
curate estimation of the total arterial compliance requires a lumped parameter
model of the arterial tree, such as the Windkessel models discussed in section
1.5.1 of Chapter 1.
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Measurement
Dierent methods to calculate the global arterial compliance exist, all of which
require the assessment of at least the aortic pressure waveform. A distinction
can bemade betweenmethods requiring the additionalmeasurement of cardiac
output, and others requiring the assessement of the entire ow waveform at the
ascending aorta:
1. Decay-time and area method. Assuming a 2-element Windkessel model for
the arterial circulation, the pressure decay in diastole is exponential, with the
time constant τ given by the product of resistance and compliance (τ = R.C)
(see 1.5.1). Since R can be calculated as the ratio of mean pressure and mean
ow, C can be derived as τ/R. eoretically, this only holds when there is no
ow during diastole, which is only true in the aorta.
Alternatively, the time constant in a 2-element Windkessel model can be
derived from the area under the pressure curve in diastole as:
τ = ∫ t2t1 P(t) dt
Pt1 − Pt2 , (2.4)
with t1 to t2 to be chosen freely between the dicrotic notch and the end of di-
astole [80]. Again, C is found as τ/R. Both methods are illustrated in gure
2.11.
Figure 2.11:e decay-time (le) and the area method (right) [5].
2. Pulse pressure and model tting method. In the pulse pressure method, R is
calculated from the mean pressure and mean ow and an initial value for C is
assumed. Using these values as well as the measured ow waveform, the pulse
pressure resulting from the model is calculated and compared to the measured
pulse pressure. Although it is not possible to accurately reproduce the entire
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pressure waveformwith a two-elementWindkessel model, pulse pressure (low-
frequency behavior) can be modeled with more precision.erefore, an itera-
tive scheme is followed in which the total arterial compliance is changed until
the model and the predicted pulse pressure agree within reasonable limits [81].
Similarly, the model tting method ts the calculated to the measured pressure
waveform by changing the input impedance of a 3- or 4-element Windkessel
model [6].
Clinical application
e clinical use of the global arterial stiness is rather limited. In one of the
few clinical studies on total compliance, de Simone et al. demonstrated that a
decreased SV/PP was an independent predictor of cardiovascular outcome in
50 patients followed up over a period of 10 years [82].
2.4 Wave reflections
ere are dierent methods to quantify wave reection. e gold standard is
by separating pressure and ow in their forward and backward components, a
method called wave separation analysis.is separation can be done in the fre-
quency domain (impedance analysis) or in the time domain (intensity analysis).
Both approaches require the assessment of aortic pressure and ow waveforms.
As it is oen inconvenient and time-consuming to assess both waveforms,wave
shape analysis based on the pressure waveform alone might provide an alterna-
tive. In this section, the three approaches are described in more detail.
2.4.1 Wave shape analysis
Denition
Although resulting from a multitude of small reections on dierent locations,
in most cases the apparent arrival of a reected wave can be identied on the
pressure waveform. It is recognized as an inection (Pi) in the pressure curve
and can occur before or aer the peak systolic pressure.e augmentation in-
dex (AIx) is a surrogate of wave reections based on the inection point of the
pressure waveform. As illustrated in gure 2.12, the AIx can be calculated in
two dierent ways: either as the ratio of augmented pressure (AP) and pulse
pressure (PP), or as the ratio of P2 and P1. Depending on which one occurs
rst, P1 and P2 are the pulse pressure and the pressure at the inection point
minus diastolic pressure. When the reected wave arrives before peak systole, a
so-called A-type (aged) waveform is obtained where the peak systolic pressure
is increased or ’augmented’ by the wave reection. In this case, augmented pres-
sure is positive (as is AP/PP), and P1 equals the pressure at the inection point
while the pulse pressure is P2. In the case of a reection aer peak systole, a so-
called C-type (control) waveform is obtained where the systolic pressure is not
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augmented, AP/PP is negative and P1 now equals the pulse pressurewhereas the
pressure at the inection point is P2.e augmentation index can be calculated
on the carotid, radial or synthesized aortic pressure waveforms. An important
drawback of this index is its dependence on both the timing and the magnitude
of wave reection.
< 100
P1
P2
AP<0
AP>0
> 100
P1
P2
AP
100
100
C-type waveform A-type waveform
PP=P1 PP=P2
< 0
PP
AP > 0
PP100
100
Figure 2.12: Augmentation index dened as 100P2/P1 or 100AP/PP for C-type (le) and A-type
waveforms (right). AP=augmented pressure, PP=pulse pressure, P1 and P2 are the pulse pressure
and the pressure at the inection point or vice versa, depending on which one occurs rst [40].
Clinical relevance
e augmentation index is the most widely used index of wave reections.is
is mainly due to the availability of relatively inexpensive applanation tonometry
systems allowing for reliable non-invasive assessment of the pressurewaveform.
Following a recent meta-analysis of 11 longitudinal studies, central AIx, calcu-
lated on synthetized aortic waveforms, has a signicant predictive value of CV
events and all-cause mortality, independent of blood pressure and heart rate
[83].ough carotid AIx can be used as a surrogate for central AIx, radial AIx
was shown to correlate better with central AIx [84]. Furthermore, the radial in-
ection point was shown to correspond with the central SBP, rendering radial
AIx even more relevant [85].
However, the augmentation index is a composite measure, and although
it is related to wave reection, it is obvious that other factors co-determine its
value [86]. One major problem is that the AIx loses sensitivity around the age
of 60, where it levels o to a plateau value of 30%, as shown in gure 2.13.is
is a bad feature of an index intended for clinical purposes as the majority of
subjects suering from hypertension is older than 60 [87].
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Comparison between seated and supine hemodynamics.
Values for seated AIx and PP amplification were signifi-
cantly higher than supine values (AIx, 8  14% vs. 7 
16%, p  0.001; PP amplification, 1.59  0.21 vs. 1.55 
0.21; p  0.001). These differences disappeared, however,
when the data were corrected for the postural-induced
changes in MAP and HR (p  0.32, and p  0.19,
respectively).
DISCUSSION
Although age is one of the most important determinants of
cardiovascular risk, large artery stiffness is also a key inde-
pendent predictor of cardiovascular mortality (4–8). A
number of indexes, including aortic PWV and AIx, can now
be easily assessed non-invasively and have been included in
several outcome studies. The aim of the current study was to
determine the effect of aging on these indexes in a large
cohort of healthy, normotensive individuals. Our main
novel findings were that the age-related changes in central
AIx and aortic PWV follow different patterns. Changes in
AIx were more prominent in younger individuals (50
years), whereas the changes in aortic PWV were more
marked in older individuals (50 years). In addition, we
confirmed previous observations of a widening of peripheral
PP after the age of 50 years, but extended this to show for
the first time that central PP rises linearly with age. Overall,
these data suggest that central AIx might be a more sensitive
marker of arterial aging in younger individuals, and aortic
PWV more sensitive in those over 50 years of age.
Several previous studies have highlighted the positive
association between age and central AIx, which is often
considered to be linear (22). Mitchell et al. (12) recently
questioned this view, reporting that AIx changes less with
age in older individuals and actually declines after the age of
60 years. In the present study, the relationship between age
and AIx was clearly non-linear, with a greater age-related
effect in younger individuals, supporting the findings of
Mitchell et al. (12) and suggesting that AIx might be a more
sensitive marker of arterial aging in younger individuals.
Indeed, previous data demonstrate that low birth weight is
associated with increased AIx in adolescents (23); however,
we found no evidence of a decline after the age of 60, rather,
Figure 1. Blood pressure averaged for deciles of age for males (left) and females (right). Symbols represent peripheral systolic (closed triangles), central
systolic (open triangles), and diastolic (closed squares) blood pressures.
Figure 2. Regression curves representing the effect of age on parameters of
arterial stiffness and wave reflection for males (circles, solid lines) and
females (squares, dashed lines). Panel A represents augmentation pressure
(open circles/open squares) and augmentation index (closed circles/
closed squares). Panel B represents aortic pulse wave velocity. Data points
are the group means for each decile of age. The estimated functions for
these relationships appear in Table 2.
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Figure 2.13: Evolution of augmentation index (closed circles for males, closed squares for fe-
males) and augmented pressure (open circles for males, open squares for females) with age [40].
Data points are the group means for each decile of age.
2.4.2 Wave separation via impedance analysis
Denition
First introduced byWesterhof [19], impedance analysis is performed in the fre-
quency domain, throughFourier-transformation of the pressure andowwave-
forms. erefore, the equations below should be applied for each individual
harmonic of pressure and ow.ough Fourier-decomposition of a signal the-
oretically results in an i nite number of armonics, i ractice, the rst 10 to
15 harmonics suce to reliably describe the pressure and ow waveforms [88].
It is assumed that the pressure and ow harmonics are the sum of a forward
and a backward component:
P = Pn, f + Pn,b (2.5)
Q = Qn, f + Qn,b (2.6)
e characteristic impedance (Zc) relates forward (backward) pressure with
forward (backward) ow harmonics:
Pn, f = ZcQn, f (2.7)
Pn,b = −ZcQn,b (2.8)
e minus sign in the relation for reected waves results from the fact that ow,
compared to pressure, is directional: positive for blood owing away from the
heart and negative for blood owing towards the heart.
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Combining the above equations, each individual harmonic n of the forward
and backward waves can be calculated as:
Pn, f = Pn + ZcQn2 (2.9)
Pn,b = Pn − ZcQn2 (2.10)
e complete forward and backward pressure and ow waves can then be re-
constructed from these harmonics.
Wave intensity analysis: a newer and better
time domain approach?
The Fourier analysis we previously discussed has some
important limitations. Strictly speaking it is only applicable
in linear systems with periodic signal changes and the
analysis is quite complex due to the necessity of Fourier
decomposition. A newer approach to analyzing wave re-
flections is wave intensity analysis which is more intuitively
comprehensible due to its execution in the time domain. As
for the more ‘classic’ impedance analysis, this technique
also requires that pressure and flow are measured at the
exact same location and preferably at the same time.
Fourier analysis implied that a wave is conside ed to be
composed of sinusoidal wave trains. On the other hand, in
the context of wave intensity analysis, an arterial wave-
form is considered as consisting of the summation of
sequential infinitesimal wavefronts.28 These wavefronts
can be interpreted as follows. A disturbance to the flow
causes temporal changes in pressure dP and flow velocity
dU over one sampling interval. These elemental wavefronts
dP and dU propagate with a wave velocity c and can be lo-
cated in time and space, unlike the sinusoidal waveforms
which only have a phase and frequency. They represent el-
emental units of energy transmitted within and between
th blood vessels and the he rt. Similar to the splitting of
the sinusoidal harmonics in a forward and backward
Summary:
Pros e True index of wave reflection.
e The nature of the reflection can be easily
assessed with the reflection coefficient.
e Not sensitive to noise; the high frequency
content is filtered because only the first
harmonics are taken into account.
Cons e Both pressure and flow need to be recorded.
e Due to the analysis in the frequency domain,
the approach is less intuitive.
e A linear system is ssumed: arterial waves
are considered to be the sum of a number
of harmonics.
e Pressure and flow should be measured at the
same location: substitutes are however possible.
e Pressure and flow should be measured
simultaneously or alignment in time of both
curves should be estimated correctly.
e Only the net-e fect of the forwar and
backward running waves can be analyzed.
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Figure 3 Schematic representation of the frequency domain method. The measured pressure and flow wave are decomposed
into a series of harmonics, from which characteristic impedance (ZC) is estimated. Using Westerhof’s formulas, for each harmonic,
the forward and backward component is calculated. The final result of the analysis can then be a display of the (real part of) the
reflection coefficient as a function of frequency. Alternatively, one can make a summation of all forward and backward harmonics
to obtain the forward and backward pressure wave. The ratio of their amplitudes yields the reflection magnitude.
Arterial pressure wave reflection 127
Figure 2.14: Sche atic representation of the frequency domainmethod. Measured pressure and
ow are decomposed in a series of harmonics, from which the characteristic impedance (Zc) is
calculated. For each harmonic, the forward and backward component is alcul ted, which can be
used to display the (real part) of the reection coecient as a function of frequency. Alternatively,
the reection magnitude can be calculated from the ratio of the amplitudes of the reconstructed
forward and backward waves [87].
e amount of wave reection can be quantied in a number of ways.e
reection coecient (Γ) is obtained as the ratio of the backward and forward
waves: Pb,n/Pf ,n for each harmonic n, and thus consists of an amplitude and a
phase per harmonic. An elegant way to interpret the reection at a given lo-
cation and a given frequency is to express the real part of Γ per harmonic, as
illustrated in gure 2.14. A positive real part of Γ indicates constructive inter-
ference, while a negative value indicates destructive interference.
Two other reection indices are based on the global forward and backward
wave: the reection index (RI) is dened as the ratio of the amplitudes of the
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backward wave and the sum of the forward and backward waves ∣Pb ∣∣P f ∣+∣Pb ∣ , while
the reection magnitude (RM) expresses the ratio of the amplitude of the back-
ward and the forward wave: ∣Pb ∣∣P f ∣ (see also gure 2.14).
Clinical relevance
eoretically, pressure and ow should bemeasured simultaneously at the same
location, immediately distal to the aortic valve. In practice, this is only feasible
in invasive studies. For most non-invasive studies, carotid pressure is used as a
surrogate for aortic pressure. When combining pressure and ow, it is impor-
tant to align both signals in time in order not to introduce phase errors upon
Fourier-decomposition. Furthermore, for the sake of simplicity, the separation
of pressure and ow is oen performed in the time domain by approximating
Zc by the average of ∣Pn∣/∣Qn∣ from the 4th to the 10th harmonic [5].
A number of large-scale studies have reported on reection magnitude and
reection coecient. Mitchell et al. showed that RM as well as AIx were ele-
vated in subjects with systolic hypertension [89]. In an apparently healthy pop-
ulation of middle-aged community-dwellers, Segers et al. [86] found a high
correlation (R=0.78) between the reection magnitude and Γ1, the amplitude
of the reection coecient at the heart frequency, but a markedly lower corre-
lation between AIx and either of these indices (R<0.6). Between the age of 35
and 55, all three indices of wave reection increased signicantly. However, un-
like for AIx, which is systematically higher in women than in men, no gender
dierence in Γ1 or RM was observed.
2.4.3 Wave separation via intensity analysis
Denition
Although impedance analysis allows a more accurate study of wave reections
compared to wave shape analysis, the analysis in the frequency domain is less
intuitive and quantication of the amount of wave reection is hampered by the
fact that both the amplitudes and the phases have to be taken into account. As an
alternative approach, Parker and Jones introduced the wave intensity analysis,
which allows to separate pressure and ow in the time domain [90].
Instead of decomposing the pressure and ow waveforms into sinusoidal
components, wave intensity analysis considers the arterial pressure and ow ve-
locity waveforms to consist of a summation of innitesimal ’wavelets’ or ’wave-
fronts’. Wave intensity (dI) is dened as
dI = dP ⋅ dU [W/m2], (2.11)
where dP is the change of pressure across a wavefront and dU is the change in
velocity across a wavefront.
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e wave intensity represents the energy ux carried by the wavefront. dI
is positive for forward (+) traveling wavefronts and negative for backward (-)
traveling wavefronts. is holds for both compression (dP>0) and expansion
(dP<0) waves. When there are simultaneous forward and backward waves in
the artery, the wave intensity is the algebraic sum of the wave intensities of the
two wavefronts intersecting at the measurement site at the time of measure-
ment.e sign of the net wave intensity therefore immediately reveals whether
the forward or the backward waves are dominant, as illustrated in gure 2.15.
Time (s)
FCW BCW          FEW
Figure 2.15: Illustration of the wave intensity analysis method. Measured aortic pressure and
ow wave (bold line) are separated in their forward (thin line) and backward (grey line) compo-
nents. Total, forward and backward wave intensity are calculated. FCW: forward compression
wave, BCW: backward compression wave, FEW: forward expansion wave [91].
dP and dU are connected via the water hammer equation:
dP± = ρc dU± (2.12)
with ρ the blood density and c the local wave speed. Assuming the wavefronts
to be additive so that dP = dP+ + dP− and dU = dU+ + dU−, these equations
can be rearranged in terms of the forward and backward pressure wavefronts
dP+ = (dP + ρc dU)/2 (2.13)
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dP− = (dP − ρc dU)/2. (2.14)
e corresponding changes in the velocity can be found as
dU+ = (dP + ρc dU)/2ρc (2.15)
dU− = −(dP − ρc dU)/2ρc. (2.16)
e total forward (backward) pressure wave can be obtained by summing all
forward (backward) wavefronts
P+ = Pdia + t∑
i=0 dPi+ (2.17)
P− = t∑
i=0 dPi− (2.18)
with Pdia the diastolic blood pressure.
Likewise, the forward and backward velocity waves are obtained as
U+ = t∑
i=0 dUi+ (2.19)
U− = t∑
i=0 dUi− (2.20)
us, in order to separate pressure or ow into its forward and backward
components, one needs a pressure and a ow wave at one location as well as the
local wave speed.is implies that the wave speedmeasured by the foot-to-foot
method (see section 2.3.2) cannot be used in wave intensity analysis, as it is a
weighted average of the wave speed between the measurement sites rather than
a local wave speed. Local wave speed can be obtained from measured pressure
and velocity waveforms using the water hammer equation. In early systole, re-
ections are assumed to be minimal, so the slope of the P-U loop, the curve
obtained when plotting P versus U, equals ρc [92]. In practice, it appears that
both impedance and wave intensity analysis give essentially identical results for
the determination of the forward and backward waveforms [93].
Clinical relevance
ough wave intensity analysis allows to study local reections by assessing the
change in impedance, it is only the quantication of the overall wave reections
through a global reection coecient that has clinical relevance.erefore, the
use ofwave intensity analysis in clinical studies liesmore in facilitating the inter-
pretation of data or observed phenomena, as it is possible to follow individual
waves as they reect and rereect within the arterial system [92].
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2.5 The Asklepios study
From the above described methods and concepts, it is clear that quantication
of arterial wave reections and arterial stiness requires the assessment of pres-
sure, ow and/or diameter distension waveforms at dierent arterial locations.
Since thesemeasurements are not (yet) performed in routine daily clinical prac-
tice, it is not obvious to obtain such data, surely not at a large scale. Fortunately,
the data gathered during the Asklepios study provided a rich source of infor-
mation that was gratefully used for a number of methodological studies during
this PhD.
e Asklepios study is a longitudinal population study focusing on the in-
terplay between aging, cardiovascular hemodynamics and inammation in (pre-
clinical) cardiovascular disease [94]. e rst round was conducted between
2002 and 2004 and included 2524 participants (1301 women), aged 35 to 55 years.
Participants were randomly sampled from the twinned Belgian communities of
Erpe-Mere andNieuwerkerken andwere free from overt cardiovascular disease
at study initiation. All measurements were performed by the same operator.
Next to basic clinical data and advanced biochemical analysis, the study has
a strong biomechanical component. Both cardiac and vascular structure and
function were assessed in detail. Carotid and femoral arteries were scanned for
the presence of plaques and the intima-media thickness of both arteries was as-
sessed in high and low shear regions. Flow and diameter distension waveforms
were assessed at the carotid and femoral arteries using a Vivid 7 ultrasound
scanner (GEVingmedUltrasound, Horten, Norway). Pressure waveformswere
obtained at the brachial, radial, carotid and femoral arteries using a high-delity
strain gauge sensor (Millar SPT 301, Millar Instruments, Houston, Texas, USA)
and a custom-built acquisition platform.
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Validation and development of
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Outline
e analysis of wave reections and arterial stiness has increasingly gained
attention over the last 15-20 years and is now in the transition between clinical
research and clinical practice, as illustrated by the inclusion of PWVas amarker
of subclinical organ damage in the 2007 ESC/ESH1 guidelines [26].
With regard to this anticipated introduction in clinical practice, the focus
in assessing arterial stiness and wave reections has shied from an accurate,
complete characterisation as (should be) used in clinical research to a more
pragmatic compromise between accuracy and time- and cost-eectiveness of
the measuring technique.
is second part of this PhD-dissertation describes four studies on either the
development or the validation of a new method to quantify arterial stiness or
wave reections:
Chapter 4 details the results of a validation study in which an approach of wave
separation based on a measured pressure waveform and an estimated (trian-
gular) ow waveform is compared to the more traditional approach of wave
separation using a measured pressure and ow waveform. ough approxi-
mative, this new approach has the advantage of bypassing the oen expensive
and time-consuming assessment of an aortic owwaveform.e approach was
recently introduced by Westerhof et al. [95] to estimate reection magnitude,
with promising results in a small dataset. Qasem et al. [96] used the same ap-
proach to derive pulse transit time and aortic pulse wave velocity from a central
1ESC: European Society of Cardiology; ESH: European Society of Hypertension
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pressure waveform. We veried these approximation techniques for reection
magnitude and transit time using carotid pressure and aortic ow waveforms
measured non-invasively in the Asklepios study and explored the accuracy of
approximating the ow waveform by using a person-specic time-scaled nor-
malized average ow waveform.
Chapter 5 relates to the non-invasive assessment of carotid artery pressure
waveforms. Calibration of the carotid tonometric curve is based on brachial
DBP andMAP, the latter ideally obtained as the arithmetic average of the brachial
pressurewaveform.erefore, proper non-invasive assessment of carotid artery
pressure ideally useswaveforms recorded at two anatomical locations: the brachial
and the carotid artery. As tonometry recordings are dicult to obtain in obese
patients, the use of calibrated diameter distension waveforms could provide a
more widely applicable alternative for local arterial pressure assessment than
applanation tonometry.is approachmight be of particular use at the brachial
artery, where the feasibility of a reliable tonometricmeasurement has been ques-
tioned.e aim of this study was to evaluate an approach based on distension
waveforms obtained at the brachial and carotid arteries.is approach will be
compared to traditional pulse pressures obtained through tonometry at both
the carotid and brachial arteries (used as a reference) and themore recently pro-
posed approach of combining tonometric readings at the brachial artery with
linearly or exponentially calibrated distension curves at the carotid artery.
Chapter 6 focuses on the impact of radial artery waveform calibration on
central blood pressure assessment and calculated pressure amplication. Cen-
tral blood pressure can be estimated from radial artery pressure waveforms us-
ing a generalized transfer-function. However, the obtained central pressure
waveform depends on the calibration of the radial waveform. In this study,
three calibration methods are compared using the radial and carotid tonomet-
ric waveforms acquired in the Asklepios study: calibration using brachial artery
DBP and (i) brachial SBP, (ii) MAP estimated with the one-third rule and (iii)
MAP estimated as 40% of brachial artery pulse pressure.
In chapter 7, the determinants of a newly proposed stiness index, the Am-
bulatory Arterial Stiness Index (AASI) are explored using a previously vali-
dated 1D computer model of the arterial circulation [97]. Based on 24-hour
ambulatory blood pressure recordings, the AASI is calculated as one minus the
slope of the linear regression line between systolic and diastolic blood pressure
values [98, 99] and thus does not require the recording of a pressure, ow or
diameter distension waveform. Although appealing because of its simplicity, it
requires 24-hour blood pressure recordings and there is controversy as to which
extent it reects stiness or is aected by other cardiovascular parameters. We
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assessed the relative importance of ve parameters (arterial distensibility, pe-
ripheral resistance, heart rate, cardiac contractility and venous lling pressure)
on the AASI by varying each parameter from 80 to 120% of its initial value in
steps of 10% to mimick the daily uctuations in one theoretical, normotensive
subject. To assess the ability of AASI to detect large changes in stiness, two
additional subjects were simulated with a distensibility of 50% and 25% of the
default distensibility, respectively.
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Evaluation of non-invasivemethods
to assess wave reflection and pulse
transit time from the pressure
waveform alone
e results of this study were published in:
Jan G. Kips, Ernst R. Rietzschel, Marc L. De Buyzere, Berend E. Westerhof,
ierry C. Gillebert, Luc M. Van Bortel, Patrick Segers. Evaluation of Noninva-
sive Methods to AssessWave Reection and Pulse Transit Time From the Pressure
Waveform Alone. Hypertension 2009, 53:142-149.
4.1 Introduction
e pressure wave can be considered as the composite of a forward pressure
wave, travelling from the heart to the periphery, and of a reected pressure
wave, travelling backward towards the heart. Early return of this reected wave
boosts (central) systolic blood pressure, increasing the load on the heart and
boosting the amplitude of the pressure wave, factors that have been shown to
increase cardiovascular risk [100–103].erefore, analysis of pulse wave veloc-
ity and pressure wave reection have been of clinical interest for many years
now.
Severalmethods to quantifywave reection emerged [55], themostwidespread
probably being the augmentation index (AIx) [104, 105]. AIx is a parameter
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based on analysis of the pressure waveform, and expresses the ratio of aug-
mented pressure (attributed to wave reection) to pulse pressure. However, be-
cause several factors inuence its value [40, 95, 106, 107], AIx might not be the
most appropriate parameter for an accurate quantication of the magnitude of
wave reection [108].
More accurate methods to assess wave reection are based on wave sepa-
ration analysis [4, 19]. ese methods are based on measurement of pressure
and ow, ideally measured simultaneously and at the same anatomical location,
preferentially the central aorta [54]. Although approximated approaches, based
on aortic ow and carotid [94] or subclavian [109] pressure measurements are
feasible, implementation of these extendedmeasurement protocols in a clinical
setting is not evident. In an attempt to merge the benets of a method based
on measurement of pressure waveform alone, and of the wave separation ana-
lysis, Westerhof et al. recently advocated a new method, where the ow wave
is approximated by a triangle. eir analysis yields an approximation of the
reection magnitude (RM), the ratio of the amplitude of the reected to the
forward wave.e method was found to give promising results, but the initial
study was, overall, based on a relatively low number of data-sets (29 beats of 19
humans) [95].
In recent work, Qasem and co-workers proposed a newmethod of deriving
pulse transit time and aortic pulse wave velocity from a central pressure wave-
form.emethod is based on assessing the time delay between the forward and
backward pressure component, decomposed from a central pressure waveform.
e triangular ow wave approximation is used for pressure wave decomposi-
tion. Linear regression between calculated andmeasured carotid-femoral pulse
transit time showed promising results in a cohort of 46 subjects [96].
e objective of this study is threefold: (i) to verify the triangular ow wave
approximation method and the assessment of the reection magnitude as pro-
posed by Westerhof et al.; (ii) to verify the assessment of aortic pulse wave ve-
locity from a single pulse recording as proposed by Qasem et al.; (iii) to ex-
plore the possibility of approximating the ow wave by using a person-specic
time-scaled normalised average ow waveform and to assess its impact on the
estimates of reection magnitude and pulse wave velocity.
4.2 Materials and methods
4.2.1 e Asklepios population
A total number of 2325 datasets including non-invasive aortic ow and carotid
artery pressure measurements recorded within the framework of the Asklepios
Study [94] are used. Carotid pressure waveforms were obtained using applana-
tion tonometry at the le common carotid artery, following an earlier described
calibration scheme based on brachial artery tonometry [61, 94].e aortic ow
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waveform was assessed using pulsed Doppler ultrasound (Vivid7, GE Vingmed
Ultrasound) in the le ventricular outow tract (LVOT). Carotid-femoral pulse
wave velocity (PWV)wasmeasured byDoppler ultrasound owmeasurements
in the femoral and carotid artery, respectively. Details on the study protocol and
specications of the measurement techniques and pressure and ow wave pro-
cessing are found elsewhere [107].
4.2.2 Triangular waveform construction
Following Westerhof et al. [95], a triangular ow waveform (Q tri) was con-
structed. Whereas the authors of that study obtained timing information from
the pressure waveform, we approximated the ow using timing information for
start, peak and end of ow from themeasured owwaveform itself. By doing so,
we can evaluate the isolated eect of the triangular shape approximation, inde-
pendent of errors introduced via the assessment of the timing from the pressure
waveform. As such, these results can be considered as the best possible results
that can be obtained with a triangular approximation of the ow waveform.
e root mean square error (RMSE) between the approximated ow wave-
form and the measured one is calculated and expressed as mean (SD).
4.2.3 Linear wave separation analysis and derived parameters
Using ow and pressure, forward (Pf ) and backward (Pb) pressure waveforms
were calculated using the linear wave separation technique as rst described by
Westerhof et al. [19]. e forward and backward pressure waveforms derived
using the measured ow serve as a reference. Agreement between the approx-
imated (derived using approximated ow) and reference forward (and back-
ward) pressure waveform is assessed by calculating the RMSE between the two
waveforms.e amplitudes of the approximated forward (|Papproxf |) and back-
ward (|Papproxb |) pressure waves are compared to the reference forward (|P
re f
f |)
and backward (|Pre fb |) pressure wave amplitudes via linear regression analysis
(R2-values) and their mean dierence is displayed as mean (SD).
4.2.4 Reection magnitude assessment
Reference (RMre f ) and approximated reectionmagnitude (RMapprox) are cal-
culated as the ratio of the amplitudes of backward and forward pressure wave:
RM∗=|P∗b |/|P∗f |, with ∗ referring to either the reference or the approximation.
Agreement between reference and approximation was studied via linear regres-
sion analysis (R2-values) and Bland-Altman analysis. In addition, we also cal-
culated the augmentation index (AIx) as a measure of wave reection. We refer
to previous work [107] for a description of how AIx was derived.
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4.2.5 Pulse wave velocity assessment: time delay between Pf and Pb
To assess the time delay between Pf and Pb, Qasem et al. proposed to rst
modify the pressure waveforms [96] using three criteria:
• dPb(t)/dt=0 0 ≤ t ≤ peak ow
• dP f (t)/dt<0 peak ow ≤ t ≤ end ejection
• P f+Pb=P at all times
We refer to Qasem et al. for details on these assumptions [96]. Basically, it is
assumed that the forward pressure wave reaches its peak at the moment of peak
ow.e backward pressure wave arrives at the moment of peak ow and only
plays a role from that moment on (gure 4.1).
Figure 4.1: (A) Triangular and averaged ow waveform approximation principle. e triangu-
lar ow waveform is constructed based on timing of beginning, peak and end of the measured
ow waveform.e averaged physiological ow waveform is constructed using measured ows
of 74 subjects and stretched in time based on timing of the beginning and end of the measured
ow waveform. (B) Pulse transit time (TT) approximation principle, applied with triangular
ow waveform. Forward and backward pressure components are modied (see text for modi-
cation criteria). Cross-correlation is performed on normalised pressure components. Aortic TT
is estimated as half of the time lag at maximum correlation.
Aer normalization of the modied forward and backward pressure wave-
forms, the time lag between Pf and Pb was obtained using cross-correlation
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techniques, assuming that the correct time-lag is the value for which there is
maximum cross-correlation [110] between the two normalized waveforms. Fol-
lowing Qasem et al. [96], the pulse transit time (TT) is obtained as half of the
time lag.
is method was applied using either themeasured owwaveform (Qmeas)
or the approximated waveform (Q tri). Transit times obtained from these ap-
proaches are indicated as TT∗, with ∗ referring to either themeasured approach
or the approximative approach. TT∗swere also compared to the carotid-femoral
pulse transit times measured by Doppler ultrasound (TT re f ), which serve as a
reference here.
4.2.6 Averaged physiological ow waveform
In a third part of this study, approximation via triangular ow waveform pro-
les was le aside, and the analysis (assessment of RM and TT) was repeated
by using a more physiological ow waveform (Qavg) obtained from normalis-
ing and averaging measured ow waveforms. Using data from 74 subjects (32
women, 42 men; 3.1 % of the total database), the average ow waveform was
calculated aer normalising each individual ow curve in time and amplitude.
e physiological waveform is mathematically described as a Fourier-series us-
ing the rst 20 harmonics.e subjects used to construct the physiological ow
waveform were subjects where aortic ow was available, but where other data
were missing due to various technical reasons. To approximate the actual ow
waveform, the averaged and normalised waveform was scaled in time using the
timing of beginning and end of each individual measured ow waveform.
4.2.7 Synthesized aortic pressure
e analysis (assessment of RM andTT)was repeated by using synthesized aor-
tic instead of carotid pressure, obtained from radial tonometry via a generalized
pressure transfer function [111].
4.3 Results
Basic population and hemodynamic data are given in table 4.1.e mean age of
the subjects (1209 women, 1116 men) was 46 years, ranging from 35 to 55 years.
A total number of 651 subjects with hypertension was included, of whom 237
were under drug treatment.
4.3.1 Triangular and averaged ow waveform approximation
Table 4.2 gives an overview of the impact of the dierent ow waveform ap-
proximations on the forward and backward pressure waveforms and derived
parameters. e RMSE between approximated and measured ow waveform
decreases markedly from the triangular (0.12) to the averaged waveform ap-
proximation (0.04). Note that these errors are based on a normalised peak ow
of 1.0, i.e. the minimal error is 4%.
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Table 4.1: Basic clinical data.
Parameter Data
No. of subjects 2325
Age (years) 45.9 (6.0)
BMI (kg/m2) 25.6 (4.1)
Systolic BP (mmHg) 127.0 (14.0)
Diastolic BP (mmHg) 80.0 (10.0)
Heart rate (bpm) 63.6 (9.4)
Data are presented as mean (SD) unless otherwise
specied. BMI indicates body mass index.
Table 4.2: Approximation errors on ow and forward and backward pressure.
Flow waveform
Variable Measured (Q re f ) Triangular (Q tr i) Averaged (Qav g)
RMSE Q, AU NA 0.12 (0.02) 0.04 (0.03)
Accuracy of estimating forward component
RMSE Pf , AU NA 2.38 (1.50) 1.08 (0.82)
|Pf |, mmHg 42.61 (9.45) 48.46 (12.89) 42.60 (9.49)
|Pf |approx -|Pf |re f , mmHg NA 5.84 (7.18) -0.01(3.19)
R2 approx vs ref NA 0.70 0.89
Accuracy of estimating backward component
RMSE Pb , AU NA 2.38 (1.50) 1.08 (0.82)
|Pb |, mmHg 20.22 (5.35) 23.18 (7.65) 20.35 (5.35)
|Pb |approx -|Pb |re f , mmHg NA 2.97 (5.59) 0.13 (1.88)
R2 approx vs ref NA 0.47 0.88
Q indicates ow; |Pf |, amplitude of the forward pressure component Pf ; |Pb |, amplitude of the
backward pressure component Pb ; ref, reference; approx, approximate; AU, arbitrary units.
Data for RMSE and pressure amplitudes are expressed as mean (SD).
4.3.2 Agreement between approximated and reference reection
magnitude
e RMSE between the approximated and reference forward pressure waves
varied between 1.1mmHg (averagedwaveform) and 2.4mmHg (triangularwave-
form). Regression analysis between the amplitudes of the approximated for-
ward and backward pressure waves and the reference waves reveals that the
highest correlations are found for the averaged waveform. Also, the mean dif-
ference |Pf |-|Pf |re f (or |Pb|-|Pb|re f ) is smaller when using the averaged wave-
form, see table 4.2.
Mean reference RMwas 0.48 (0.09), while mean RM for triangular and av-
eraged ow waveform were 0.48 (0.10) and 0.48 (0.09), respectively. Figure 4.2
shows the results of the linear regression and Bland-Altman analysis between
approximations of RM and RMre f . Bland-Altman analysis shows a constant
mean dierence around zero for both ow approximations, with a tighter dis-
persion around the mean when the averaged waveform is used.
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Figure 4.2: Panel A-B: Linear regression plots between approximated and reference reection
magnitude (RM). Trend line equations and R2-values are reported. Panel D-E: Bland-Altman
plots between approximations of RM and RM re f . Mean value (solid line) and mean±2SD
(dashed lines) are displayed. Panel C shows the relation between augmentation index (AIx) and
RM re f . RM tr i and RMav g are approximations of RM using triangular ow and averaged ow
respectively, whereas RM re f is the reference RM using measured ow.
4.3.3 Agreement between approximated and measured pulse transit time
Pulse transit time (carotid-femoral)measured directly with ultrasound (TT re f )
was 67.8 (11.9) ms, while 77.9 (23.3) ms was the mean pulse transit time found
based on the principle of wave decomposition using themeasured pressure and
aortic ow (TTmeas). When using a triangular ow approximation, estimated
pulse transit time (TT tri) was 72.5 (14.8) ms, whereas the averaged ow ap-
proximation yielded a TTavg of 75.9 (20.1) ms.e best agreement between the
TT estimated using the measured and either of the approximated ow wave-
forms was found when using the averaged ow waveform (TTavg ; R2=0.82).
However, when studying the relation between TTapprox and TT re f , R2-values
were not higher than 0.28 (gure 4.3). Interestingly, also the agreement between
TTmeas and TT re f was weak (R2=0.27, gure 4.3). Bland-Altman plots show a
strong trend of overestimation towards higher TT-values for all cases (gure
4.3).
4.3.4 Synthesized aortic pressure
Using synthesized aortic pressure instead of carotid pressure waveforms for
the calculation of RM (gure 4.4), agreement ranged from R2=0.66 (triangu-
lar ow) to R2=0.79 (averaged ow). Transit times were also recalculated using
aortic pressure, yielding levels of agreement below R2=0.13 for both ow wave-
forms, see gure 4.4.
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Figure 4.3: Panel A-C: Linear regression plots between approximated and reference pulse transit
time (TT). Trend line equations and R2-values are reported. Panel D-F: Bland-Altman plots
between approximations of TT and TT re f . Mean value (solid line) andmean±2SD (dashed lines)
are displayed. TT tr i and TT av g are approximations of TT using triangular ow and averaged
ow respectively, TTmeas uses measured ow, whereas TT re f is obtained via the carotid-femoral
pathway via Doppler ultrasound.
4.4 Discussion
We applied the triangular ow wave approximation method to estimate reec-
tion magnitude as proposed by Westerhof et al. [95], on 2325 non-invasively
recorded data sets, consisting of carotid artery pressure and aortic ow wave-
forms. Despite the fact that we used timing information directly from the mea-
sured owwaveforms, the correlation thatwe found between approximated and
actual RM for the triangular ow wave approximations (R2 = 0.55) is still con-
siderably lower than the values reported by Westerhof et al.(R2 = 0.79 - 0.85).
When approximating the ow wave by a subject-specic time-scaled averaged
physiological ow waveform, the correlation between approximated and actual
RM improved substantially (R2 = 0.74).
A rst issue that needs to be addressed is the question how well the ow
waveforms are actually described by a triangle. It is seen from table 4.2 that the
triangular approximation yields a RMSE from the measured ow waveform of
0.12, which is three times higher than the value of 0.04 that can be achieved
when using a more physiological waveform. Another observation is that, us-
ing a triangular ow, the agreement between approximated and actual RM only
reached an R2-value of 0.55, which is still considerably lower than the values
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Figure 4.4: Panel A-B: Linear regression plots between approximated and reference reection
magnitude (RM), both based on synthesized aortic pressure waveforms. Panel C-D: Linear re-
gression plots between approximated and reference pulse transit time (TT). Panel E-F: Com-
parison between RM (TT) obtained using carotid pressure and synthesized aortic pressure.e
dotted line represents the line of identity. Trend line equations and R2-values are reported.
reported by Westerhof et al. ese observations indicate that, at least in our
setting, the triangle is a relatively poor approximation of the measured wave-
forms, which is the main reason for the discrepancy between our ndings and
those of Westerhof et al.
A logical subsequent question is why the triangle is a poorer approxima-
tion in this study. A rst possible reason can be sought in the dierent nature
of the population. Westerhof et al. used a mixed population of 19 subjects,
age ranged from 29 to 57 years, with a mean age of 50 years, with data ob-
tained from various sources, including digitised data. All subjects underwent
catheterization and were patients. e examples displayed in the manuscript
show a more triangular pattern than the waveforms that we measured in our
middle-aged, healthy subjects. It is further clear from their gures that mean
RM is in the range of 0.6-0.7, which is substantially higher than the value of
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0.48 in our study. To assess the impact of RM on the morphology of the mea-
sured ow waves, we also calculated averaged, normalised ow waveforms for
the database, with subjects grouped into four strata of values of RM (data not
shown). e eect of increased RM on the ow wave morphology is a slight
shi of the peak to the le, but there is no real better resemblance with a tri-
angular waveform for the higher RM. A second possible reason can be sought
in methodological dierences between the two studies.e ow waveforms as
used by Westerhof et al. were aortic ow velocity waveforms, measured with
an invasively applied electromagnetic ow velocity sensor, while we used ow
velocity waveforms measured using ultrasound in the le ventricular outow
tract. Ultrasound data were measured by an experienced cardiologist following
best practice guidelines. On the other hand, literature sources state that both
techniques are equivalent [112, 113]; so it is unclear whether the method used to
acquire the ow does play a role in our ndings.
In an attempt to increase the levels of correlation reported thus far for ap-
proximated RM, we tested a new approximation principle, based on an aver-
aged and normalised aortic ow waveform. As clear from table 4.2 and gure
4.2, using an averaged physiological waveform performs signicantly better in
estimating RM than using a triangular ow waveform. As for the triangular ap-
proximations, there is no systematic dierence between RMavg and RMre f , as
evident from the Bland-Altman plot (gure 4.2).
Another possible reason for the low levels of correlation can be sought in
the fact that the pressure waveforms as used byWesterhof et al. were not carotid
waveforms, but invasively measured aortic waveforms [95]. Although carotid
pressure is generally accepted as a surrogate for central aortic pressure, we cal-
culated RMs based on synthesized aortic pressure waveforms to assess whether
this methodological dierence could possibly explain the dierent results, but
could not nd important qualitative dierences. Compared to the correspond-
ing values using carotid pressurewaveforms, agreement betweenRMcalculated
with the measured and approximated ow waveforms was slightly better when
using synthesized aortic pressure. On the other hand, agreement between esti-
mated and measured pulse transit times using synthesized pressure waveforms
was lower than the corresponding values using carotid pressure.
Interestingly, the agreement between RM obtained using the carotid on the
one hand and synthesized aortic waveforms on the other hand, both using the
measured ow waveform, showed only poor correlation (R2=0.14), see gure
4.4. Our data do not allow to address which of the two pressure waveforms,
the carotid or reconstructed radial pressure waveform, is closest to the actual
central aortic pressure. Nevertheless, it is an important nding that derived
parameters, sensitive to wave morphology, can be quite dierent when using
carotid or reconstructed pressure waveforms. is was earlier demonstrated
for the augmentation index [84], but this conclusion also seems to pertain to
estimates of the RM.
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e two reported approximations, RM tri and RMavg , can be considered as
the best possible approximations in terms of timing, as they make use of the
actual timing of beginning, peak and end of the measured ow to construct an
approximated ow waveform. As such, they indicate the theoretical potential
of the approximation technique. It is therefore also important to determine the
further degradation in accuracy when timing information is obtained from the
pressure waveform. An averaged ow waveform was scaled in time, using the
start of the systolic upstroke in the pressure waveform as the onset of ow, while
the end of the ejection period was assumed to coincide with the dicrotic notch.
In a similar way, a triangular ow waveform was constructed. To estimate the
timing of the peak of the triangle, we used the timing of systolic blood pressure
forwaveswith late inection point (C-typewaves), while the shoulder pointwas
used for waves with an early inection point (A-type waves), the shoulder point
being identied with an algorithm based on the 4th-order derivative [107, 114].
RM was calculated, using each of these two ow waveforms, and compared to
RMre f (data not shown). As expected, the levels of agreement with RMre f were
markedly lower, with R2-values of 0.26 for the triangular waveform, and 0.41
for the averaged waveform.
emain rationale to applywaveformdecompositionwith an approximated
waveform is to nd new ways to overcome some of the limitations of the aug-
mentation index, which is an index related to wave reection but subject to
confounding factors such as heart rate and body length. As such, it is relevant
to see to what extent these approximated methods provide an improvement
over AIx in terms of correlation with RMre f . In fact, we found that the corre-
lation between AIx and RMre f (R2=0.34, see Figure 4.2) is only slightly worse
than the correlation between RMre f and RM tri , and still higher than the de-
composition based on the triangular approximation using timing info from the
pressure waveform. As such, it is questionable whether these more complex
methods oer, at this moment, any added value over AIx.
In a second part of this study, we evaluated amethod to estimate pulse tran-
sit times from the time delay between the forward and backward pressure wave-
forms, as previously described by Qasem et al. [96].e correlation we found
between estimated and directly measured (carotid-femoral) transit times using
approximated ow waveforms was rather limited (R2<0.29), compared to the
values reported byQasem et al.(R2=0.45-0.64), see gure 4.3. FollowingQasem
et al., we assessed the time delay between the forward and backward wave using
a cross-correlation technique. However, because cross-correlation can be prob-
lematic when the waveforms are dissimilar (andmay thus be an underlying fac-
tor in the poor correlations we found), we tried to limit the cross-correlation to
a ’window’ around the peak of the modied forward and backward waveforms.
Results, however, did not improve (data not shown). Other techniques to as-
sess timing as foot-to-foot delays and the timing of the inection and shoulder
point did not lead to better results (data not shown).
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Unlike Qasem et al. [96], we also estimated pulse transit times using the
measured ow waveform instead of an approximated waveform. Interestingly,
agreement with ultrasound-derived carotid-femoral transit times did not in-
crease at all when using the measured ow waveform (gure 4.3). Moreover,
Bland-Altmanplots showa stronger increasing trend forTTmeas than forTT tri .
is seems to imply that the modication of the forward and backward pres-
sure components is not appropriate when the measured ow waveform is used
to separate pressure. Indeed, when calculating transit times without modifying
the forward and backward pressure waveform, mean transit time is 71.2 (26.6)
ms, which is closer to TT re f (67.8ms) than when usingmodied pressure com-
ponents, although the agreement remains rather poor (R2 =0.22).is seems to
suggest that methods based on wave decomposition generally perform poorly
in estimating transit time.is is in line with recent work fromWesterhof et al.
[115], who demonstrated in a theoretical study that methods based on the time
delay between the forward and backward pressure waves should not be used to
assess pulse wave velocity. ey showed that the moment of return of the re-
ected wave is not only determined by the wave speed and distance of travel but
also by the time shi at the reection site. As a result, with an assumed location
of the reection site, the PWV cannot be derived. Transit times derived from
wave reection analysis (TTmeas, TT tri , TTavg) depend on the pulse wave ve-
locity, the location of reection and the nature of the reection [115]. On the
other hand, TT re f , measured along the carotid-femoral pathway, depends only
on PWV.With increasing age, PWV increases, but it has also been reported that
the reection sites shi in a direction towards the heart [4, 107]. erefore, in
older people, we expect the TT from wave reection analysis to become pro-
gressively lower than TT re f . is is indeed conrmed by gure 4.3, and this
phenomenon also explains the trend of overestimation of TT re f for the higher
TT-values. is shi of the reection site towards the heart is not reported by
Qasem et al. [96], where the eective length of the arterial tree seemed to in-
crease with age, as also earlier reported by Mitchell [116]. We have previously
suggested that this nding is related to the fact that identication of the mo-
ment of return of the reected wave based on pressure waveform information
(timing of shoulder or inection point) alone is not accurate enough [107].
Although themean age of the population inQasem et al. was slightly higher
(56±14 years) than ours, they were also healthy volunteers, making it unlikely
that dierences could be explained by the dierent nature of the study popula-
tion. We used transit times measured with Doppler ultrasound as a reference,
whereas Qasem et al. used tonometry to obtain carotid-femoral transit times.
Although both techniques are accepted in literature to measure aortic PWV
[55, 71], it is possible that the approximative method based on pressure waves as
described byQasem et al. will correlate better with a pressure-derived reference
transit time than with a ow-derived transit time between the same anatomical
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locations. A secondmethodological dierence is the fact that Qasem et al. used
synthesized aortic pressure waveforms instead of carotid waveforms. How-
ever, when assessing the impact of this methodological dierence, we found
the agreement between approximation and reference TT to be even lower, with
R2-values below 0.13. Similar as for RM, the agreement between TT obtained
using the carotid on the one hand and synthesized aortic waveforms on the
other hand, both using themeasured owwaveform, yieldedweak correlations,
see gure 4.4.
4.5 Limitations
e main limitation of this study is that it is entirely based on non-invasively
measured data which implies an approximation of the central aortic pressure
waveform. Ideally also, pressure and ow are measured simultaneously and
at the same anatomical location. For this study, pressure was measured non-
invasively using applanation tonometry at the common carotid artery, while
ow was measured at the level of the le ventricular outow tract with Dopp-
ler ultrasound. Although carotid pressure is commonly used as a surrogate for
central aortic pressure, both curves are not entirely equal, diering from each
other in timing and in waveform. e time delay between aortic and carotid
pressure waveform is corrected for by visual time-alignment.e dierence in
waveform persists, and may have an eect on the accuracy of timing approxi-
mations for beginning, peak and end of ow used for the ow reconstructions.
One could therefore expect better correlations between approximated and ac-
tual RM when using invasively measured aortic pressure and ow waveforms,
which might also contribute to the better results reported byWesterhof et al. In
addition, the fact that the results based on the carotid waveforms and synthe-
sized aortic waveforms correlate rather poorly, underlines the need for invasive
data. Furthermore, the age range of our study population is rather narrow.is
might be a reasonwhyno signicant age eectswere noticed in the dierent RM
approximation methods. It is also expected that the physiological ow wave-
form as assessed from this dataset will be less representative for subjects with
age or clinical characteristics far beyond those of our Asklepios population.
4.6 Perspectives
Quantication of wave reection by using a triangular ow wave approxima-
tion shows limited accuracy when applied to non-invasively measured pres-
sure and ow data from our Asklepios population database. A newly proposed
methodmaking use of amore physiological owwaveform yields a signicantly
better agreement between approximated and actual reection magnitude, but
considerable deviations still persist. Unlike the ndings of Qasem et al. [96],
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assessment of pulse transit time, and hence of pulse wave velocity from a single
pulse recording, shows a rather limited correlation with the pulse transit time
measured over the carotid-femoral pathway when tested on our middle-aged
population. It cannot be totally excluded that these relatively poor results are
to a certain extent due to the non-invasive nature of our study, where the ap-
proximation of central aortic pressure by the carotid pressure waveform might
introduce some scatter in the data. Another factor that might play a role is the
limited age range in our population, testing the methods over a limited range
of possible parameter values. However, if the techniques are to be applied clini-
cally, PWV (and wave reection magnitude) will be determined on an individ-
ual basis and based on non-invasive data, and not on a large population with a
wide age range. Also, the age range of the Asklepios population, 35-55, might be
the range of age to start screening for cardiovascular disease andwhere sensitive
methods are required to identify subjects at increased risk.
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The use of diameter distension
waveforms as an alternative for
tonometric pressure to assess
carotid blood pressure
e results of this study were published in:
JanKips, FlorisVanmolkot, DriesMahieu, SebastianVermeersch, Isabelle Fabry,
Jan de Hoon, Luc Van Bortel and Patrick Segers.e use of diameter distension
waveforms as an alternative for tonometric pressure to assess carotid blood pres-
sure. Physiological Measurement 2010, 31:543-553.
5.1 Introduction
Central (aortic) bloodpressure has gained clinical interest, mainly because some
studies have suggested that it has a higher predictive value for cardiovascular
events than peripheral (brachial) blood pressure [117–123]. Carotid blood pres-
sure is oen used as a surrogate for central aortic blood pressure. An invasive
study showed carotid pulse pressure (PP) to dier by only 1.8 mmHg from cen-
tral aortic PP [59].
Unlikemean arterial pressure (MAP), pulse pressure is not constant through-
out the large artery tree, but increases towards the periphery [4, 124], implying
that brachial pulse pressure will generally be higher than aortic or carotid pulse
pressure. e latter can be obtained non-invasively following a well-known,
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linear calibration technique, using applanation tonometry on the brachial and
carotid artery combined with brachial oscillometry [61, 84]. However, high-
quality tonometric readings require a well-trained operator and may be more
dicult to perform in elderly and particularly obese patients [4].
Recently [125], two alternative approaches for estimating carotid artery pres-
sure, using a combination of applanation tonometry performed at the brachial
artery and either linearly or exponentially calibrated diameter distension wave-
forms at the carotid artery, were compared to the more common approach of
using applanation tonometry on the brachial and carotid arteries. Using cali-
brated diameter distension waveforms instead of tonometric waveforms avoids
the technical diculties and necessary operator skills associated with appla-
nation tonometry [59]. e assessment of diameter distension waveforms of
supercial arteries can be performed accurately by ultrasound wall tracking
algorithms [126–128] which require less training and can more easily be per-
formed in obese patients. For calibration, however, these alternative approaches
still rely on tonometry readings performed at the level of the brachial artery, of
which the feasibility of performing a reliable tonometricmeasurement has been
questioned recently [129, 130].
It is the aim of this study to evaluate a methodology for non-invasive es-
timation of carotid pulse pressure based solely on diameter distension wave-
forms obtained at the brachial and carotid arteries.e results of this approach
will be compared to the pulse pressures obtained through tonometry at both
the carotid and brachial arteries and to the more recently proposed approach
of combining tonometric readings at the brachial artery with linearly or ex-
ponentially calibrated diameter distension curves at the carotid artery. As an
intermediary step, the morphology of brachial and carotid tonometry and dis-
tension waveforms will be compared and themean arterial pressure (MAP) will
be computed using either tonometry or distension curves.
5.2 Methods
5.2.1 Study population
Brachial (BA) and common carotid artery (CCA) distension (D) and tonom-
eter (T) waveforms recorded for two previous studies were used [131, 132]. A
total number of 148 subjects was selected, none of whom had a history of cere-
brovascular or cardiovascular disease, arterial hypertension (>90/140 mmHg),
diabetes mellitus, hyperlipidaemia (total cholesterol >6.5 mmol/l), or were cur-
rently pregnant or lactating. Subjects on regular use of vasoactive drugs were
excluded. Subjects were allowed 10-15 min of rest in a temperature controlled
environment before the examinations.
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5.2.2 Measurement of local pressure and distension
Brachial oscillometric blood pressure was measured using either an Omron
705IT (OMRON Healthcare, Hoofddorp,e Netherlands; 100 subjects) or a
Dinamap 950 (Critikon Inc, Tampa, Florida; 48 subjects). Applanation tonom-
etry was performed using a Millar pen-type tonometer (SPT 301, Millar In-
struments, Houston, Texas) and computer soware (SphygmoCor, Atcor Med-
ical, Sydney, Australia). Distension waveforms were obtained with an ultra-
sound wall tracking system (Esaote AU5 or Scanner 350, Esaote-Pie Medical,
the Netherlands). An ultrasound probe holder was used at the brachial artery
to ensure that the distension curves were not deformed by the pressure exerted
on the probe.
5.2.3 Waveform calibration
At the brachial artery, both tonometry and distension waveforms were linearly
calibrated using SBP and DBP obtained from oscillometry. For each wave-
form type, MAP was calculated as the arithmetic mean of the scaled wave-
form. Hence, for each subject, two estimates are given: MAPT obtained from
the tonometric waveform, andMAPD obtained using the distension waveform,
respectively. At the carotid artery, diameter waveforms were calibrated using
a linear and an exponential calibration scheme. Both calibration schemes are
based on the assumption that DBP and MAP remain constant throughout the
large arteries. In the linear calibration scheme, the diameter waveform is cali-
brated by assigning the minimum and mean value of the curve to the brachial
DBP and MAPT or MAPD, respectively [59]. For the exponential calibration,
an iterative procedure was followed as rst described by Meinders et al. [133].
In brief, the diameter waveforms are scaled assuming an intrinsic exponential
relation between pressure and diameter:
p(t) = pdeα( d2(t)d2d −1), (5.1)
where p(t) is the pressure waveform, d(t) the diameter waveform, pd the di-
astolic blood pressure, dd the diastolic diameter and α the wall rigidity coef-
cient. An iterative scheme can be followed to calculate α based on DBP and
MAPT . In summary, by combining brachial and carotid tonometer and disten-
sion waveforms, we obtain four dierent estimates of carotid PP indicated by
the following subscripts:
• PTT : using brachial and carotid tonometer waveforms (considered here
as the reference value)
• PTDl in: using brachial tonometer and linearly scaled carotid distension
waveforms [125]
• PTDexp: using brachial tonometer and exponentially scaled carotid dis-
tension waveforms [125]
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• PDD: using linearly scaled brachial and carotid distension waveforms
PTT will be considered as the reference method in further analyses since it is
accepted to be the most accurate non-invasive method to assess local pressure
[59].
5.2.4 Waveform comparisons
To assess whether scaled diameter waveforms can be used as a surrogate for
tonometry waveforms and to investigate the impact of the dierent calibration
methods, two morphological parameters are calculated to quantify the overall
agreement between the scaled diameter and the tonometric waves. e root-
mean-squared error (RMSE) is ameasure of the absolute dierence between the
scaled diameter and tonometry waveforms and, as such, allows to quantify how
closely the values of the waveforms match across the entire waveform. RMSE is
calculated between the reference carotid waveform (PTT) and each of the ve
other approaches (generically called ’Papprox ’ hereaer) as :
RMSE = √∑n1 (Papprox ,i − PTT ,i)2
n
(5.2)
e form factor (FF) [134] is a measure of how peaked the waveform is, and is
dened as the ratio of the dierence between the mean and minimum value of
the wave and its amplitude (maximal -minimal value): FF=(mean-minimum) /
amplitude, see gure 5.1. Unlike RMSE, FF is independent of calibration for the
linear calibration scheme, which allows a comparison between carotid disten-
sion and tonometry waves, irrespective of which curve was used at the brachial
artery. Moreover, the form factors of brachial and carotid curves are important
determinants of the carotid pulse pressure, which renders them more relevant
for this study than the overall match between two waveforms as expressed by
the RMSE-value.
5.2.5 Statistical analysis
Data are presented as mean (SD). Relative errors inmean and peak pressure are
reportedwith respect to pulse pressuremeasured at the brachial artery with cu
sphygmomanometry. Correlation between variables was assessed using Pear-
son correlation coecients. Eects of gender were assessed using ANOVA ana-
lysis. P-values lower than 0.05 were considered as statistically signicant. To
assess the major determinants of the dierences in carotid PP estimates, a step-
wise forward multiple linear regression analysis was performed including age,
gender, length, BMI and brachial PP as potential factors. Only the factors that
were signicant in univariate analysis were entered into multivariate analysis.
A univariate general linear model was constructed to assess whether the form
factor diered between the carotid and brachial artery, and between distension
and tonometer waveforms. All analyses were performed using SPSS 15 (SPSS
Inc., Chicago, IL, USA).
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Figure 5.1: Distension waves (black) obtained via echo-tracking are less peaked than tonometric
waves (grey).e tonometric wave was normalized, whereas the distension wave was calibrated
to have same mean and minimal value as the tonometric wave.
5.3 Results
General clinical characteristics of the population can be found in table 5.1.
Table 5.1: General description of the study population.
Parameter Data
Subjects (male/female) 148 (29/119)
Age (years) 29.6 (10.1)
Weight (kg) 66.8 (11.6)
Length (cm) 171.0 (7.8)
BMI (kg/m2) 22.8 (3.3)
Systolic BP (mmHg) 113.2 (9.8)
Diastolic BP (mmHg) 68.0 (7.1)
PP (mmHg) 45.2 (7.4)
Heart rate (bpm) 64.4 (9.0)
Data are presented as mean (SD) unless otherwise
specied. BMI indicates body mass index.
5.3.1 Comparing waveforms by form factor
When comparing tonometry and distension waveforms at the same location by
their form factor, we nd a higher FF for distension than for tonometry wave-
forms at both the brachial and the carotid site (table 5.2). When looking at
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dierences between brachial and carotid artery waveforms, we nd brachial FF
(both FFD and FFT) to be lower than carotid FF. However, the relation between
the form factor of the tonometer and distension waveforms is not dierent for
the carotid and brachial artery, as can be seen in gure 5.2. e interaction
term between location (brachial or carotid) and technique (tonometer or dis-
tension) was not signicant (p=0.75) in the general linear model. Additionally,
both brachial and carotid FF (both FFD and FFT) were signicantly higher in
women than in men. is dierence remained signicant aer correction for
height and heart rate.
Table 5.2: (A): Mean (SD) values of brachial and carotid form factors derived from tonome-
ter (FFT ), linearly scaled distension waves (FFDl in) and exponentially scaled distension waves
(FFDex p). (B): Mean (SD) values of PP and RMSE for the dierent carotid pressure waveforms.
(A) Mean (SD)
brachial FFT 40.0 (3.8)
FFD 46.2 (3.3)
carotid FFT 45.4 (3.3)
FFDl in 51.4 (3.0)
FFDex p 43.6 (6.3)
(B) PP (mmHg) RMSE (mmHg)
PTT 39.9 (8.7)
PDD 40.8 (7.8) 5.0 (2.1)
PTDl in 35.1 (7.3) 3.5 (1.8)
PTDex p 42.5 (12.7) 3.9 (2.5)
PP, Pulse Pressure; RMSE, root-mean-squared error.
5.3.2 MAPD versus MAPT
e use of diameter distension waveforms instead of tonometry waveforms to
calculate MAP introduces a dierence of 6.2% or 2.8(1.8) mmHg. MAPD was
higher than MAPT : 88.8(7.8) versus 86.0(8.0) mmHg. ere was an excellent
correlation between both estimates (R=0.97), but the dierence was highly sig-
nicant (P<0.001), see gure 5.3.
5.3.3 Carotid pulse pressure
Table 5.2 lists the resulting carotid pulse pressure values for the dierent ap-
proaches, as well as the RMSE values associated with each approach. PDD,
the pressure waveform obtained via linearly scaled diameter waveforms at the
brachial and carotid arteries, yields the carotid PP closest to the reference tech-
nique: 40.8 (7.8) mmHg compared to 39.9 (8.7) mmHg for PTT .e dierence
between both techniques depended on age only (table 5.3). Figure 5.4 shows
the correlation between the reference carotid PP (PPTT) and the value obtained
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Figure 5.2: Relation between distension and tonometric form factors at brachial and carotid
artery: regression plots (A,B) and Bland-Altman plots (C,D).
with three other approaches, as well as the corresponding Bland-Altman plots.
PTDl in, the approachusing brachial tonometry and linearly scaled carotid diam-
eter waveforms yielded the highest correlation (R=0.97) and the smallest RMSE
with the reference technique. However, PTDl in underestimates the carotid PP
on average by 4.8 mmHg.
Table 5.3: Inuence of confounding factors on the dierence in carotid pulse pressure (PP) es-
timates.
Variable Determinant (cumulative) R2 β SE normalized β
PPDDl in - PPTT Age 0.10 -0.16 0.04 -0.32
PPTDl in - PPTT PPbra 0.21 -0.13 0.02 -0.39
Age + PPbra 0.29 -0.09 0.02 -0.36
Age + HR + PPbra 0.34 0.06 0.017 0.24
PPTDex p - PPTT Age 0.42 0.36 0.04 0.53
Age + HR 0.51 0.21 0.04 0.34
Age + HR + PPbra 0.54 0.18 0.05 0.20
HR, heart rate (bpm); PPbra , brachial PP from oscillometry (mmHg). We refer to the text for
explanation of the abbreviated PP approaches.
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5.4 Discussion
e results from the present study suggest that, when diameter distensionwaves
are used as an alternative to tonometry pressure readings at the carotid and/or
brachial arteries, it is recommended to measure diameter distension waves at
both the brachial and carotid arteries, instead of combining tonometer waves
at one artery with distension waves at the other artery. Although previous stu-
dies have assessed carotid pressure using only diameter distension waves [59]
or using brachial tonometry and carotid distension waves [125], an approach in
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which carotid pulse pressure is calculated using brachial and carotid distension
curves has not been tested before. Given the reported problems with brachial
tonometry, this approach might have clinical relevance. Furthermore, it should
be noted that calibrated tonometric curves might not exactly coincide with in-
vasively measured pressure waves, due to limitations inherent to the principle
of applanation tonometry. In theory, there should be a constant balance be-
tween (internal) blood pressure and applied pressure, i.e. a constant position
throughout the cardiac cycle.is creates a problem during peak and late sys-
tole where the reboundmay temporarily induce an outwardmotion and, hence,
an underestimation of blood pressure. Likewise, a pressure overestimation can
be anticipated in early systole. Another issue with applanation tonometry is the
questioned reliability in obese subjects. e tonometer has to sense through
more (fatty) tissue, and the artery cannot condently be attened as there is
less direct support of bone behind the artery.
Brachial and carotid distension waveforms were found to be signicantly
"atter" (i.e., having a higher form factor) than the corresponding tonometric
waves. e fact that distension waveforms were atter than tonometric wave-
forms can be explained by the non-linear pressure-diameter relationship, which
blunts at higher pressures (i.e., the vessel distends less with increasing pres-
sure due to the increasing recruitment of collagen bers in the stretched vessel
wall).is non-linear relation between pressure and diameter was the rationale
for using an exponential calibration scheme [133]. A particular consequence
of the dierence in "peakedness" between tonometry and diameter-tracings is
that the MAP determined from the area under the brachial distension wave-
form is on average 2.8 mmHg (6.2% of the pulse pressure) higher than MAP
obtained via brachial tonometer waveforms.is dierence inMAP has an im-
portant impact on the dierences between the various carotid pressure waves,
since each calibration method on the carotid artery is strictly dependent on the
(brachial) MAP. Although the two MAP-estimates correlate well, this correla-
tion is highly enhanced by the use of the same (sphygmomanometrically ob-
tained) SBP and DPB to scale the brachial pressure and distension waveforms
for each subject. To eliminate this eect, one could compare MAPT-DBP to
MAPD-DBP. Given, however, the denition of the form factor and the fact that
PP at the brachial artery is the same, irrespective of themeasurement technique,
the ’unscaled’ correlation is nothing but the relation between FFD and FFT at
the brachial artery, which is displayed in gure 5.2. is correlation is notably
lower (R=0.47).
When comparing the dierent carotid pulse pressure values, the dierence
between PPDD and PPTT is the lowest, being 0.9 (4.9) mmHg or 2.3%. It is even
lower than the dierence between MAPD and MAPT , which seems to imply
that a part of the dierence introduced by using a distension waveform at the
brachial level is compensated by the second use of a distension waveform at the
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carotid artery.is can easily be understood when taking into account that
PPCCA = FFBAFFCCAPPBA. (5.3)
is illustrates that the pulse pressure at the carotid artery is determined by the
ratio of the brachial and carotid form factors.erefore, systematic dierences
in FFBA and FFCCA are partially compensated for. MAP, on the other hand, is
determined by the brachial form factor only. When using tonometer curves at
both sites, the ratio FFBA/FFCCA is 0.88 (see table 5.2) versus 0.90 when using
distension data at both sites, explaining why the dierence between PPDD and
PPTT is smaller than the dierence between PPTDl in or PPTDexp and PPTT ,
respectively (where the ratio FFBA/FFCCA is 0.78 and 0.92, respectively).
Using brachial tonometer and carotid distension waves to calculate carotid
pulse pressure (PPTDl in) yielded the estimate with the highest correlation with
PPTT , but a considerable underestimation of 4.8(2.5) mmHg when compared
to PPTT . is is in line with the results of Vermeersch et al., who found the
same approach to underestimate PPTT by 6.4 mmHg in a large population of
middle-aged people [125].ey found that the underestimation was highly de-
pendent on brachial PP, with increasing underestimation for higher brachial
PP. We could conrm this dependency on brachial PP in our population (table
5.3), which also explains why our PPTDl in performs somewhat better than in
the study of Vermeersch et al., where the average brachial pulse pressure was
higher (56.2 vs. 45.2 mmHg).
e added value of an exponential calibration scheme for carotid diameter
distension waves in combination with brachial artery tonometry is arguable.
Although exponential calibration yields a form factor and pulse pressure closer
to the reference (FFT and PPTT , respectively), the overall t between the ex-
ponentially scaled diameter waveform and the tonometric reference waveform
was poorer than for a linearly scaled diameter waveform (table 5.2).
eoretically, two other - non-reported - approaches to obtain a carotid
pressure wave are possible: a rst one combining brachial distension curves
with carotid tonometry, and a second one using linearly scaled brachial disten-
sion and exponentially scaled carotid distension curves. Both methods were
tested on the study population, but yielded considerable overestimations of
carotid PP: 16% and 25%, respectively (data not shown).
One important limitation of this study is the absence of invasive pressure
data as a reference to compare the results of the dierent non-invasive approaches.
Furthermore, the limited sample size and age range of our populationmay ham-
per the generalizability of our results. A nal point of debate is the questioned
practical feasibility of brachial applanation tonometry as argued by O’Rourke
and colleagues [129, 130]. Figure 5.2 shows that the relation between the form
factor of the tonometer and distensionwaveforms is not dierent for the carotid
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and brachial arteries in our population. Since it can be reasonably assumed that
the reliability of distensionmeasurements is the same at the carotid and brachial
arteries, this may suggest that applanation tonometry was acquired with a simi-
lar degree of reliability at the brachial and carotid arteries and supports the fea-
sibility of applanation tonometry as a reliable technique to obtain non-invasive
pressure waveforms at the brachial artery.
5.5 Conclusions
In conclusion we can state that, when aiming to assess carotid artery pres-
sure non-invasively, the use of linearly scaled diameter distension waves at the
brachial and carotid arteries introduces only a small error (0.9 mmHg) com-
pared to the reference approach with brachial and carotid tonometry curves.
erefore, it is recommended to stick to one technique, either tonometry or
diameter distension waves, rather than using a mix of both techniques.
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Non-invasive assessment of central
and peripheral arterial pressure
waveforms: implications of
calibrationmethods.
e results of this study were published in:
Dries Mahieu, Jan Kips, Ernst R. Rietzschel, Marc L. De Buyzere, Francis Ver-
beke, ierry C. Gillebert, Guy G. De Backer, Dirk De Bacquer, Pascal Ver-
donck, Luc M. Van Bortel, Patrick Segers, on behalf of the Asklepios investi-
gators. Noninvasive assessment of central and peripheral arterial pressure (wave-
forms): implications of calibrationmethods. Journal ofHypertension 2010, 28:300-
305.
6.1 Introduction
e past decade has known an increasing interest in central bloodpressuremea-
surement and pressure waveform analysis. Some studies even suggest that cen-
tral blood pressure has a higher predictive value compared with the traditional
sphygmomanometer measurement at the brachial artery level [117, 120].
One non-invasive approach to central blood pressure is to use the carotid
(or subclavian) pressure waveform, obtained via applanation tonometry, as a
surrogate [61, 84, 135]. It has been shown that carotid tonometry overestimates
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central aortic systolic blood pressure by only 1.8 mmHg [59]. Applanation to-
nometry on the carotid artery, however, implies some diculties: in addition
to the fact that these waveforms require calibration, the absence of underlying
bone makes it more dicult to stabilize and atten the artery, which requires
trained personnel. Another technique is to derive central pressure waveforms
from non-invasive radial artery pressure waveforms (by applanation tonome-
try) and applying a generalized transfer function [54, 111, 136–139]. Irrespective
of the validity of the principle of using a generalized transfer function [140, 141],
the method also requires calibration of the radial pressure waveform.
In a non-invasive procedure, the only information available to calibrate
tonometer pressure waveforms is the pressure as measured by cu sphygmo-
manometry, generally providing systolic (SBP) and diastolic (DBP) blood pres-
sure. For the calibration of the tonometer curve at the carotid artery, it is most
common to calibrate this waveform using diastolic and mean (MAP) blood
pressure, assuming that these two pressures (or the dierence between them)
remain rather constant throughout the arterial tree [58]. MAP is then com-
monly estimated from SBP and DBP using approximative equations such as
the well-known rule of thumb (MAP= DBP + 1/3 PP, with PP=pulse pressure).
For the calibration of the radial artery waveform, two approaches can be fol-
lowed: one can either again use DBP and MAP to calibrate the radial pres-
sure waveform, but it is also common to simply calibrate the radial curve using
brachial DBP and SBP.is way, the eventual brachial-to-radial amplication
of the pressure pulse is ignored. e debate on the importance of brachial-to-
radial amplication is still ongoing [142, 143].
When adhering to the calibration based on DBP and MAP, an issue which
is given relatively little attention is the estimate of MAP. Given the fact that it
is basically the dierence between DBP and MAP (which is in the range of 15
to 20 mmHg in normotensive subjects) that determines the calibration of the
radial and carotid pressure waveforms, errors in MAP of a few mmHg may
have a large impact on the result obtained aer calibration. Some oscillometric
devices assess MAP, however these MAPs have never been validated [144–146].
e still most widely used technique is to derive MAP using the well known
rule of thumb. Recently, the applicability and accuracy of this simple formula
has been questioned, in particular the fraction of PP which should be added
to DBP [147, 148]. Bos et al. reported that, at the brachial artery site, 40% of
PP should be added to DBP instead of 33% as used in the one-third rule [60].
is dierence could have an important impact on non-invasive assessment of
central blood pressure when applying the methods mentioned above.
e purpose of this study, based on the population data from the Asklepios
study [94], is to investigate the inuence of dierent calibration methods of
the radial pressure waveform on the estimate of central blood pressure and to
analyze the obtained central-to-brachial and brachial-to-radial pulse pressure
amplication following the dierent calibration schemes.
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6.2 Materials and methods
e Asklepios study cohort consists of 2524 volunteers (aged between 35 and 55
years) and 1873 subjects were suitable for this specic analysis. For these sub-
jects, applanation tonometry data were available at the radial (RA) and carotid
artery (CA).e study was approved by the local ethics committee and written
informed consent was obtained from all subjects. All mathematical calcula-
tions were done usingMatlab (eMathWorks, Natick, Ma), automatically in a
blindedway. Subjects were allowed 10-15min of rest in a temperature controlled
environment before the examinations. First, SBP and DBP were measured with
a validated oscillometric blood pressure monitor, Omron HEM-907 (Omron
Matsusaka Co. Ltd., Japan) [149, 150]. Direct measurement of MAP was not
available with this device. is was followed by radial and carotid tonometry
(gure 6.1). Tonometry measurements were done using a custom built acqui-
sition system with a pen tonometer (SPT 301, Millar Instruments, Houston,
Texas, USA) and a soware platform developed in Matlab (e Math Works,
Natick, Ma) [61, 84].
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Figure 6.1: Schematic overview of the tonometry measurements and dierent calibrationmeth-
ods (CB=R ,C1/3rd ,C40%). First, the brachial artery pressure waveform is calibrated with absolute
blood pressure measured with the sphygmomanometer. Radial and carotid waveforms are cal-
ibrated with the three dierent methods. A transfer function is applied to the calibrated radial
pressure waveform in order to assess central blood pressure.
6.2.1 Central blood pressure from radial artery pressure waveforms
ree dierent calibration methods were used to calibrate the radial pressure
waveforms:
• (i) (CB=R): In the rst method, we assumed the brachial systolic and dias-
tolic blood pressure equal to the radial systolic and diastolic blood pres-
sure .
• (ii) (C1/3rd ): Secondly, the radial pressure waveforms were calibrated us-
ingDBP andMAP, estimated with the one-third rule applied to the PPBA.
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• (iii) (C40%): Instead of adding 33% of the pulse pressure to the diastolic
blood pressure, we used 40%of the PPBA to assessMAP in a thirdmethod
(calibration as advocated by Bos et al. [60]).
e transfer function (TF), published by Karamanoglu et al. [138] was ap-
plied to calculate central blood pressure waveforms from the radial pressure
waveform. Although not exactly the same, this TF is very similar to the one
implemented in the Sphygmocor system or to the TF published by Chen et al.
[111].
6.2.2 Carotid blood pressure as surrogate for central blood pressure
Carotid tonometrywas performed for comparisonwith estimated central blood
pressure. e carotid pressure waveforms were calibrated in the same three
dierent ways as described above.
6.2.3 Central-to-brachial and brachial-to-radial pressure amplication
e absolute central-to-brachial (CTB-amp) andbrachial-to-radial systolic pres-
sure amplication (BTR-amp)was determined by the dierence between carotid
and brachial, brachial and radial pulse pressures respectively, while the relative
CTB and BTR-amp was calculated as a percentage of the carotid and brachial
PPs respectively. Amplicationwas calculated for calibrationmethods (ii) (C1/3rd )
and (iii) (C40%) while amplication is ignored in method (i).
6.2.4 e form factor
e form factor (FF), dened as the percentage of the amplitude of the wave-
form to be added to the minimal value to obtain the mean value, was calculated
with the following formula:
FF = mean(Pw f ) −min(Pw f )
max(Pw f ) −min(Pw f ) (6.1)
with Pw f the measured pressure waveform andmean the calculated arithmetic
mean. Min and max are the minimum and maximum of the waveform respec-
tively.
6.2.5 Statistical analysis
Data are presented as mean (standard deviation). A p-value lower than 0.05
was considered statistically signicant. Dierences were examined by paired-
samples t tests or independent-samples t tests where applicable. Statistical ana-
lysis was performed using SPSS 15 (SPSS Inc., Chicago, United States).
6.3 Results
emedian age of subjects was 46 years (interquartile range [IQR], 41-51 years).
A summary of the subject characteristics is presented in table 6.1.
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Table 6.1: Subject characteristics for the study cohort of 1873 subjects from the Asklepios popu-
lation.
Men Women
Amount 978 895
Age (years) 46.1 (6.0) 45.5 (6.2)
Height (cm) 175.6 (6.4) 163.2 (6.0)
Body mass index (kg/m2) 26.0 (3.4) 24.3 (4.1)
Hypertensives (treated) 93 84
Hypertensives (untreated) 222 89
Normotensives 676 735
SBPBA (mmHg) 134.1 (14.0) 128.6 (15.9)
DBPBA (mmHg) 77.9 (10.7) 75.1 (10.7)
MAPBA(mmHg) 101.0 (11.6) 98.4 (12.3)
Heart rate (beats/min) 61.5 (9.8) 65.0 (8.7)
Data are presented as mean (SD). BA, brachial artery.
Hypertension is dened as SBP>140 or DBP>90.
6.3.1 Estimated central blood pressure
Central pressure assessed either via radial artery pressure waveforms and the
transfer function or via carotid tonometry, is given in table 6.2 for each calibra-
tion method. When estimating central systolic pressure from the radial pres-
surewave, the value varies from 117.8 (14.2)mmHg (C1/3rd ) to 126.0 (15.4)mmHg
(C40%). Carotid systolic blood pressure varied from 118.4 (14.4) mmHg (C1/3rd )
to 131.4 (15.2) mmHg (CB=R).
Table 6.2: Carotid tonometry and transfer function derived central blood pressure (in mmHg),
obtained aer application of three dierent calibration methods to the measured carotid and
radial artery pressure waveforms
BTR-amp Calibration Carotid artery TF-derived Dierence
included? method SBPCA SBPTF SBPCA − SBPTF
No CB=R SBPBA & DBPBA 131.4 (15.2) 123.5 (15.7) 7.9 (4.9)
Yes C1/3rd 1/3rd rule 118.4 (14.4) 117.8 (14.2) 0.6 (3.1)
Yes C40% 40% PP 126.8 (15.7) 126.0 (15.4) 0.8 (3.8)
BA, brachial artery; BTR-amp, brachial-to-radial amplication; CA, carotid artery
PP, pulse pressure; TF, transfer function.
6.3.2 Central-to-brachial and brachial-to-radial systolic pressure
amplication
When waveforms were calibrated following the one-third rule (C1/3rd ), the am-
plication of pulse pressure from carotid to radial artery was 6.7 (5.6) mmHg,
with an amplication from carotid to brachial of 13.0 (3.6) mmHg and a damp-
ing of -6.3 (4.5) mmHg from the brachial to radial artery. When calibrating
the waveforms using C40% method, the total amplication was 8.1 (6.7) mmHg,
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with a carotid-to-brachial amplication of 4.6 (3.8) mmHg, and a brachial-to-
radial amplication of 3.4 (5.5) mmHg. e relative central-to-brachial and
brachial-to-radial pulse pressure amplication for each calibration method is
also presented in gure 6.2. Obviously, when assuming equal carotid, brachial
and radial SBP, amplication is ignored.
Figure 6.2: Relative pressure amplication, central to brachial (CTB-amp) and brachial to radial
(BTR-amp), for calibration method C40% and C1/3rd for dierent age ranges.
6.3.3 Form factor
e form factor was higher at the carotid (43.9 (3.3)%) than at the radial artery
(38.1 (3.3)%; see also table 6.3.3). FFRA was 2.7 (0.1)% higher in women than
in men (p<0.001). FFCA was also signicantly higher in women than in men,
but only by 0.3% (p<0.05). While FFRA was 0.6 (0.2)% higher in hypertensives
compared to normotensives (p<0.001), FFCA was 0.5 (0.2)% lower in hyperten-
sives (p<0.020).
Table 6.3: Radial and carotid FF in the Asklepios population.
Normotensive Hypertensive Men Women Total
(n=1390) (n=483) P (n=978) (n=895) P (n=1873)
FFRA (%,SD) 37.9±3.3 38.5±3.2 0.001 36.8±3.1 39.5±2.9 0.001 38.1±3.3
FFCA (%,SD) 44.2±3.1 43.7±3.6 0.020 43.8±3.2 44.1±3.4 0.040 43.9±3.3
P-values are given for the dierence between normotensives and hypertensives, men and women respectively
FFCA, carotid artery form factor; FFRA, radial artery form factor.
6.4 Discussion
e major nding of this study is that the value of MAP that is used to calibrate
applanation tonometry waveforms is of paramount importance for the non-
invasive assessment of (central systolic) blood pressure. In particular, the use
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of MAP estimated with the widely applied one-third rule leads to results con-
tradicting prevailing insights in arterial physiology and central-to-peripheral
pressure amplication.is provides indirect proof that the 1/3rd factor for the
calculation of MAP is too low, and is better replaced by a factor close to 40%.
It is clear that the method used to calibrate tonometric waveforms is essen-
tial when estimating central blood pressure. As can be seen in table 6.2, for the
carotid artery, use ofMAP1/3rd orMAP40% for the calibration introduces amean
dierence of around 8mmHg in estimated carotid systolic blood pressure. Sim-
ilar dierences are foundwhen estimating central systolic blood pressure via the
radial artery and a pressure transfer function.
However, it is also observed that when calibration of the radial and carotid
waveforms is performed using MAP and DBP (with MAP derived either using
C1/3rd or C40%) the dierence between TF and carotid derived central pressures
is small (below 0.8 mmHg; table 6.2) which is in full agreement with previous
ndings from our group [84, 151]. is supports the use of TF for estimating
central systolic and pulse pressure - provided the radial pressure waveforms are
calibrated appropriately [84, 151]. As the TF published by Karamanoglu et al. is
close to the one used in the SphygmoCor system, we expect our conclusions to
be also applicable to this system.
When using the SphygmoCor system, it is common to apply the transfer
function to the radial pressure waveform which is calibrated using brachial di-
astolic and systolic blood pressure, ignoring brachial-to-radial amplication. It
can be deduced from table 6.2 that the value found for central systolic pressure
(123.5(15.7) mmHg) is relatively close to the value of carotid systolic blood pres-
sure obtained when calibrating the carotid waveform using C40% (126.8 (15.7)
mmHg). Especially given the knowledge that central systolic blood pressure is
about 2mmHg lower than carotid pressure, the two values are remarkably close.
Intriguingly, when we used the one-third rule to assess MAP (C1/3rd ) for
calibration of the radial and carotid waveforms, we found a total carotid-to-
radial amplication of 6.7 (5.6) mmHg, but with a very strong amplication up
to the brachial artery, followed by damping (a negative value for the brachial-to-
radial systolic pressure amplication) over the brachial-to-radial path.is is in
contrast with the knowledge of increasing pulse pressure towards the peripheral
arteries. We therefore consider this to be non-physiological [4], and important
indirect evidence that the one-third rule is not the most accurate method to
estimate MAP.
When estimatingMAP using the one-third rule, one assumes a form factor
of 33%. As can be observed in table 6.3.3, the FFs we found at the carotid and
radial level are higher than the conventionally applied 33%, and are in line with
the values obtained in the invasive studies by Bos [60] and Chemla [148]. In the
former, a form factor of 39.5% was found at the brachial artery. Chemla et al.
calculated the form factor at aortic root level and found a value of 41.2%. e
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somewhat higher values for the FF in our study may be attributable to the non-
invasivemethod used, i.e. applanation tonometry calibrated with an automated
blood pressure monitor and a younger population. Also, our population age
range was only 20 years (35-55) compared to 34-83 years for the study of Bos et
al. As early wave reections in older subjects increase pulse pressure, the lower
FF in the study of Bos et al. might also (in part) be explained by the dierence
in age between the groups. Note also that we found the FF to decrease from
the carotid (43.9 (3.3)% ) to the radial artery (38.1 (3.3)%), which is consistent
with a progressive peaking of the pressure waveform and central-to-peripheral
pressure amplication.
It is clear from these studies that use of the one-third rule leads to under-
estimation of MAP. Question is then which value of the form factor should be
used to obtain more reliable values of MAP. Bos et al. suggest to use 40% at the
brachial artery, but a drawback of their study is the lack of normotensive sub-
jects, and their results may only be applicable to hypertensives. On the other
hand, our results showed relatively small dierences in form factor between
normo- and hypertensives. Nevertheless, the FF was higher in women than
in men at all locations (table 6.3.3). As such, the optimal formula to estimate
MAP from brachial DBP and SBP should account for gender (or hemodynamic
and/or body size factors explaining these gender eects).
We previously advocated amethod to estimateMAP as the arithmeticmean
value of a calibrated brachial tonometric pressure waveform [84, 151]. As our
main goal was to demonstrate some of the inconsistencies that are obtained
when using MAP1/3rd to calibrate tonometer waveforms, and as there is still
some debate regarding the applicability of this method, we chose not to report
the data obtained using that method in order not to divert the debate. Anyhow,
given the fact that the average FF of the brachial curve is around 42% in our
population (data not shown), the results obtained with that method are close to
C40%, although that method yields a somewhat lower carotid-to-brachial and
higher brachial-to-radial amplication.
6.5 Limitations
It is clear that the most important limitation of the study is the lack of invasive
measurements as reference. However, to the knowledge of the authors, this
is the rst study with non-invasive data supporting the ndings of Bos [60]
and Chemla [148], which are based on invasive data. Also, carotid tonometry
measurements have been used as reference for central blood pressure, while it
has been shown that carotid tonometer derived systolic blood pressure in itself
is on average 1.8 mmHg higher than the invasive central aortic pressure [59]. In
the present study, this dierence (between carotid and central systolic pressure
derived with a TF) was 0.8 mmHg. Nevertheless, this has no impact on our
results in general.
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6.6 Conclusion
ese ndings indicate that the one-third rule should not be used to estimate
MAP frombrachial artery pressurewithin the calibration process of non-invasive
pressure waveforms. We therefore support the use of the value of 40% above the
one-third rule as advocated by Bos et al.
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Ambulatory Arterial Stiffness Index
(AASI): another ambiguous stiffness
index
e results of this study are assembled in:
Jan Kips, Sebastian Vermeersch, Philippe Reymond, Pierre Boutouyrie, Nikos
Stergiopulos, Stephane Laurent, Luc Van Bortel, Patrick Segers. Ambulatory
Arterial Stiness Index (AASI) does not accurately assess arterial stiness, sub-
mitted for publication to Journal of Hypertension.
7.1 Introduction
Arterial stiness is increasingly recognized as an early marker of and impor-
tant risk factor for the development of cardiovascular diseases [55, 152]. e
gold standard technique to assess arterial stiness is pulse wave velocity (PWV)
[55], which, though straightforward and relatively easy to perform, still requires
measurements at two separate arterial locations, remaining cumbersome for
routine clinical practice. A relatively new parameter, the Ambulatory Arterial
Stiness Index (AASI) was recently proposed as a surrogate measure for ar-
terial stiness. is method is based on (24-hour) ambulatory recordings of
blood pressure, and is calculated as 1 - (the slope of the linear regression line
between systolic and diastolic blood pressure values) [98, 99]. Previous studies
have shown that AASI correlates well with PWV [98], and that it has predic-
tive value for cardiovascular mortality [153, 154], in particular for stroke [155].
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As such, it appears to provide additional value to the 24-hour blood pressure
recording. However, several other studies have questioned whether AASI truly
is ameasure of arterial stiness [156–160] andwhether it can be used as an alter-
native for PWV [161]. It has been suggested that the AASI is largely inuenced
by peripheral resistance and by ventriculo-arterial coupling [158, 159]. Others
reported the degree of nocturnal BP fall as an important confounder to AASI
and its interpretation as a measure of arterial stiness [156].
In the present study, this ongoing discussion is addressed using a computer
model of the le heart and systemic arterial circulation [97]. e aim of this
study is to explore the determinants of the AASI and to assess their relative im-
portance in a well-controlled setting with exact knowledge of all cardiovascular
parameters in order to assess to which extent AASI can be used as a measure of
arterial stiness.
7.2 Methods
Ambulatory blood pressure (BP) recordings were simulated using a previously
validated and applied 1-D model of the arterial circulation (represented by one
hundred and three arterial segments). On the downstream end, terminal beds
are mimicked with so-called 3-element Windkessel models. For each segment,
properties such as distensibility, diameter, and length can be individually ad-
justed. Changes in arterial resistance can be simulated by changing the resis-
tance properties in the distal models.e interaction of the heart with the arte-
rial tree is included in the simulations, with the heartmodeled as a time-varying
elastance model. is implies that blood pressure (or stroke volume) can not
directly be altered as an input parameter of the system but is the result of the
interaction between the heart and its arterial load, similar to the in vivo situa-
tion. We refer to Reymond et al. [97] for details on the properties of individual
segments and the computational methods used to solve the 1-D ow equations.
7.2.1 AASI in the "default" subject
e AASI of a ’default subject’ was calculated by generating multiple BP-values,
mimicking regular ambulatory BP-measurements over the course of a day. Each
BP-value was the result of a dierent set of input parameter values. Input pa-
rameters that were changed include both cardiac (maximal elastance, heart rate,
venous lling pressure) and vascular (resistance, distensibility) parameters. Ar-
terial distensibility, resistance, venous pressure, maximal elastance and heart
rate were altered within a ±20% range around their initial value in steps of 10%.
Permutations of these ve parameters, each with ve possible values, lead to
3125 dierent sets of input parameter values and corresponding BP-values.e
initial values of themodel parameters were chosen, eachwithin their physiolog-
ical range, to yield a mean brachial BP of 120/80 mmHg [162, 163].e applied
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variation of ±20% is considered to be representative of the physiological uctu-
ations occurring over the course of one day. Vascular resistance was changed by
multiplication of the default resistance value of each segment with a constant
factor (i.e., we did not consider eects of dierential changes in the resistance
of vascular beds).
To calculateAASI for the default subject, 72 BP-valueswere randomly picked
out of the total number of available BP-values, hereby mimicking the number
of BP-recordings obtained during 24-hour ambulatory BP-monitoringwith one
BP-recording every 20 minutes.is random selection of 72 BP-values was re-
peated 10 000 times and a histogram of AASI-values was constructed.is ap-
proach also serves to illustrate the eect of sampling the continuously varying
blood pressure at a number of discrete moments in time, which is unavoidably
the case when using ambulatory blood pressure values.
7.2.2 Contribution of cardiac and arterial parameters to AASI in the
default subject
Table 7.1 provides an overview of the simulations used to assess the eect of
individual parameters. To study the relation between arterial distensibility and
AASI, an AASI was calculated for each of the ve levels of distensibility. Each
value of AASI was therefore based on 625 BP-values corresponding with the
variations in resistance, venous pressure, maximal elastance and heart rate at
that level of distensibility.
Table 7.1: Overview of the simulations used to assess the eect of individual parameters.
Parameter C R Emax Pv HR # simulations
Default subject ↑ 120%↓ 80% ↑ 120%↓ 80% ↑ 120%↓ 80% ↑ 120%↓ 80% ↑ 120%↓ 80% 55=3125
Eect of C - ↑ 120%↓ 80% ↑ 120%↓ 80% ↑ 120%↓ 80% ↑ 120%↓ 80% 5x54=5x625
Eect of R - - ↑ 120%↓ 80% ↑ 120%↓ 80% ↑ 120%↓ 80% 5x35=5x125
Eect of Emax -
↑ 120%↓ 80% - ↑ 120%↓ 80% ↑ 120%↓ 80% 5x53=5x125
Eect of Pv -
↑ 120%↓ 80% ↑ 120%↓ 80% - ↑ 120%↓ 80% 5x53=5x125
Eect of HR - ↑ 120%↓ 80% ↑ 120%↓ 80% ↑ 120%↓ 80% - 5x53=5x125
C, distensibility; R, resistance; Emax , maximal cardiac elastance, Pv , venous lling pressure; HR, heart rate.
To study the inuence of the other (individual) parameters on the AASI,
the same methodology was applied: for each value of the parameter of inter-
est, ranging from 80 to 120% of its initial value in steps of 10%, an AASI was
calculated based on the BP-recordings generated by varying the other param-
eters. As we specically want to isolate the eect of changes in distensibility
from changes in the other parameters, vascular distensibility was held constant
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for these analyses, reducing the number of BP-recordings per AASI to 125. For
this analysis, AASI was calculated from all available values (i.e., not limiting to
subsets of 72 data points).
7.2.3 Ability of AASI to detect large changes in stiness
To assess the sensitivity of AASI in identifying dierences in arterial stiness
among subjects, three theoretical subjects were simulated, each with a clearly
dierent level of arterial stiness mimicking the increase in arterial stiness
typically occurring with aging. is was done by multiplying the default dis-
tensibility of each segment with 100%, 50% and 25% respectively.ese levels of
arterial distensibility correspond with an average PWV of 5.9, 8.3 and 11.8 m/s,
respectively (this theoretical value of PWVwas obtained by averaging the PWV
for each segment of the aorta, weighted according to the segment lengths; PWV
for each segment was calculated from the model parameters as PWV= 1/√ρD;
with ρ the blood density (1050 kg/m3 in the model) and D the distensibility of
the segment).
For each theoretical subject, a set of 3125 BP-recordings was generated sim-
ilarly as before: by varying the distensibility, resistance, maximal cardiac elas-
tance, venous pressure and heart rate from 80 to 120% of their initial value in
steps of 10% and calculate the brachial BP for each permutation of these param-
eters. In order to be useful as a marker of arterial stiness in clinical practice,
the AASI must be clearly dierent in the three theoretical subjects. is ques-
tion is addressed by comparing the AASI-histograms.
7.3 Results
7.3.1 AASI in the "default" subject
Figure 7.1A shows all 3125 BP-values generated for the rst theoretical subject.
e corresponding AASI is 0.43. e dierent AASI-values obtained by re-
peated random selection of 72 values out of the total number of 3125 generated
BP-values for the rst theoretical subject follow a normal distribution with a
mean value of 0.43 and a standard deviation of 0.04 (gure 7.1B).is mean
value is the same as the value obtained when all available BP-values are taken
into account to calculate AASI.
7.3.2 Contribution of cardiac and arterial parameters to AASI in the
default subject
For a 120 to 80% decrease in arterial distensibility (increase in stiness), the
AASI increased by 21% from 0.38 to 0.46 as shown in gure 7.2 for three of
the ve applied levels of distensibility. Figure 7.3 gives an overview of the ef-
fect of changes in resistance, heart rate, maximal cardiac elastance and venous
pressure on the AASI, when distensibility is kept constant at its default value.
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Figure 7.1: (A) Scatter plot of all 3125 ambulatory BP-recordings for the default theoretical sub-
ject, with corresponding regression line; (B) AASI-histogram for rst theoretical subject with
overlying normally distributed envelope. e histogram was obtained by calculating an AASI
for each of the 10 000 random selections of 72 BP-recordings out of the available 3125 recordings.
While venous pressure and maximal cardiac elastance do not seem to have a
pronounced eect on AASI, heart rate, distensibility and resistance consider-
ably alter AASI. An 80 to 120% increase in maximal cardiac elastance changes
the AASI by less than 3%, whereas the same relative increase in resistance and
heart rate causes the AASI to decrease by 9 and 38%, respectively. Heart rate,
distensibility and resistance are all inversely related with AASI.e fact that the
AASIs at 100% of the initial value of each individual parameter dier is caused
by the fact that they are based on a dierent set of BP-values, as illustrated for
heart rate and venous pressure in the right panel of gure 7.3.
Figure 7.2: Relation between AASI and arterial stiness. Simulated ambulatory BP-recordings
and corresponding AASI are shown for 80% (le), 100% (middle) and 120% (right) of the default
stiness value.
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Figure 7.3: Le: inuence of maximal cardiac elastance (Emax ), venous pressure, heart rate and
vascular resistance on the AASI. Right: the blood pressure values used to calculate the AASI
at 100% of the initial heart rate (open squares) and 100% of the initial venous pressure (closed
circles).
7.3.3 Ability of AASI to detect large changes in stiness
e usefulness of AASI as a marker of stiness was assessed by considering
two additional theoretical subjects with an average distensibility of 50 and 25%
of the default theoretical subject, respectively. Figure 7.4 shows the envelopes
of the AASI-histograms obtained for the three theoretical subjects. As could
be expected from their lower average distensibility, the two additional subjects
have a highermean (SD)AASI: 0.50 (0.04) for the subject with the intermediate
distensibility level and 0.67 (0.04) for the subject with the lowest level of arterial
distensibility.e overlap between the dierent envelopes is considerable: 36.8
% between the two more compliant subjects and 3.6 % between the two stier
subjects.
Figure 7.4: Le: envelopes of theAASI-histograms of three theoretical subjects, with a respective
average distensibility of 100% (solid line), 50% (dashed line) and 25% (dotted line) of the default
theoretical subject. Right: scatterplot of AASI versus PWV for the three theoretical subjects.e
error bars denote the mean value plus or minus twice the standard deviation.
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7.4 Discussion
e Ambulatory Arterial Stiness Index (AASI) was recently proposed as a rel-
atively inexpensive and easy-to-measure surrogate marker of arterial stiness
[98, 99], which would provide additional information on arterial stiness from
24-hour blood pressure recordings. However, there has been quite some debate
about this new parameter and the use of AASI as a surrogate for arterial stiness
has repeatedly been questioned. Using a numerical 1D-model of the arterial cir-
culation, this study shows thatAASI, although related to arterial stiness (gure
7.1B), is also largely inuenced by vascular resistance and heart rate (gure 7.3).
is hampers the usefulness of AASI as a new parameter for risk stratication
or as an alternative for PWV as it leads to considerable variability in AASI.
While our simulations clearly demonstrated a strong relation between ar-
terial stiness and AASI, they also demonstrated that vascular resistance and
especially heart rate have an important (inverse) eect on the AASI. In fact, the
inuence of heart rate on AASI was even stronger than that of distensibility and
resistance. is conrms the hypothesis of Westerhof et al. [158] that AASI is
proportional to T/RC, with T the cardiac period (1/heart rate) and that it reects
ventriculo-arterial coupling rather than arterial stiness alone (with T/RC rep-
resenting the coupling parameter, T being the time constant of the heart, and
RC the time constant of the arterial circulation). e inverse relation between
heart rate and AASI was previously reported by Adiyaman et al. [164], but not
by Schillaci et al. [156] (positive relation) and Li et al. [98] (no correlation).is,
however, does not necessarily imply that AASI might not be a useful marker of
cardiovascular risk, as it has been shown to predict outcome over and beyond
classical risk factors [153].
An immediate consequence of the fact that AASI reects more than sti-
ness alone, is that, for a given level of stiness (and variations within the normal
physiological range around that value), AASI can vary considerably depending
on the concomitant changes in resistance and heart rate. is dependency on
the sampling of BP-values is illustrated by the histogram of AASI-values ob-
tained by repeated selections of 72 BP-values out of the total available number
of BP-values for one theoretical subject. e standard deviation of 0.04 indi-
cates that, when calculating the AASI based on 72 ambulatory BP-recordings
sampled from the available dataset, there is a 32% chance that the true AASI
corresponding with that subject is more than 8.5% higher or lower than the cal-
culated value.
To assess to which extent this may hamper its use in clinical practice, three
theoretical subjects with a clearly dierent average level of arterial stiness were
simulated. Whereas there was no overlap in the ranges over which total arte-
rial distensibility (or PWV) varied for the three theoretical subjects, there is a
substantial amount of overlap in the AASI histograms. Consider a subject for
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whom anAASI of 0.47 is calculated. Based on the histograms in gure 7.4, there
is a considerable chance that this value is measurable in both the subject with
intermediate stiness (PWV of 8.3 m/s) as in the subject with the lowest sti-
ness value (PWVof 5.9m/s). Assuming that the point at which both histograms
cross (AASI = 0.46) is taken as the cut-o point, there is still a 16.0% chance that
an AASI-value higher than 0.46 is found for the subject with the lowest sti-
ness, and a 20.8% chance that an AASI-value lower than 0.46 is found for the
subject with intermediate stiness.
It is not uncommon to assess day- and nighttime values for 24-hour blood
pressure recordings and AASI-values could be derived for these subsets. It is,
however, not trivial to simulate the physiological eects of sleep in the present
model. ese involve physiological eects due to the change in posture with
associated uid shis, hydrostatic pressure dierences (aecting distensibility),
eects on cardiac preload and changes in sympathetic and parasympathetic
tone modulating heart rate, arterial tone, etc. As such, we chose to limit the
present analysis to changes of a number of well dened model parameters over
a limited range without any attempt to separately model day- and nighttime
data.
7.5 Limitations
It is to be acknowledged that this is a theoretical model study with its pros and
cons. e model is only an approximation of reality and although it was vali-
dated [97] by comparison to non-invasively assessed pressure and ow wave-
forms of young, healthy volunteers, it cannot be completely excluded that some
of the observed eects in this study are exaggerated or masked when compared
to reality. However, we took care to limit the changes of the model parameter
values to the advocated range [97]. Furthermore, the model does not explic-
itly include the microcirculation, with vascular resistance modeled as a wind-
kessel model approximation at the distal end of each arterial path. It is possible
that the observed range in AASI histograms is slightly exaggerated, as a result
of non-physiological combinations of dierent parameter values. However, we
consider a ±20% variation during 24 hours as rather conservative, especially re-
garding heart rate. Because vascular distensibility is (per denition) pressure-
dependent, the reported eects of heart rate and resistance on AASI could be
biased by underlying changes in stiness, as a change in heart rate (resistance)
also aects the BP-level and thus distensibility. To assess the importance of this
eect, all model simulations were repeated with a pressure-independent dis-
tensibility. e results of these simulations did not essentially dier from the
original ones.
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7.6 Conclusion
Using a computer model of the le heart and the systemic circulation, we iden-
tied arterial distensibility, vascular resistance and heart rate as the main de-
terminants of the Ambulatory Arterial Stiness Index.is seriously limits the
use of AASI as a marker of arterial stiness.
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Outline
Along with the increased attention for the role of the large arteries in the de-
velopment of hypertension and concomitant cardiovascular diseases and espe-
cially since the ESC/ESH guidelines include the measurement of PWV for the
management of patients with hypertensive disease, the number of devices to
measure wave reections and arterial stiness has boosted. is third part of
the PhD-dissertation describes the validation studies that were performed on
two relatively new devices, as well as the development of a low-cost device for
use in African settings (see part IV).
Chapter 9 details the results of a numerical validation of the working prin-
ciple of the Arteriograph (Tensiomed, Budapest, Hungary), a device that claims
to assess aortic pulse wave velocity by means of a simple brachial cu. Brachial
blood pressure is measured during supra-systolic pressure ination of the cu,
yielding pressure waveforms with pronounced rst and secondary peaks. e
secondary peak is ascribed to a reection from the aortic bifurcation, and PWV
is calculated as the ratio of twice the jugulum-symphysis distance (∼ aortic root
- bifurcation) and the time dierence between the two peaks. To test the validity
of this working principle we used a previously validated [97] numerical model
of the arterial tree to simulate pressures and ows in the normal conguration
and in a conguration with an occluded brachial artery.
Chapter 10 reports on the comparativemeasurements betweenOmronHEM-
9000AI (Omron Healthcare, Kyoto, Japan) and SphygmoCor in an attempt to
validate the central systolic pressure (cSBP) estimate provided byOmronHEM-
9000AI.e OmronHEM-9000AI is the rst automated tonometer to provide
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an estimate of cSBP, which is considered to bemore predictive of cardiovascular
events than the conventional brachial pressure. However, considerable dier-
ences between the cSBP-estimate of Omron and that of SphygmoCor have been
reported [165], but not explained.is study assesses the sources of dierences
between both cSBP-estimates and provides a handle on which estimate is clos-
est to reality. For this purpose, calibrated carotid SBP was used as device- and
algorithm-independent reference.
e available devices to assess arterial stiness and wave reections are ex-
pensive and not necessarily accurate, as illustrated in chapters 9 and 10. As these
relatively high prices may pose an obstacle for research in developing countries
such as most countries in sub-Saharan Africa, we developed a low-cost device
to acquire ow and pressure waveforms and hence derive PWV, local blood
pressure and augmentation index.e development of hardware and soware
of this Tono-Doppler device is outlined in chapter 11.
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Pulse wave velocity from a single
brachial cuff recording: the
Arteriograph revisited
e results of this study were published in:
B. Trachet, P. Reymond, J. Kips, A. Swillens, M. De Buyzere, B. Suys, N. Ster-
giopulos, P. Segers. Numerical validation of a new method to assess aortic pulse
wave velocity from a single recording of a brachial artery waveform with an oc-
cluding cu. Annals of Biomedical Engineering 2010, 38:876-888.
9.1 Introduction
With the increased attention for large artery stiness and the obvious role of
arterial stiening in the patho-physiology of (isolated) systolic hypertension,
the 2007 ESC and ESH guidelines for the management of arterial hypertension
[166] now formally recognize large artery stiness as a factor inuencing the
prognosis of patients and measurement of arterial stiness as a useful indica-
tor of vascular damage. Large consensus exists that of all available methods
to quantify arterial stiness or aspects of it, measurement of (carotid-femoral)
pulse wave velocity (PWV) is, at present, the only non-invasive comprehensive
method which is simple and accurate enough to be considered as a diagnostic
procedure feasible on a large scale in a clinical setting, with high values being
indicative of stiened arteries [55, 166]. In essence, measurement of PWV is
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simple and straightforward, and it is calculated as the ratio of the distance be-
tween twomeasuring locations and the time it takes for the waves to travel from
one location to the other (the pulse transit time). And yet, there is still much
ambiguity inmeasuring PWV, arising on the one hand fromdiculties in accu-
rate measurement of the transit time and identication of the foot of the wave
front, and on the other hand from measuring the actual travel distance of the
waves.e latter is particularly ambiguous for carotid-femoral PWV, where at
the moment the wave is picked up at the carotid artery, it is already travelling
further down the aorta towards the femoral artery.
With the Arteriograph (Tensiomed, Budapest, Hungary), a new method
(and device) to measure pulse wave velocity has recently been introduced onto
the market. Unlike most other devices aiming to measure PWV, this device
measures the pulse waves at one single location. e device makes use of a
brachial cu that is over-inated to 35 mmHg over the systolic blood pressure.
It is claimed that, as a result of this over-ination, the reected wave from the
lower body can be detected more easily. e time dierence between the rst
systolic wave and the second reected wave is then used as the transit time,
i.e., the time needed for the wave to travel back and forth to the reection site.
Assuming that the measured external distance from jugulum to symphysis can
be used as an approximation of the distance to this reection site, pulse wave
velocity can be computed as the ratio of travelled distance and transit time.
Validation data on the Arteriograph are still rather limited, but they seem to
suggest that there is a relation between PWVmeasured by this new device and
PWVmeasured bymore generally acceptedmethods. However, the underlying
principle of this intriguing method is still not fully understood, since no clear
explanation has been given for the appearance of a pronounced second peak
when the brachial cu is over-inated.is second peak is assumed to originate
from a reection of the pressure wave in the lower body, but no reasonable
explanation for the fact that this reection is more pronounced in the case of
an over-inated brachial artery cu has yet been published. Furthermore, little
is known about the underlying assumptions one has to make to calculate PWV
with the Arteriograph.
e principal aim of this work is to gain a better understanding and vali-
dation of the working principle behind this new method. We used a computer
model of the arterial tree to simulate pressure and ow waveforms in a normal
arterial system, and in a conguration representing an over-inated brachial
artery (occluded model).e pressure waveforms and wave reection patterns
in the occludedmodel were studied, and transit time and PWVcalculated using
the Arteriograph method were compared to the actual transit time and PWV
for dierent stiness values in the model.
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9.2 Materials and methods
9.2.1 Arteriograph: principle of operation
e Arteriograph is basically a simple upper arm cu connected to a piezoelec-
tric sensor that picks up the pressure signals. Upon operation, the cu is in-
ated to a pressure of 35 mmHg over the systolic blood pressure.e pressure
in the underlying occluded artery is transmitted through the cu to the pressure
sensor and is reported to show multiple peaks (see gure 9.1). e rst is the
systolic peak, corresponding to the ejection of blood from the le ventricle into
the aorta, while the second peak is assumed to originate from a reection of the
rst pressure wave in the lower body.e time dierence between the rst and
second wave in the pressure signal is used as the return time ∆Ts1−s2, i.e. the
time needed for the pressure wave to travel from the aortic arch to its reection
point and back, with the iliac bifurcation assumed to be the dominant reec-
tion point.e exact algorithm used by the device to determine the transit time
is unknown but for our analysis we systematically used the peak-to-peak time
dierence.e travelled distance corresponding to this return time is twice the
distance from aortic arch to iliac bifurcation, which is approximated by mea-
suring the distance between jugulum and symphysis externally (see gure 9.1).
Figure 9.1: Illustration of the working principle of the Arteriograph.
9.2.2 Model simulations
To gain a better insight into the origin of the pressure waveforms occurring dur-
ing the over-ination phase of theArteriograph, we simulated pressure and ow
waveforms in the arterial tree using an improved version [97] of the original 1D
model of Stergiopulos et al. [167].is model is based on the one-dimensional
ow equations and includes nonlinearities arising from geometry and mate-
rial properties. One hundred and three (103) arterial segments, representing
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the various major arteries, are combined and terminated with three-element
Windkessel models to form a model of the arterial system. For each segment,
properties such as compliance, diameter and length can be adjusted. Resis-
tance can be altered in the distal Windkessel models. We refer to Reymond et
al. [97] for details on the properties of individual segments and the compu-
tational methods used to solve the 1-D Navier-Stokes equations. We used this
model to simulate pressure and ow in the normal conguration, and in a con-
guration with the le brachial artery completely occluded (over-ination of
the Arteriograph cu). e superuous segments of the brachial artery were
thus removed, resulting in an adjusted model containing only 99 segments (see
gure 9.2).e pulse wave velocity in the model was assessed in three dierent
Figure 9.2: Representation of the arterial topology used in the computer model (adapted from
[97]). In the occluded model, segments 22-25 were removed in order to simulate the occlusion
of the brachial artery by the cu.
ways.
First, PWV was determined by measuring the foot-to-foot transit time be-
tween the pressure signals at the carotid and femoral arteries (PWVcar− f em).
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e foot of the pressure waveform was determined as the maximum of its sec-
ond derivative [168, 169].e distance between two nodes could be determined
by adding up the lengths of the dierent segments that connect these nodes.e
carotid-femoral distance was then determined as the distance from the aortic
root to the femoral artery minus the distance from aortic root to carotid artery,
thus correcting for the time the waves are travelling in the opposite direction.
e resulting distance was 52.8 cm.
Second, the theoretical PWV value for each segment was calculated from
the model parameters as
PWV = 1√
ρD
(9.1)
with ρ the blood density (1050 kg/m3 in the model) and D the distensibility of
the segment. A description of how segment distensibility was determined has
been provided by Reymond et al. [97]. Averaging of PWV for all segments of
the aorta, weighted according to the segment lengths, yielded the theoretical
PWV which we considered as the gold standard in this work (PWVtheor).
In a third approach, PWV was calculated using the Arteriograph method:
the distance from jugulum to symphysis was approximated by adding the seg-
ment lengths from the thoracic aorta (starting just aer the branch towards
the occluded brachial artery) to the aorto-iliac bifurcation, resulting in 37.5 cm.
Twice this distance was divided by the transit time between the two peaks in
the pressure signal (see also gure 9.1) to nd values for pulse wave velocity,
PWVATG .
All simulationswere performed for 6 dierent levels of stiness of themodel,
obtained via multiplication of the default compliance value of each segment
with a constant compliance factor, changing the compliance from 40% to 140%
of its default value in steps of 20%. By changing the compliance in each segment
of the arterial tree, we were able to assess the inuence of the arterial stiness
on the pulse wave velocity in both congurations of the model. Apart from the
compliance of the segments, three more model parameters were varied to test
the robustness of themethodology. Extra simulations were run on the occluded
model by changing the default arterial resistance of each terminal Windkessel
to 80% and 120% of its original value, by changing the duration of a heart cycle
to 0.7 and 0.9 seconds instead of the original 0.8 seconds and by changing the
maximal elastance (Emax) of the heart model to 1.5 and 3.5 mmHg/ml instead of
the default value of 2.5mmHg/ml.is allowed us to compute 7 dierent PWV-
values for each compliance level. We thus found a cloud of PWV’s for each of
the three methods, and these were analysed using Bland-Altman analysis. To
further test the method’s sensitivity to isolated changes in stiness along the
brachial trajectory, two extra simulations were performed: in a rst simulation
only the compliance of the brachial segments was changed (from 40% to 140%
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of its default value in steps of 20%) while all other segments maintained their
default compliance value. In a second simulation compliance was changed for
all segments in the arterial tree except the brachial ones.
For both the occluded and the original model, pressure and owwaveforms
were calculated at 5 equidistant locations along the brachial artery using the de-
fault model parameters (default compliance and resistance values, heart cycle
of 0.8 s, Emax of 2.5 mmHg/ml). Furthermore, we also calculated similar data
at 5 locations along the ascending, descending and abdominal aorta to inves-
tigate whether the propagation of the reected waves in the abdominal aorta
was similar in both models. e obtained pressure and ow waveforms were
further processed in Matlab (Mathworks, Natick, MA) [94, 170].
9.2.3 Data and wave reection analysis
We performed wave intensity analysis on the pressure and ow signals of a sim-
ulation on the occludedmodel with default parameters (default compliance and
resistance values, heart cycle of 0.8 s, Emax of 2.5 mmHg/ml) to gain more in-
sight into the nature and origin of the dierent peaks occurring in the signals
[87, 90]. e theory of wave intensity analysis was elaborated by Parker and
Jones [90] and we refer to their work for details on the method. In brief, dis-
turbances to the ow lead to changes in pressure (dP) and ow velocity (dU),
”wavelets”, which propagate along the vessels with a wave speed (PWV). Each
wavelet is, in its turn, composed of a forward (subscript +) and backward (sub-
script -) running component, related by
dP± = PWV ⋅ ρ ⋅ dU± (9.2)
with PWV the local PWVtheor provided by the computermodel. Waves charac-
terized by a dP>0, that is a rise in pressure, are called compression waves, while
waves with dP <0 are expansion or suction waves.e nature of a wave was fur-
ther assessed by analysing the wave intensity, dI, which is dened as the product
of dU and dP, and equals the rate of energy ux carried by the wavelet. When dI
is positive forward waves are dominant; negative dI indicates dominant back-
ward waves. Wave intensity in itself was then also separated in a net forward
and backward wave intensity: dI+ = dP+ ⋅ dU+ and dI− = dP− ⋅ dU− , where
the "+" denotes a forward travelling wave, while "-" denotes a backward trav-
elling wave. Aer having computed forward and backward intensity waves in
the brachial artery, we computed the distance travelled by these waves to their
reection point. In order to do so, the transit time between a forward wave
and its backward reection is combined with the local theoretical PWV in the
brachial artery. Since the wave is travelling back and forth to its reection site,
this allows us to compute the distance to the reection site as
L = ∆T PWV theor
2
. (9.3)
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Beside the wave intensity analysis, we also determined the forward and back-
ward pressure components at dierent locations in the aortic trunk and in the
brachial artery to unravel the patterns of wave reection in the normal and oc-
cluded conguration. Pressure (P) and ow (Q) can be considered to be com-
posed of one forward running component Pf (Q f ) and one backward running
component Pb (Qb), where the single forward and backward running compo-
nents are the resultant of all forward and backward travelling waves.ese for-
ward and backward components were derived as [19]:
Pf = ΣdP+ (9.4)
Pb = ΣdP− (9.5)
9.3 Results
9.3.1 Eect of brachial occlusion on the pressure waveform
Figure 9.3 shows pressure waveforms at the distal end of the brachial artery
(immediately proximal to the occlusion site) for both the control (top le) and
the occluded model (top right). To assess the inuence of the stiness of the
arteries on the obtained pulse wave velocity the pressure signals were computed
for 6 dierent levels of arterial compliance, keeping all other model parameters
on their default value.e time delay between the rst and second systolic peak
in the occluded model ∆Ts1−s2, that should be related to aortic PWV according
to the Arteriograph principle (see gure 9.1), decreased from 0.271 s to 0.123 s
for compliance decreasing from 140% to 40% of its original value (not all values
are shown in gure 9.3 to improve visibility).
Figure 9.3 also shows the resulting brachial pressure waveforms when com-
pliance of the occluded model is only altered in the brachial segments (bottom
le), and in all segments except the brachial ones (bottom right). It is observed
that ∆Ts1−s2 is proportional to the change in compliance when compliance was
altered in all segments and when it was altered in the brachial segments only,
but there was no change in the time delay between the rst and second systolic
peaks when the compliance in the brachial segments was not altered.
9.3.2 Impact of model stiness, resistance and cardiac parameters on
PWV
In gure 9.4, the three methods used to determine PWV are compared. For all
methods, PWV increased signicantly over the simulated range, varying from
about 5.2 m/s to 9.2 m/s (theoretically calculated values).is is consistent with
a nearly 4-fold decrease in total arterial compliance. ere was a good cor-
relation between PWVtheor and PWVcar− f em (R2=0.95), but PWVcar− f em was
systematically lower than PWVtheor (dierence: 1.08±0.70m/s). Bland-Altman
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Figure 9.3: Pressure waveforms at the location of the cu (brachial artery) for three levels of
total arterial compliance (in % of the default value). Top le: normal model. Top right: occluded
model, compliance altered in all segments. Bottom le: occludedmodel, compliance altered only
in brachial segments. Bottom right: occluded model, compliance altered in all segments except
the brachial segments.
analysis showed that the underestimation increased with higher values of PWV
(gure 9.4). ere was also a good correlation between the theoretical pulse
wave velocities and those calculated using the Arteriographmethod (R2=0.94),
but again PWVATG was lower than PWVtheor (dierence: 2.17±0.42 m/s), the
underestimation increasing with higher values of PWV (gure 9.4). Compar-
ing PWVcar− f em with PWVATG , both methods correlate well (R2=0.90), with
PWVcar− f em being on average 1.09±0.48 m/s higher than PWVATG . e dif-
ference between both, however, becomes smaller with higher values of PWV.
We conclude that, although PWVATG correlates well with both PWVtheor and
PWVcar− f em, the numerical values of theArteriographmethod are clearly lower
than those of the other methods.
Reducing the resistance of each terminal Windkessel to 80% of its default
value resulted in a decrease of mean blood pressure and, given the non-linear
coupling between blood pressure and stiness, a lowering in PWVwith 8±3% of
its initial value (average normalized dierence± SD for 18 simulated cases: 3 dif-
ferent methods and 6 compliance levels per method). Increasing the resistance
to 120% of its initial value increased PWV with 7±4%. Shortening the heart
cycle from 0.8 s to 0.7 s resulted in an increase in (blood pressure and) PWV
with 5±3% of its initial value, whereas PWV decreased with 6±3% when the
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Figure 9.4: Correlation between dierent methods to compute pulse wave velocities with vary-
ing model parameters. Resistance (R), heart cycle length (HC) and maximal heart elastance
(Emax). Top: carotid-femoral PWV vs theoretical PWV. Middle: arteriograph PWV vs theoret-
ical PWV. Bottom: arteriograph PWV vs carotid-femoral PWV.
heart cycle was elongated to 0.9 s. Finally, PWV values decreased with 14±7%
when the maximal heart elastance Emax was lowered from 2.5 mmHg/ml to 1.5
mmHg/ml, and PWV values increased with 9±5% when Emax was raised to 3.5
mmHg/ml. ese changes were again modulated by the changes in operating
blood pressure.
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9.3.3 What is causing the change in transit time?
In gure 9.5 the inuence on PWVATG of altering compliance in only the brachial
segments is compared to the inuence of altering compliance in all but the
brachial segments. When compliance is decreased in all but the brachial seg-
ments, PWVtheor and PWVcar− f em increase but PWVATG remains constant.
is can also be observed in gure 9.3 (bottom right), since transit times did
not change in the occluded model when compliance in the brachial segment
was kept at its original value. Similar results are found by altering compliance
only in the segments of the aortic trunk, where most of the compliance of the
arterial system resides (not plotted). On the other hand, increasing compliance
only in the brachial artery results in an increase of PWVATG whereas PWVtheor
and PWVcar− f em obviously remain constant since stiness in the aorta is not
changing. We also observe that the corresponding transit times (and result-
ing PWVATG values) are identical to the simulation where compliance in all
segments was altered. is implies that all correlations between PWVATG and
PWVtheor or PWVcar− f em as they are plotted in gure 9.4 are modulated by the
local change in stiness in the (occluded) brachial artery and not by the change
in aortic stiness of the complete model as such. To further investigate the ori-
Figure 9.5: Correlation between dierent methods to compute pulse wave velocities when alter-
ing compliance only at the brachial segments, when altering compliance in all segments except
the brachial segments, and when altering compliance in all segments (default). Le: Arterio-
graph PWV vs theoretical PWV. Right: Arteriograph PWV vs. carotid-femoral PWV.
gin of the second peak in the pressure signal of the occludedmodel, the pressure
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waveforms and their forward and backward components are compared on 5 dif-
ferent locations throughout the brachial artery (gure 9.6) and the aortic trunk
(gure 9.7).is was done for both the normal and the occluded model using
default parameters. In gure 9.6, the timing of the forwardwaveforms through-
out the brachial artery is similar in both models: the more distal in the brachial
artery, the greater the time delay since the pressure wave arrives later.e am-
plitude of the forward waveforms is similar in both models, depending on the
compliance. In the backward waveforms, more important dierences between
both congurations can be noticed. e amplitude of the backward compo-
nents in the occluded model is much higher. Also in the occluded model, the
reected wave appears rst at the occlusion and only later at the proximal part
of the brachial artery, while the timing of the backward component is scattered
in the non-occluded conguration.
Figure 9.6: Pressure waveforms at 6 locations throughout the brachial artery (distances are ex-
pressed in cm to the aortic root). Top: total pressure; middle: forward pressure; bottom: back-
ward pressure.
Studying thewaveforms (and the forward andbackward components) along
the aortic trunk (gure 9.7) did not reveal obvious dierences between the oc-
cluded and non-occluded conguration.is is another indication that the sec-
ond peak in the pressure signal is probably caused by a local phenomenon in
the brachial artery, and is not linked to waves travelling back from the lower
body.
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Figure 9.7: Pressure waveforms at 6 locations throughout the descending and abdominal aorta
(distances are expressed in cm distal from aortic root). Top: total pressure; middle: forward
pressure; bottom: backward pressure.
9.3.4 Wave intensity analysis
e results of the wave intensity analysis performed on the pressure and ow
signals just proximal to the occlusion of the brachial artery are shown in gure
9.8. Analysis of the normal model reveals a forward compression wave (P1),
arising from the systolic ejection. is wave is followed by a backward com-
pression wave (P2), a (positive closed end) reection of the rst forward wave
in the brachial artery itself.en there is a forward expansion wave (P3) linked
with the relaxation of the le ventricle. Performing the same analysis for the
model of an occluded brachial artery reveals that now the peak intensity of the
rst backward compression wave (P′2) is almost three times stronger than in the
original model.is strong backward compression wave is caused by the total
reection of the incidentwave on the brachial occlusion. Next, we observe a for-
ward expansion wave P′3 , that is most probably a reection of P′2. To assess the
origin of this reection, the distance travelled by the reected wave was calcu-
lated. Combining the peak-to-peak time dierence between P′3 and P′2 and the
local theoretical PWV in the brachial segment, the distance from the measure-
ment point to the reection point was determined to be 29.5 cm.is distance
approximates the distance to the point where the subclavian artery, later be-
coming the brachial artery, branches from the aortic arch (35.05 cm upstream
from the location where wave intensity analysis is performed). We therefore
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hypothesize that the reected backward compression wave P′2 is re-reected at
the location where the subclavian branches from the aorta, and is picked up at
the location of the cu as the forward expansionwave P′3 . Next, P′4 is a backward
expansion wave caused by the reection of P′3 on the occlusion and P′5 is again a
forward compression wave, caused by the reection of P′4.e distance match-
ing the peak-to-peak transit time between P′4 and P′5 is 30.2 cm, thus we can
reasonably assume that this wave is reected at the same point as the previous
wave. It is obvious from the timing in gure 9.8 that P′5 is the wave causing the
pronounced second peak in the pressure signal picked up by the Arteriograph.
Using wave intensity analysis, we have thus shown that P′5 is a forward compres-
sion wave, caused by a re-re-re-reection of the rst incident wave.is wave is
travelling back and forth between the occlusion of the cu and the point where
the subclavian artery branches from the aortic trunk.
Figure 9.8: Wave intensity analysis at the location of the cu (brachial artery) for C=100%.
Bottom: wave intensity analysis in normal model (le) and occluded model (right). Top: eect
of wave intensity on pressure signal and forward and backward pressure components in normal
model (le) and occluded model (right).
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9.4 Discussion
emain conclusions that we can draw from this computermodel study are: (i)
occlusion of the brachial artery introduces a total reection at the upper arm
which introduces a pronounced second peak in the brachial pressure curve;
(ii) when compliance of the model is altered over the complete arterial tree,
the pulse wave velocity calculated following the Arteriograph principle is lower
than but correlates well with both the theoretical and carotid-femoral PWV;
(iii) this correlation, however, is modulated by local stiness modications in
the brachial artery and is not linked to aortic stiness in the remaining parts of
the arterial system.
Our study questions the working principle of the Arteriograph and, at the
same time, also raises some concern with respect to the ability of the device to
provide accurate values of PWV, comparable to transit timemethods.emain
dierence between the Arteriograph andmost other methods to measure pulse
wave velocity from transit times is that the Arteriograph only measures at one
location: the upper arm. As such the device has a clear practical advantage over
other techniques since it is much easier in use and measurements can be done
signicantly faster.
As for available in vivo data, in a rst validation study, pulse wave veloc-
ity measured by the Arteriograph was compared to that of other devices, and
a reasonable agreement has been found [171–173]. Baulmann et al. [171] de-
termined PWV on 64 patients with three dierent devices. PWV measured
with the Arteriograph was 8.6±1.3 m/s , which was dierent from that mea-
sured by two frequently used transit time based methods (with measurements
on the carotid and femoral artery), i.e., the Complior system®(10.1±1.7 m/s) but
similar to measurements with Sphygmocor®(8.1±1.1 m/s). e dierences in
PWVwere entirely ascribed to dierent techniques used to determine the trav-
elled distance, since there was no statistical dierence between measured tran-
sit times. e correlation between Arteriograph and Complior (p=0.005) and
Arteriograph and Sphygmocor (p=0.043) was signicantly worse than the cor-
relation between Complior and Sphygmocor (p=0.001). Magometschnig [173]
found values of 9.1±1.8 m/s for Arteriograph and 8.4±1.5 m/s for Sphygmocor.
However both measurement techniques did not correlate (r=-0.04). Illyes [174]
also measured PWV as a function of age for 2299 patients and found a linear
correlation between measured PWV and age (r=0.52). is is in line with the
expectations since PWV is known to rise with age.
We tried to match these literature results with the results from the present
study. As can be observed fromgure 9.3, occlusion of the brachial artery intro-
duces a second peak in the brachial pressure curve which, in normal circum-
stances, is hardly noticeable.is nding supports the basic working principle
of the Arteriograph: ination of the brachial cu to a supra-systolic pressure
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occludes the artery and leads to an amplication of the second peak making
the signal strong enough to be picked up by the sensor embedded in the cu.
In gure 9.4 the threemethods to compute PWVwere compared.e excel-
lent correlation between the theoretical PWV and PWVcar− f em indicates that
this method, which is oen used to measure PWV in vivo since these arteries
are relatively easy to access with a tonometer or an ultrasound probe [59, 175–
177] can be suciently accurate to determine pulsewave velocities in vivo. Note,
however, that the absolute value of PWV provided by this method is also sub-
stantially lower than the theoretical PWV.Moreover, the Bland-Altman plot re-
veals a trend of underestimation of PWVcar− f em for higher values of PWV. We
speculate that the discrepancy between the theoretical PWV and PWVcar− f em
is due to the fact that the theoretical PWV value, derived from the Bramwell-
Hill equation [178], applies to the ideal case of an innitely long tube ignoring
eects of viscous friction and wave reection. Furthermore, an error is intro-
duced via the ambiguity of the travel path of the carotid and femoral pulse [179].
As for PWVATG - focusing on the simulations where stiness is altered to
the same degree over the complete arterial territory - the correlation with the-
oretical PWV is similar (R2=0.94) but the numerical values are systematically
lower than PWVcar− f em.emost obvious explanation for this phenomenon is
that, despite the fact that the measured transit times correlate well to the actual
PWV values, the distance that was used to calculate PWV from these transit
times does not yield correct results. One of the major assumptions made in the
Arteriograph is that the second peak in the pressure signal is caused by a reec-
tion of the forward wave at the aorto-iliac bifurcation, which is assumed to be
the single reection point.
In order to further investigate this assumption, we have tried to explain the
origin of the secondary peak in the pressure signal of the occluded model by
making use of wave intensity analysis (gure 9.8). It is particularly the appear-
ance of a third forward wave (P’5) that is of interest for this analysis. Linking
the timing of P’5 to the pressure signal in gure 9.8 shows that this wave is caus-
ing the second peak in the pressure signal that is picked up by the Arteriograph
and used to determine the PWVATG . Since both dP and dI are positive, P’5 is
a forward compression wave. At rst sight this supports the assumption made
in the Arteriograph, since a reection coming from the lower body should be
a compression wave travelling in the forward direction in the brachial artery.
However, analyzing the wave intensity results and the distances that correspond
with the transit times between the dierent waves, we see that dP’5 is actually a
re-reection of P’3, which in turn is a re-reection of P’1.us, the wave is trav-
elling back and forth between the occlusion and the location where the subcla-
vian artery branches from the aortic arch, and there is no reection originating
from the lower body.
is nding is supported by gure 9.5, showing that the correlation be-
tween PWVATG and aortic PWV is entirely due to local stiness changes in
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the brachial artery, contradicting the supposed working principle of the Arte-
riograph. If the second peak in the pressure signal would indeed be caused by
a wave travelling back from the lower body, its timing should be inuenced by
a change in aortic stiness of the aortic segments it is passing through, which
is not the case. Also, this wave should be noticeable in the abdominal aorta
waveforms, which is not the case either (gure 9.7). In the brachial artery wave-
forms however, we clearly see a backward travelling wave (gure 9.6). All this
leads us to conclude that, even though PWVATG correlates well to PWVtheor
and PWVcar− f em, the underlying principle causing this correlation is probably
not a wave reected from the lower body, but a local reection occurring in the
brachial artery.
e excellent correlation between theoretical PWV and PWVATG found in
gure 9.4 is driven by the fact that the stiness of the brachial arteries and cen-
tral vessels was changed to the same extent. Also in humans, stiness of the
upper brachial segment is likely to be related to aortic stiness [180], which
might explain some of the reported in vivo ndings. On the other hand, espe-
cially for the more peripheral, muscular arteries, there might be discrepancies
in the evolution of stiness with age (and disease) compared to the more cen-
tral, elastic arteries [125].e key question therefore remains to what extent the
arteries in the brachial segment reect the properties of the large, central aorta.
Anyhow, it follows from our analysis that any value of PWV derived from the
Arteriograph is, at best, an indirect and unspecic estimate of the stiness of
the aorta.
9.5 Limitations
is is a computer model simulation study with its inherent strengths and lim-
itations. Its strength lies in the fact that pressure and ow signals can be calcu-
lated at every location in the arterial tree with great accuracy without any mea-
surement error. A numerical model, however, remains an approximation of re-
ality: the arterial tree is notmodelled into great detail (e.g. themicrocirculation
has not been taken into account). However the model has been validated and
has been shown to produce realistic waveforms [97]. Still, the pressure curves
that were simulated in this work represent an ideal case and do not take into
account any damping of the pressure signals in the cu nor the damping that
will occur in the transmission of the pressure signal from the brachial artery
through the skin towards the pressure sensor.erefore the curves that are ac-
tually measured by the Arteriograph will probably show a less distinct second
peak, making it harder to recognize and measure the transit time.
In our simulations the le brachial artery was occluded. Typically, the le
subclavian artery (later becoming the brachial artery) arises directly from the
aortic arch as the third and nal of the great vessels, while the right subcla-
vian artery arises from the bifurcation of the brachiocephalic trunk.erefore
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occlusion of the right brachial artery might result in slightly dierent wave re-
ections, although we don’t expect large dierences.
e exact algorithm used by the device to determine the transit time and
the corresponding pulse wave velocity is unknown. We calculated the transit
time from the peak-to-peak time dierence between the rst and second peak.
It is generally agreed upon that the foot-to-foot method usually yields the most
accurate results, but it is not always easy to determine the foot of the second
peak in the signal. It is unclear what method is used by the Arteriograph to
determine the transit time, so it is possible that, providedwith the samepressure
curves, the device would calculate dierent transit times.
9.6 Conclusions
We have validated the working principle of a newly proposed method to mea-
sure aortic pulse wave velocity (the Arteriograph method) using a numerical
model of the arterial tree. is method bases its transit time calculation on a
second peak in the pressure signal of the over-inated brachial cu, which also
appeared in our simulations. However, exactly the same change in transit time
was observed by altering brachial compliance only, indicating that PWVATG is
only dependent on brachial stiness and not on stiness in the remaining part
of the arterial tree. Wave intensity analysis also showed that the wave causing
the second peak in the pressure signal is travelling back and forth between the
occlusion and the location where the subclavian artery branches o from the
aorta, and is not originating from a reection in the lower body. Despite this,
numerical values of PWVATG correlate well to standard methods such as the
carotid-femoral transit time or the theoretical Bramwell-Hill equation, but the
Arteriograph yields lower absolute values. A possible explanation for this corre-
lation is that the stiness of the upper brachial segment is likely to be related to
aortic stiness. Finally, one should keep in mind that this is a numerical study
aiming to test the theoretical principle behind the Arteriograph, and we cannot
make any judgement on the functioning of the device itself. An independent
clinical study would be needed to conrm our results and to test the robustness
of the device and its algorithms when confronted with non-theoretical mea-
surement data.
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Central systolic blood pressure:
Omron HEM-9000AI versus
SphygmoCor device
e results of this study were published in:
Jan G. Kips, Aletta E Schutte, Sebastian J. Vermeersch, Hugo W. Huisman, Jo-
hannes M. Van Rooyen, Matthew C. Glyn, Catharina M. Fourie, Leone Malan,
Rudolph Schutte, LucM.Van Bortel, Patrick Segers. Comparison of central pres-
sure estimates obtained from SphygmoCor, Omron HEM-9000AI and carotid ap-
planation tonometry. J Hypertension 2011, accepted for publication.
10.1 Introduction
Central systolic blood pressure (cSBP) has received extensive attention in recent
years because there is increasing evidence that it may be a better predictor of fu-
ture cardiovascular events than brachial pressure [78, 117–119, 121, 123, 181].e
use of central pressures in daily clinical practice is currently hampered by the
fact that most measurement devices, although non-invasive, require a trained
operator, introducing potential operator dependence. With the recent develop-
ment of automated and hence operator-independent devices such as theOmron
HEM-9000AI (Omron Healthcare, Kyoto, Japan), data collection is facilitated,
bringing central pressure a step closer to routine clinical practice. However,
Richardson et al. [165] recently compared the central pressure estimates from
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Omron HEM-9000AI and SphygmoCor (Atcor Medical, Sydney, Australia) in
a relatively small (n=33) population sample of healthy Caucasians, aged 20 to 61
years.ey found a high correlation (r=0.95), but amean (SD) dierence of 12.2
(4.6) mmHg between both cSBP estimates, the Omron HEM-9000AI yielding
the highest estimate.e reason for this dierence remains unclear. Although
both devices derive cSBP from the radial pressure waveform, SphygmoCor uses
a radial-to-aortic generalized transfer function, whileOmronHEM-9000AI re-
lies on the relation between cSBP and the second systolic peak (P2) in the radial
pressure waveform.ough previous studies [165, 182–184] have used radial P2
as such as an estimate of central pressure, the Omron HEM-9000AI makes use
of an additional linear equation to calculate cSBP from the radial P2.e aims
of this study are: (1) to perform an extended comparison between the cSBP-
estimates ofOmronHEM-9000AI and SphygmoCor in a large population sam-
ple of rural black SouthAfricans; (2) to assess the sources of dierences between
both cSBP-estimates, and (3) to assess which of the two methods is most likely
to provide themost accurate estimate of central systolic blood pressure. For this
last objective, non-invasively measured carotid pressure is used as a reference
since it can bemeasured directly, does not rely on any transfer function andwas
found to be only 1.8 mmHg higher than central aortic pressure in an invasive
study by Van Bortel et al. [59, 61].
10.2 Methods
10.2.1 Study population
A total of 143 rural black South Africans (aged 39-91 years), enrolled as part of
the Prospective Urban Rural Epidemiology (PURE) study [185], were included
in this study. Subjects had fasted and measurements were taken in seated posi-
tion aer at least 10 minutes of supine rest and 5 minutes of seated rest.
10.2.2 Measurements
Radial artery tonometry was performed on the le arm of each subject, rst
with an Omron HEM-9000AI (acquiring 30 seconds of wave data) and subse-
quently with a SphygmoCor (acquiring 10 seconds of wave data). Both record-
ings were calibrated using the cu blood pressure measured with the Omron
HEM-9000AI just prior to central pressure assessment. Additional tonometer
measurements were performed on the le brachial artery and the le carotid
artery with the SphygmoCor.e quality of the recordings was assured by dis-
carding all Omron recordings with an error message and all SphygmoCormea-
surements with an operator index below 80.e Omron HEM-9000AI device
was operated by two cardiovascular physiologists. All SphygmoCor measure-
ments were performed by a single experienced operator (JK).
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10.2.3 Central blood pressure estimation
Central pressure recordingswere obtainedusing the SphygmoCor (cSBP-Sphygmo)
and Omron HEM-9000AI (cSBP-Omron) as advocated by their manufactur-
ers and user manuals, i.e. from radial pressure waveforms calibrated using
brachial SBP and DBP. Carotid systolic pressure (cSBP-Carotid) was obtained
fromcarotid pressurewaveforms recorded by SphygmoCor, calibratedwith brachial
MAP and DBP obtained from brachial tonometry. is calibration method
assumes the MAP and DBP to remain constant throughout the large arter-
ies [59, 61]. Assuming that carotid SBP overestimates the invasive cSBP by 1.8
mmHg [59], an alleged aortic SBP (cSBP-Aortic)was calculated as cSBP-Carotid
minus 1.8 mmHg. e calibration method using brachial MAP and DBP has
been shown to yield more accurate central pressure estimates, as it takes into
account the brachial-to-radial pressure amplication [61]. erefore, central
pressure using radial SphygmoCor recordings was re-calculated using brachial
MAP and DBP (cSBP-Sphygmo2).
In order to assess whether potential dierences betweenmethods are due to
the use of dierent radial pressurewaves as input or due to the dierent process-
ing algorithms, we additionally calculated central pressures from radial pres-
sure waveforms recorded by Omron HEM-9000AI hardware and processed by
SphygmoCor-soware (cSBP-OmronSphygmo).
10.2.4 Comparison of measured radial pressure waveforms
To quantify dierences in waveform features, the following variables were cal-
culated:
• form factor (FF), dened as the ratio (%) of the dierence between the
mean arterial pressure (MAP) and the diastolic pressure (DBP) and the
pulse pressure (PP): FF = MAP−DBPPP , see gure 10.1.e form factor is a
measure of how peaked the waveform is, and is calibration-independent.
• radial augmentation index (AIx), dened as the amplitude of the second
systolic peak divided by the amplitude of the rst systolic peak (P2/P1)
and expressed as percentage (gure 10.1).
Whereas the form factor is a global measure reecting the overall shape of the
waveform, AIx depends on the second systolic peak (P2), a more detailed fea-
ture of the wave shape. Moreover, this second systolic peak is used by the Om-
ron HEM-9000AI to calculate cSBP and therefore relevant for this study. For
this analysis, both theOmronHEM-9000AI and SphygmoCor recordings were
processed with the SphygmoCor-soware.
10.2.5 Statistical analysis
Data are presented as mean (SD). e correlation between variables was as-
sessed usingPearson correlation coecients. Dierences between cSBP-estimates
were assessed using paired student T-tests. To assess the determinants of the
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Figure 10.1: Augmentation index (AIx) and form factor (FF).
dierence in cSBP between Omron HEM-9000AI and SphygmoCor, a forward
multiple regression analysiswas performed including age, gender, BMI, brachial
SBP and DBP as potential factors. P-values lower than 0.05 were considered as
statistically signicant. All statistical analyses were performed in PASW Statis-
tics 18 (IBM, Chicago, IL, USA).
10.3 Results
Basic population characteristics are shown in Table 10.1.e ratio male/female
was 63/80 and 59 of all subjects were hypertensive according to ESH guidelines
(15) (prevalence of 41%).
Table 10.1: Basic population characteristics.
Parameter Mean (SD)
Age (years) 56.3 (10.6)
Weight (kg) 58.9 (12.8)
Length (cm) 162.1 (8.4)
BMI (kg/m2) 22.4 (4.8)
Systolic BP (mmHg) 137.7 (25.6)
Diastolic BP (mmHg) 82.1 (12.9)
MAP (mmHg) 104.2 (16.4)
Heart rate (bpm) 70.6 (13.1)
BMI,Body Mass Index; BP, blood pressure;
MAP, mean arterial pressure
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Central blood pressure estimation
e mean (SD) values of all central pressure estimates are listed in Table 10.2.
When using both devices as advocated by their manufacturers, the correspond-
ing central pressure estimates (cSBP-Omron and cSBP-Sphygmo) correlated
strongly (r=0.99, p<0.001), but the mean dierence was substantial: 18.8 (4.3)
mmHg, p<0.001 (Figure 10.2), with Omron HEM-9000AI yielding the highest
estimate and the dierence increasing for higher cSBP-values.e only signif-
icant determinant of this dierence was brachial SBP (r=0.66, p<0.001).
Table 10.2: Central pressure estimates and second radial systolic peak.
Mean (SD)
cSBP-Omron 147.9 (27.2)
cSBP-Sphygmo 129.1 (24.1)
cSBP-Carotid 138.0 (26.4)
cSBP-Aortic 136.2 (26.4)
cSBP-OmronSphygmo 129.7 (24.4)
cSBP-Sphygmo2 133.2 (26.2)
Compared to aortic SBP, the Omron cSBP-estimate was on average 11.7 (5.5)
mmHg higher, whereas the SphygmoCor cSBP-estimate was on average 7.1 (5.0)
mmHg lower. Alternative calibration of the radial SphygmoCor-curves with
brachial MAP and DBP instead of brachial pressures yields a central pressure
(cSBP-Sphygmo2) that is, on average, 3.0 (4.1) mmHg lower than aortic SBP.
In order to focus on dierences in waveform features only, the curves from
both devices were processed with the same soware (SphygmoCor), yielding
strongly related central pressure estimates (cSBP-Sphygmoand cSBP-OmronSphygmo;
r=0.99, p<0.001)with a small but signicant dierence (0.6 (2.1)mmHg, p<0.001).
Further comparison of the Omron HEM-9000AI and SphygmoCor wave-
form features was done by comparing the form factor and augmentation index.
Comparison of form factors reveals an average dierence of 2.3 (3.0), with FF-
Omron the highest (p<0.001), see Figure 10.3.e correlation between both FFs
was r=0.65 (p<0.001). e radial AIx of Omron HEM-9000AI and Sphygmo-
Cor curves are strongly correlated (r=0.88, p<0.001) with no signicant mean
dierence (-1.0 (7.4) mmHg; Figure 10.3).
To assess whether the second systolic peak was detected properly in both
algorithms, Omron’s P2 is compared to the P2 of Omron waves re-analysed
through SphygmoCor-soware. In this way, potential dierences are due to
dierences in soware only. Figure 10.4 shows an average dierence of 2.2 (2.7)
mmHg, the Omron-soware yielding the lowest P2.
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Figure 10.2: Omron HEM-9000AI’s versus SphygmoCor’s central systolic pressure estimate:
regression (A) and Bland-Altman plot (B). cSBP-SphygmoCor was obtained via calibration of
the radial waves with brachial pressures.
10.4 Discussion
e results from this study demonstrate a considerable dierence between the
central pressure estimates from SphygmoCor and Omron HEM-9000AI. Ad-
ditionally, by comparing both Omron HEM-9000AI and SphygmoCor cSBP-
estimates to carotid systolic pressure and derived alleged aortic pressure, this
study is the rst to provide a handle on which estimate is closest to reality. Fur-
thermore, re-processing of the Omron-waves through SphygmoCor-soware
allows to clearly separate the impact of any dierence in recorded waveforms
(due to potential dierences in tonometry acquisition) from the impact of the
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Figure 10.3: Comparison of radial pressure waveforms measured by Omron HEM-9000AI and
SphygmoCor, both processedwith SphygmoCor-soware. Bland-Altmanplots of the form factor
(A) and radial AIx (B).
processing soware (due to dierent tonometry signal processing) on the ob-
served dierence in central pressure estimates.
A rst important nding is that, when using both devices as advocated by
their manufacturers, the mean dierence in cSBP was 18.8 (4.3) mmHg. Two
factors can contribute to this dierence. Firstly, a dierence in acquisition-
hardware, whichwouldmean that thewaveforms recordedwith the two devices
are not similar, and, secondly, dierences in the algorithm to calculate cSBP.
To assess the rst factor, radial pressure waves recorded by Omron a HEM-
9000AI and SphygmoCor were compared by their form factor and augmen-
tation index. e Omron-waveforms had, on average, a higher form factor,
indicating that they are less peaked. Although the average AIx was very similar
131
10. cSBP: OmronHEM-9000AI versus SphygmoCor
Figure 10.4: Bland-Altman plot of the second systolic peak in radial OmronHEM-9000AI pres-
sure waves, detected with Omron-soware (P2-Omron) and with SphygmoCor-soware (P2-
Omron2).
in Omron- and SphygmoCor-waves, large individual dierences in AIx were
observed (Figure 10.3). ese dierences however, seem to have little impact
on the estimate of cSBP when using the SphygmoCor soware. Indeed, when
processing Omron-measured curves with SphygmoCor soware, similar cSBP-
estimates are obtained: the mean dierence between cSBP-OmronSphygmo
and cSBP-Sphygmo was 0.6 (2.4) mmHg, or less than 4% of the dierence be-
tween cSBP-Omron and cSBP-Sphygmo. Unfortunately, the inverse, i.e. to pro-
cess Sphymocor-measured curves with the Omron soware was not possible.
Nevertheless, it appears that the main reason for the dierence in cSBP is to be
sought in dierences between the two algorithms, rather than in dierences in
measured waveforms.
A rst potential dierence between the two algorithms lies in the detection
of the second systolic peak, which is used by the Omron HEM-9000AI to de-
termine cSBP via a linear relationship. An overestimation of P2 by the Omron
HEM-9000AI would lead to a higher cSBP via the linear regression equation.
Contrary to what could be expected, the Omron-soware places the second
peak lower than the SphygmoCor-soware does (Figure 10.4). Hence, the rea-
son for the dierence between cSBP-Sphygmo and cSBP-Omron should not be
sought in the detection of the second peak either.
e use of a linear equation to transform P2 to central SBP could be ques-
tioned. Previous studies [182, 184, 186] have used untransformed radial P2 as
an estimate of central SBP. In our population, radial P2 was on average 3.0 (3.3)
mmHg higher than cSBP-Sphygmo.
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Another potential dierence could be due to the eect of ethnicity. It cannot
be excluded that one of the two cSBP-algorithms (or both) perform dierently
in this black South African population as compared to Caucasian populations.
e OmronHEM-9000AI algorithm appears to be based on a regression equa-
tion derived from Japanese subjects only [85]. SphygmoCor on the other hand
has already been used in Africans [187–189], but was never validated with in-
vasive measurements in a black population, and could therefore also be prone
to errors. e applicability of both algorithms to the present population de-
pends on whether the relation between radial and central pressure is dierent
in Africans compared to other ethnicities. Verbeke et al. [61] measured carotid
and central pressure with SphygmoCor in a middle-aged Caucasian popula-
tion. ey found the carotid pressure to be 9.7 mmHg higher than the central
pressure when calibrating radial waveforms with brachial pressures (cfr cSBP-
Sphygmo), or 5.7mmHgwhen calibrating radial waveforms with brachialMAP
and DBP (cfr cSBP-Sphygmo2).is matches very well with the corresponding
dierences found in the current study: 8.9 mmHg and 4.8 mmHg, respectively.
While this only suggests that the relation between carotid and radial pressure
does not dier between Caucasians and Africans, it seems reasonable to ex-
trapolate that the relation between radial and central aortic pressure does not
dier either1. Furthermore, the fact that Richardson et al. [165] found a similar
dierence in cSBP between Omron HEM-9000AI and SphygmoCor in their
Caucasian population, renders it unlikely that ethnicity is the main reason for
the observed dierence in cSBP.
e obvious question remains: which estimate is closest to ‘reality’? As in-
vasive data are not available, one approach to answer this question is by com-
paring the cSBP-estimates to carotid SBP. Carotid SBP is calculated directly
from carotid tonometry waveforms calibrated with brachial MAP and DBP,
and therefore does not imply any assumption on the relation between radial
and central pressure. Carotid SBP is intermediate between cSBP-Omron and
cSBP-SphygmoCor, suggesting that the true, invasive cSBP should be sought
in- between both estimates. To judge which device yields the closest estimate to
the true aortic cSBP, wemade use of the reported 1.8 mmHg dierence between
aortic and carotid SBP from an invasive study [59] and used cSBP-Aortic as the
reference cSBP. Compared to cSBP-Aortic, cSBP-Omron provides an average
overestimation of 11.7 (5.5) mmHg, while cSBP-Sphygmo provides an average
underestimation of 7.1 (5.1) mmHg.
A nal factor is the calibration of the radial waveforms. SphygmoCor and
Omron HEM-9000AI both calibrate the radial waveforms using brachial pres-
sures, assuming that the brachial-to-radial pressure amplication is negligible
1e relation between radial and central aortic pressure in Africans is further assessed in a
study in Nigerian women described in chapter 14.
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[130]. Verbeke et al. [61] however found an average dierence of 5.8 mmHg
between brachial and radial SBP2.ey demonstrated that alternative scaling
of the radial pressure waveforms using brachial MAP and DBP yields a cSBP-
estimate that more closely approximates cSBP-Aortic. In this population, cal-
ibrating the radial SphygmoCor-waveforms using radial pressures increased
the mean cSBP-estimate by 4.1 mmHg, making it only 3.0 (4.2) mmHg lower
than cSBP-Aortic. is alternative calibration procedure was only performed
for SphygmoCor-curves since it involves brachial tonometry, which cannot be
acquired using the automated Omron HEM-9000AI tonometer.
Although cSBP-Aortic is determined through carotid SBP and therefore
clearly not free from limitations, the current data do suggest that the overes-
timation of cSBP by Omron HEM-9000AI is larger than the underestimation
by SphygmoCor (p<0.001), especially when the latter is scaled using brachial
MAP and DBP. One could argue that, for most actual applications, the absolute
value of the central pressure may be of lesser concern than the repeatability, as
central pressure is mostly used in addition to brachial pressure. However, when
the same parameter (cSBP)measured by two dierent devices diersmore than
15% (18.8 mmHg), any comparison of measurements performed with dierent
devices becomes impossible. While this comparison across devices could be of
lesser concern to the individual patient, the large dierence also precludes the
use of uniform thresholds.
10.5 Limitations
e most important limitation of this study is the lack of invasive central sys-
tolic pressure values. Although we consider the cSBP-Aortic used in this study
as the best non-invasive guess for central systolic pressure, comparison of the
central pressure estimates of Omron HEM-9000AI and SphygmoCor to direct
invasive measurements of aortic pressure is still recommended. Furthermore,
the Omron HEM-9000AI and SphygmoCor were not applied in a randomised
order. For practical reasons, each subjectwas rstmeasuredwithOmronHEM-
9000AI, and then with SphygmoCor. Although subjects were at rest during
both measurements, it cannot be guaranteed that blood pressure remained un-
changed. However, since the same brachial BP was used to calibrate the radial
waveforms from both devices and given the virtually identical cSBP predicted
by the SphygmoCor soware using either the SphygmoCor- or the Omron-
measured radial waveforms, this eect seems limited.
2Chapter 6 describes the impact of dierent calibration methods on the brachial-to-radial
pressure amplication.
134
10.6. Conclusion
10.6 Conclusion
Whenusing SphygmoCor andOmronHEM-9000AI as advocated by theirman-
ufacturers in a population of black South Africans, the mean dierence in cSBP
predicted by both devices was 18.8 (4.3) mmHg.emain reason for this dier-
ence in cSBP is to be sought in dierences between the two algorithms, rather
than in dierences inmeasured waveforms. Analysis of these data using carotid
SBP minus 1.8 mmHg as device-independent reference suggests that the ‘true’
central cSBP is to be sought in-between the Omron HEM-9000AI and Sphyg-
moCor estimates.
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Development of a low-cost
Tono-Doppler device
11.1 Introduction
As outlined in chapter 2, pulse wave velocity can be obtained from either pres-
sure, diameter or ow waveforms at two anatomical locations. Whereas the
acquisition of diameter distension waveforms requires advanced and expensive
wall tracking ultrasound scanners, the assessment of ow and pressure wave-
forms can be done in a much cheaper way. However, the few established com-
mercially available devices for the assessment of PWV (SphygmoCor, Com-
plior) are rather expensive (>20 000e). Until recently, SphygmoCor was the
only commercially available device for applanation tonometry, amonopoly that
undoubtedly contributed to its high price. Since the inclusion of PWV as a
marker of subclinical organ damage in the ESC/ESH guidelines of 2007, a num-
ber of new devices has appeared.ese devices are cheaper, oen at the expense
of accuracy (see for instance chapter 9) or because of new, insuciently vali-
dated algorithms (see chapter 10). As an alternative, we have developed a low-
cost device based on existing, validated algorithms to acquire ow and pressure
waveforms and hence derive PWV, local blood pressure and augmentation in-
dex.e device is specically built for application in sub-Saharan Africa1.
1Chapter 14 reports the results of a study in Nigerian women measured with the Tono-
Doppler device
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11.2 Development
11.2.1 Hardware
Figure 11.1 gives a schematic overview of the dierent components of the Tono-
Doppler device. Each component is described in more detail below.
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Figure 11.1: Schematic overview of the dierent components of the Tono-Doppler device.
• Data-acquisition module - Pressure and ow waveforms signals are digi-
tized using theNI-9219 (National Instruments, Texas, USA), a data-acquisition
hardwaremodule that allows analog-to-digital (ADC) conversion of 4 in-
put channels at a sampling rate of 100Hz and a resolution of 24 bits over
a modiable input voltage range. is range is set at ±125mV for the to-
nometry signal and at ±1V for the Doppler signal. e digitized signals
are transferred to a computer via USB, from which the device also draws
power (at 5V). Price is around 1100e.
• Micro-tip transducer - Pressure waveforms are acquired using a SPT-304
micro-tip strain gauge transducer (Millar Instruments, Texas, USA) , the
same type of transducer as used by the SphygmoCor device. When pres-
sure is applied on this sensor, a piezoelectric element is compressed caus-
ing a voltage dierence over a Wheatstone bridge: 25µV/mmHg for a 5V
input voltage at the Wheatstone bridge.is voltage signal is digitized at
100Hz in the data-acquisition module. Price is around 1600e.
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• Doppler devices - Flowwaveforms are acquired using commercially avail-
able handheld continuous-wave Doppler devices (Huntleigh Healthcare,
Cardi, UK) with a frequency of 8MHz. ese devices have an (ampli-
ed) analog output, which is digitized at 100Hz in the data-acquisition
module. Price is around 300e.
• ECG-module - A commercially available one-channelmodule (EG01000,
Medlab GmbH, Karlsruhe, Germany) with built-in amplication, lter-
ing and sampling (300Hz) technology provides the electrocardiogram
(ECG) needed for synchronization of two consecutively measured pres-
sure or ow waveforms. e module has a serial output, which is con-
verted to USB via a serial-to-USB adapter. Price is around 350e.
• Power - As power supply from the mains is oen unreliable or unavail-
able in sub-Saharan Africa, the Tono-Doppler device is designed to be
powered from a laptop. e 5V output of a regular USB-connection is
connected to a USB-hub, from where it is distributed to the power sup-
ply of the micro-tip transducer, the ECG module and data-acquisition
module to serve as a power supply.e Doppler devices are battery pow-
ered (9V).
e ensemble is assembled in a ventilated polycarbonate enclosure, as shown
in gure 11.2. Total price is below 4000e.
1
2
3
4
6
7
7
5
Figure 11.2: Tono-Doppler hardware components: 1: data-acquisition module; 2: ECG-module;
3: ventilator; 4: serial-to-USB adapter; 5: USB-hub; 6: micro-tip transducer; 7: Doppler devices.
11.2.2 Soware
Based on existing code and algorithmsdeveloped in the framework of theAskle-
pios study, a dedicated acquisition and processing interface were developed in
Matlab (MathWorks, Natick, Massachusetts, USA). During acquisition, the fo-
cus of the operator is on getting a quick feedback on the quality of the mea-
surement. is is in contrast with the post-processing, oen performed by an
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operator with more (technical) background, where the focus is on accuracy.
erefore, the acquisition interface is designed to be straightforward and give
multiple visual quality feedback options.e processing interface, on the other
hand, allows the user to modify a number of algorithm settings as well as to
manually select or deselect individual cycles.
Acquisition interface
Figure 11.3: Acquisition interface displaying two consecutive Doppler recordings at the carotid
(upper panel) and the femoral artery (lower panel), each with co-recorded ECG-signal.
Figure 11.3 displays a screenshot of the acquisition interface. Aer entering
the basic patient information, the user has the choice between the simultaneous
assessment of twowaveforms (‘start/stop PWV’) or recording a single waveform
(‘start/stop upper (lower) window’).e technique (Doppler/tonometry) and lo-
cation (carotid, femoral, radial or brachial artery) can be set in the dropdown
boxes at the upper le of the acquisition windows and a checkbox can be se-
lected to measure an ECG along with the Doppler/tonometry curves. When
a full window (15 seconds) of data is recorded, the recording can be processed
(‘process last window’) and the average waveform is displayed at the right. Pro-
cessing includes separating the recorded signal into dierent cardiac cycles and
select the ’usable’ cycles based on cycle shape and cycle length criteria, which
are detailed in one of the following sections. In contrast to the processing in-
terface, in the acquisition interface, the cycle shape and cycle length criteria are
not user-modiable.e quality of the recording can be assessed by looking at
the shape of the average cycle as well as the number of accepted cycles (upper
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right of the average cycle window). In the case of a carotid and a femoral record-
ing (either simultaneous or consecutive with ECG-gating as in gure 11.3), the
PWV is calculated and colour-coded as an extra feedback on the quality of the
recorded waveforms. When the mean PWV-value falls outside the physiologic
range (2 m/s-15 m/s), it is coloured red to indicate an unrealistic value. When
the mean value is within the physiologic range, it is coloured green when the
standard deviation is below 10% of the mean value and orange when the stan-
dard deviation is larger than 10%.
In case of simultaneous recordings at the carotid and femoral artery, the
travelled time per cycle is obtained by subtraction of the time of the carotid foot
from the time of the femoral foot. In this way, an array with beat-to-beat transit
times is obtained, fromwhich the mean transit time and standard deviation are
easily calculated. In case of two consecutive recordings, the ECG is used to align
both recordings in time. For each recording, an array is obtained with the beat-
to-beat times between the R-tops of the ECG and the carotid (femoral) feet.
e average transit time is obtained from the subtraction of the average value
of both arrays, while the standard deviation is obtained as the square root of
the sum of the squared standard deviations of each array, following error calcu-
lation theory. For both simultaneous and consecutive recordings, the standard
deviation of the PWV is obtained as the standard deviation of the transit time
multiplied by the ratio of mean PWV and mean transit time.
Processing interface
Figure 11.4 displays a screenshot of the processing window. Upon loading of
a recording, the signals are subsampled to 1000Hz (via linear interpolation)
to allow a more accurate detection of timing parameters such as the foot of the
wave. Individual cycles can be selected or deselected from either the acquisition
window (le) or the average waveform window (right). e checkboxes and
sliders in the lower panel allow to (de)select and modify the cycle detection
and averaging algorithms outlined in the next section.
Algorithms
Both interfaces make use of the following algorithms, which are used in the
analysis of both pressure and ow waveforms:
• Cycle detection
To split up a recording into separate cardiac cycles, the points of diastolic
pressure need to be identied. is is done by selecting those points of
the signal’s rst derivative that exceed a certain threshold value, as shown
by the red line in gure 11.5.
By default, the threshold is set at 70% of the maximum of the deriva-
tive and dynamically lowered until at least 10 sample points are above the
threshold. In the processing soware, a slider allows manual selection of
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Figure 11.4: Processing interface displaying two consecutive Doppler recordings at the carotid
(upper panel) and the femoral artery (lower panel).
the treshold level between 50 and 100% of the derivative amplitude. Per
set of consecutive points above the threshold, a local maximum is calcu-
lated, as illustrated by the red asterisks in gure 11.5. Diastolic pressure
(green asterisk in gure 11.5) is then found by looking for the minimum
of the signal between two red asterisks.
• Average cycle calculation
Because recordings oen contain irregularities, not all cycles are used
to calculate the average cycle. Two criteria are used to select the ‘usable’
cycles: cycle length and cycle shape. By default, the cycle length criterium
deselects the cycles with a length outside interval [mean cycle length -
30%, mean cycle length +30%]. For the cycle shape criterium, a zone
is dened around the average waveform, as shown by the red lines in
the right panels of gure 11.3 and 11.4. If more than 10% of the points
of a cycle fall outside this zone, the cycle is rejected. e upper limit is
obtained by adding 10% of the standard deviation of all waveforms to the
average waveform, while the lower limit is obtained by subtracting the
same 10%. In the processing soware, both the cycle length and cycle
shape tresholds are user-modiable.
• Foot-detection algorithm
PWV is obtained as the ratio of travelled distance and transit time (see
chapter 2). Travelled distance is measured on the body surface according
to multiple denitions and stored along with the ’basic patient info’.e
calculation of transit time relies on the identication of wave feet. We
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Figure 11.5: Cycle detection algorithm.
dened the foot of the wave as the point at 10% of the cycle pulse height,
as illustrated by the green asterisks in gure 11.3 (denoting the last point
below and the rst point above 10% of the pulse height).
11.3 Validation
Like any other new device, the Tono-Doppler device needs to be validated by
comparison to a reference device. We performed a limited validation study
on 11 healthy volunteers (5 females), aged 23 to 33 years. Subjects were mea-
sured with the Tono-Doppler and the SphygmoCor device, in a random order.
Carotid-femoral PWVwas assessed from consecutive and simultaneous Dopp-
ler recordings with the Tono-Doppler device, and from consecutive tonometry
recordings with the SphygmoCor device. Each type of recording was obtained
in triplicate. Radial tonometry was performed with both devices. Not all mea-
surements were performed in each subject. Heart rate was monitored as an
indicator of the subject’s cardiovascular resting condition. Recordings within
the same subject were discarded when heart rate diered more than 5 bpm.
When comparingmeasurements between two devices, potential dierences
can arise from either the hardware or the soware. erefore, hardware and
soware are validated separately.
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11.3.1 Hardware validation
Since every component of the Tono-Doppler device is commercially available
and thus validated by its manufacturer, no separate validation of the ECG-,
Doppler- or tonometry-hardware is required. However, as the data-acquisition
module has a slightly lower sampling rate than the SphygmoCor device (100Hz
vs 128Hz), it cannot be ruled out that the high frequency information of a pres-
sure/ow waveform is not completely captured by the Tono-Doppler device.
is could have an impact on the augmentation index (AIx), as this index de-
pends on the higher frequency content of the pressure wave. We compared
the AIx between data recorded with the Tono-Doppler and the SphygmoCor
device. To isolate any dierences in acquisition hardware, the data were pro-
cessed through the same soware (SphygmoCor) and measured with the same
tonometer probe (SPT-304,Millar Instruments, Texas, USA). Figure 11.6) shows
a Bland-Altman plot of 10 comparative radial tonometry recordings pertaining
to 7 volunteers. Mean (SD) dierence in AIx is -0.6 (4.8)% between both de-
vices. is dierence is comparable to the reproducibility of AIx reported in
literature (0.5 (5.4) %, [190], see also gure 11.6), and thus indicates that the high
frequency information is suciently captured by the Tono-Doppler device.
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Figure 11.6: Le: Bland-Altman plot of the radial AIx obtained from the Tono-Doppler and the
SphygmoCor device. Right: reproducibility of aortic AIx assessed with the SphgymoCor device
by two dierent operators (circles and triangles), as reported by Wilkinson et al.[190]
Note that this device comparison is performed in people, whose hemody-
namics continuously vary within a small, physiological range, and by manual
handling of the tonometer probe, repositioned for eachmeasurement.e term
‘hardware validation’ should therefore be used with care, as the observed vari-
ations in AIx most likely reect changes in operator and subject’s conditions.
11.3.2 Soware validation
Acquisition soware
A crucial issue in the acquisition process that needs separate validation is the
synchronisation between the ECG-signal and the pressure or ow signal. Be-
144
11.3. Validation
cause the ECG-signal serves as a reference to align two consecutive pressure/ow
recordings in order to calculate the carotid-femoral PWV, it is important that
the pressure/ow tracing and the ECG-signal are read simultaneously (or at
least with a constant, minor time-delay). As the ECG-signal is digitized within
theECG-modulewhile the pressure/ow signal is digitized in the data-acquisition
module, the synchronization between both signals has to be assured by the
acquisition sofware.is was veried by comparing the mean carotid-femoral
transit time obtained from simultaneous ow recordings with the mean tran-
sit obtained from consecutive, ECG-gated ow recordings. Each recording was
obtained in triplicate andmedian values are reported. If the ECG-signal and the
ow signal are synchronized correctly, both transit times should be compara-
ble. Comparativemeasurements on 7 volunteers showed amean (SD) dierence
of 3.0 (7.3) ms between both methods. To enable comparison to other repro-
ducibility studies in literature, the transit times are converted to PWV-values by
means of the carotid-femoral distance. As can be seen in gure 11.7, our mean
(SD) dierence of -0.3 (0.7) m/s is within the reproducibility range reported in
literature (0.1 (1.2) m/s, Wilkinson et al. [190]; 0.3 (2.4) m/s, Frimodt-Moller et
al. [191]), indicating a correct synchronisation between the ECG-signal and the
ow signal.
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Figure 11.7: Le: Bland-Altman plot of consecutive versus simultaneously measured carotid-
femoral PWV from ow recordings with the Tono-Doppler device. Right: reproducibility of
carotid-femoral PWV obtained from consecutive tonometer recordings with the SphygmoCor
device.e circles and triangles denote measurements by two dierent operators.[190]
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Processing soware
Two of the three previously described algorithms, the cycle detection and av-
erage cycle calculation algorithms, were previously used in the Asklepios study
and as such do not require separate validation. e foot detection algorithm,
however, has not been used in a study before and is therefore validated by com-
paring the transit times calculated by theTono-Doppler soware and the Sphyg-
moCor soware. Dierent foot detection algorithms can be used in Sphygmo-
Cor. For this comparison, the algorithm using 10% of the pulse height was
selected. To isolate dierences in soware, the same data (recorded by the
SphygmoCor-hardware) were used for processing by both sowares. Figure
11.8 shows the results of a comparison of 15 consecutive carotid and femoral to-
nometry readings pertaining to 7 subjects. Mean (SD) dierence in transit time
was 0.4 (2.0) ms, while correlation between both devices was 0.95.
Figure 11.8: Comparison of transit times assessed by Tono-Doppler and SphygmoCor soware.
Carotid and femoral pressure data are recorded using SphygmoCor hardware.
11.3.3 PWV from Doppler versus PWV from tonometry
With the Tono-Doppler device, one can obtain PWV from either tonometry
or Doppler recordings. With SphygmoCor, PWV is obtained from carotid and
femoral tonometry recordings. Even though both methods are well accepted in
literature and PWV from tonometry and Doppler recordings should be equiv-
alent, comparative measurements on 7 subjects were performed as an extra val-
idation. A Bland-Altman plot of the PWV-values obtained from both methods
is given in gure 11.9. Mean (SD) dierence is -0.1 (1.2) m/s, indicating no sys-
tematic dierence between both methods and a range within the previously
reported reproducibility range [190, 191].
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Figure 11.9: Comparison of PWV obtained from ow waveforms via the Tono-Doppler device
and from tonometric waveforms via the SphygmoCor device.
11.4 Conclusion
By combining dierent commercially available hardware components and in-
house available signal processing knowhow, we have developed an accurate,
low-cost device for the assessment of pulse wave velocity and local pressure. Its
mobility and low price (<4000e) make the Tono-Doppler particularly suited
for application in remote settings and developing countries.
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Outline
e fourth part of thismanuscript focuses on the arterial properties of people of
African descent, who display a clearly dierent cardiovascular risk prole than
Caucasians. Figure 12.1 shows the geographical location of the African studies
that were performed during my PhD.
Chapter 13 elaborates on this dierence in risk prole and the potential
mechanisms that may be at the root of it. e literature on dierences in ar-
terial properties between people of African and Caucasian origin is reviewed,
with particular focus on the ethnic dierences in mechanical properties of the
large arteries. From this literature review, it is apparent that most of the re-
search on ethnic dierences between Africans and Caucasians is performed on
Africans living in Western countries such as the United States and the United
Kingdom. Given the increasing rates of cardiovascular disease in sub-Saharan
Africa, more research on Africans living in sub-Saharan Africa as a basis for
policy and treatment strategies is urgently needed.
Against this background, two studies were undertaken in Nigeria, the most
populous country in sub-Saharan Africa. Chapter 14 details the results of com-
parative study on the aortic stiness and arterial wave reections in 184 young
Nigerian women and 92 age-matched Belgian women. Mean levels as well as
determinants of pulse wave velocity (PWV), augmentation index (AIx) and lo-
cal pressure were compared across ethnicity.
In a second study described in chapter 15, the aortic stiness of 264 babies,
aged 0-1 year, was asessed in an attempt to track early changes in arterial dis-
tensibility. Based on prior ndings that the etiology of CVD in adults may have
its origin in utero and infancy, aortic pulse wave velocities measured at the age
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Ibadan, Nigeria
Ganyesa, South-Africa
Figure 12.1: Geographical study locations
of 0, 3 and 12 months were linked to infant and maternal characteristics to gain
further insight in the driving factors of early vascular development.
A third study was performed on central blood pressure in rural South-
Africa. Given its methodologic nature, the report of this study is given in part
II of this manuscript on the validation and development of new methods.
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Ethnic differences in arterial
properties between Africans and
Caucasians in literature
13.1 Cardiovascular risk profile in Africans
People of African descent display a clearly dierent cardiovascular risk prole
than Caucasians. While the prevalence of ischemic or coronary heart disease is
generally similar or lower in African-origin people [192, 193], hypertension and
diabetes are 1.5 to 3 timesmore prevalent than in Caucasians [194–198], with the
dierence most pronounced at young and middle age (20-50 years). e risk
of target organ damage associated with these conditions, such as stroke, le
ventricular hypertrophy (LVH), insulin resistance and end-stage renal disease
is disproportionately greater in those of black African descent even when con-
ventional risk factors are accounted for. In addition, pathophysiologic features
of end stage renal failure and LVH appear to be dierent. erefore, ethnicity
itself has emerged as an important independent risk factor for cardiovascular
disease [199, 200].
Over the last 50 years, many dierent hypotheses for mechanisms under-
lying this dierent risk prole have been proposed. One of the theories is that
of catch-up growth or Barker’s hypothesis [201, 202]. Based on the observation
that retarded fetal growth is associated with higher levels of blood pressure in
later life, David Barker hypothesized that a pregnant woman can modify the
development of her unborn child such that it will be prepared for survival in
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an environment in which resources are likely to be scarce, resulting in lower
renal glomerular numbers or volumes and hence altered renal handling of salt
loads.e increased salt-sensitivity among African-Americans could also be at
the base of the observed risk prole. Salt-sensitivity is the impaired ability to ex-
crete ingested salt, leading to an expansion of water volume in the blood vessels,
and accompanying elevated blood pressure.e renal vasculature of people of
African descent is particularly sensitive to the damaging eects of high blood
pressure, as illustrated by the common observation of abundant deposition of
extracellularmatrix in the renal vessels of hypertensive black patients[203]. Sev-
eral studies have shown dierences in the frequency of gene polymorphisms
for several proteins that modulate vascular function [204, 205] between Afro-
Caribbean and Caucasian patients. Black subjects also tend to have a higher
relative collagen content in the aorta and in the coronary arteries, resulting in
stier arteries and hence higher blood pressure [206, 207].
Some of these hypotheses are more speculative than others, and the true
mechanisms responsible for the dierence in risk prole between Africans and
Caucasians remain largely unclear.e above listed mechanisms all originated
from observed dierences in established (non-invasive) markers or predictors
of cardiovascular disease. As such, these observations provide the only rm
ground to describe ethnic dierences in arterial properties.e next section is
a brief summary of some of the key dierences in cardiovascular risk markers
between people of African descent and Caucasians.
13.2 Ethnic differences in arterial properties
13.2.1 Dierences in risk markers
ere is a number of cardiovascular risk markers that have been consistently
reported to dier between Caucasians and subjects of African descent. A rst
dierence is the lower amount of coronary calcium in black subjects, as indi-
cated by a lower coronary calcium score and a lower prevalence of calcied le-
sions in the coronary arteries [208–211].is is in line with the reported lower
prevalence of coronary heart disease in people of African descent [193, 211].
Secondly, increased levels of carotid intima-media thickness (IMT) were re-
ported inAfrican-Caribbeans andAfrican-Americans at various ages [212–218].
e intima-media thickness increases due to intimal hyperplasia and medial
hypertrophy in response to a pulsatile mechanical load, and might therefore
indicate a higher carotid pulse pressure [218, 219]. Another consistent nd-
ing lies in the hyperemic response in the forearm, also called the ow medi-
ated dilation (FMD). FMDwas attenuated in various samples of African-origin
subjects [220–225] and is considered indicative of the global impairment of
endothelial-dependent and endothelial-independent microvascular vasodila-
tion. Afro-Caribbeans were reported to have lower levels of creatinin-reactive
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protein (CRP), an inammationmarker, aswell as lower levels of LDL-cholesterol,
but higher levels of HDL-cholesterol [226, 227].
13.2.2 Mechanical properties of the large arteries
Given the unique role of the mechanical properties of the large arteries as early
markers of atherosclerosis as well as integrated measures of cellular or hor-
monal changes, the literature on ethnic comparisons of vascular properties in-
volving subjects of black African descent is reviewed in more detail.
Multiple large-scale cross-sectional and follow-up studies have been per-
formed to study the inuence and predictive value of markers of arterial sti-
ness andwave reections with age, dierent risk factors and various pathologies
[40, 77, 116, 121]. However, nearly all of these studies were performed on sub-
jects of European or Asian descent.e scarce literature on comparative studies
on arterial stiness and arterial wave reections in people of black African de-
scent versus Caucasians is reviewed using ISIWeb of Knowledge. Keywords in-
cluded ‘central blood pressure’, ‘augmentation index’, ‘pulse wave velocity’, ‘wave
reection’ or ‘arterial stiness’ and ‘Africans’, ‘blacks’ or ‘ethnic dierence’. Bib-
liographies were manually searched.
When comparing parameters measured in dierent population samples, it
is important to be aware of all the dierences between the sampled groups.
While dierences in continuous, exact parameters like age, bloodpressure, weight
and height can be statistically corrected for, there are many other dierences
that cannot be quantied in an exact way, such as dierences in lifestyle, envi-
ronment (do both populations live in a similar environment) or health status
(healthy versus diseased).erefore, these factors should be taken into account
for proper comparison across ethnicity. Ethnicity represents a clustering of ge-
netic and environmental factors. While Afro-Caribbeans living in the UK do
not dier from JamaicanAfro-Caribbeans in genetical terms, their dierent en-
vironment leads to a clear dierence in vascular risk prole [228], suggesting a
signicant environmental interaction with the development of cardiovascular
disease. On the other hand, the impact of the genetic dierences between Afro-
Caribbeans and Afro-Americans living in the US on their vascular risk prole
and arterial mechanical properties was found to be insignicant [229].
A number of studies has assessed arterial stiness or compliance in more
detail, either by measuring carotid-radial PWV in addition to carotid-femoral
PWV as a measure of muscular artery stiness [229–232] or by tting an ad-
vanced Windkessel model including large (C1) and small artery stiness (C2)
to the radial pressure waveform [233, 234]. We have chosen to exclude these
parameters from the literature overview, as their interpretation is unclear and
their predictive value unproven.
Table 13.1 provides an overview of the comparative studies between people
of African descent and Caucasians matching the following criteria:
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• arterial stiness and/or wave reections are assessed using established
markers (see Chapter 2)
• the reported dierences are statistically corrected for at least age and
blood pressure
• the compared ethnic groups live in the similar environment (in order to
minimize environmental dierences)
General population
Table 13.1 gives an overview of the literature on dierences in the mechanical
properties of large arteries betweenWestern and African-origin healthy or gen-
eral populations.
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13. Ethnic differences in arterial properties between Africans and
Caucasians in literature
When aortic stiness is assessed via what is considered as the gold-standard
method (carotid-to-femoral pulse wave velocity) it was found to be consistently
higher in people of African origin than in people of Caucasian origin, except
for two studies (table 13.1). In the study of Ferreira et al. [207] on Brazilian
male soldiers, the hypertensive soldiers of African origin had a higher carotid-
femoral PWV than their white counterparts, whereas normotensive soldiers
of African origin had lower values than their white counterparts. However,
the slope of increase of aortic stiness with systolic blood pressure (SBP) was
steeper for Africans than for whites along the entire range of observed BP. In the
second discordant study, carotid-femoral PWV did not dier signicantly be-
tween African-Americans and Caucasians aged 70 to 96 years [235]. It is likely
that the high age of this study population is the main reason for not nding a
dierence in aortic stiness, as survival bias may have occurred. People reach-
ing the age of 70 and certainly 96 may have benecial physical characteristics,
in particular arterial properties, thus making them less representative of the
general population. Furthermore, being marker of subclinical organ damage,
PWV is probably less relevant to quantify cardiovascular risk in populations
where organ damage is thought to be already beyond the subclinical level.
PWV is inversely related to distensibility via the Bramwell-Hill equation
(see equation 1.11 on page 19). As such, the reported lower aortic distensibility
coecient in African-Americans (table 13.1) conrms the reports of a higher
aortic stiness in blacks.
As far as local stiness is concerned, two studies report a clearly higher
carotid artery stiness in African-origin subjects as in whites. At the level of the
brachial artery, no dierence in β-stiness index nor in pulse pressure (PP), a
crude measure of stiness, was observed.
While the number of studies directly comparing arterial stiness between
people of African descent and Caucasians is low and a majority of the studies
focuses on either African-Americans living in the US or African-Caribbeans
living in the UK, the available data on ethnic dierences in wave reections are,
to the best ofmy knowledge, limited to two studies, both onAfrican-Americans.
In young men [218] and middle-aged men and women [241], arterial wave re-
ections quantied as augmentation index and pulse pressure amplication,
were found to be stronger in African-Americans than in Caucasians.
Populations with specic diseases
e incidence of cardiovascular disease in patients with type-2 diabetes and
patients on hemodialysis is much higher than in the general population.ese
patients therefore provide an interesting subgroup to gain more insight into
the etiology and development of cardiovascular disease. Two studies [230, 232]
comparedPWV inAfro-Caribbean andCaucasian patientswith type-2 diabetes
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living in the UK.ey report no ethnic dierences in carotid-femoral PWV.
Bellasi et al. [242] compared African-American and Caucasian hemodialysis
patients and reported no ethnic dierences in carotid-femoral PWVnor in aor-
tic AIx.
13.2.3 Critical notes
Some important limitations can be noted about the available data on mechan-
ical arterial properties in people of African descent. A rst limitation apparent
from table 13.1 is the small number of subjects per study. Apart from the stu-
dies of Malayeri [238], Din-Dzietham [239] and Patel [241], the sample sizes are
around or below 100 subjects per ethnic group, whichmakes it dangerous to ex-
trapolate study ndings to entire ethnic groups. A second important limitation
is the fact that most of the research on people of African descent is performed
on Africans living in Western countries, such as African-Americans and Afro-
Caribbeans living in the UK. Given the potential signicant inuence of the
environment on the development of cardiovascular disease (CVD) [228], this
means that the available data cannot readily be extrapolated to sub-Saharan
Africa (SSA).e only study I could track on sub-Saharan Africans so far was
performed in South-Africa by Shiburi et al. [188]. ey assessed radial and
central AIx as well as carotid-femoral PWV in 347 subjects and proposed pre-
liminary reference values for AIx and PWV in South-Africans, which are clearly
higher than similar data in Caucasians [243].
13.3 The need for cardiovascular research in sub-Saharan Africa
e lack of studies on mechanical properties of large arteries in sub-Saharan
Africa (SSA) is illustrative for the more general lack of research interest in car-
diovascular diseases in this region. However, there are a few good reasons why
cardiovascular research in sub-Saharan Africa is relevant and should be inten-
sied. Along with the industrialisation and urbanisation process Africa has
been undergoing for decades now, there are associated transitions on the de-
mographic and epidemiological level. On the demographic level, there is a shi
from high birth rates, high mortality rates and a short life expectancy towards
low birth and mortality rates and a longer life expectancy [244, 245]. Linked to
these demographic changes, an epidemiological shi is occurring from com-
municable or infectious diseases towards non-communicable or degenerative
diseases. As a consequence, cardiovascular diseases in SSA are becoming a ma-
jor health problem with a rapidly increasing prevalence. In 2004, the WHO
stated that "Unless current trends are halted or reversed, over a billion people will
die from cardiovascular disease in the rst half of the 21st century.e largemajor-
ity will be in developing countries and much of the life years will be lost in middle
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age.is would be an enormous tragedy, given that research in the last half of the
20th century showed that cardiovascular disease was largely preventable."
While a discussion on treatment strategies for CVD in SSA is certainly be-
yond the scope of this thesis, it is clear that, ideally, policies should be based on
(accurate) data of the prevalence and pathophysiology of CVD in SSA. How-
ever, up to date, no such accurate data exist, as illustrated by the above litera-
ture review as well as the fact that the most recent estimate of the prevalence of
hypertension in SSA showed a 95%-condence interval ranging from 65 to 93
million [246].
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Aortic stiffness and wave reflections:
comparison between Nigerian and
Belgianmiddle-aged women
14.1 Introduction
e prevalence of high blood pressure (BP) and resulting cardiovascular disease
(CVD) is generally higher among people of African descent than among Euro-
peans or other ethnic groups [27, 198]. Over the last 50 years, many dierent
hypotheses for, andmechanisms underlying this dierence have been proposed
[247–249]. An almost universal nding has been lower plasma renin in black
than in white people at any age which is generally unrelated to blood pressure.
Genetic studies thus far failed to identify specic gene variants in a consistent
manner. Lower birth weight, possibly leading to lower renal glomerular num-
bers or volumes and hence renal handling of salt loads, and recently epigenetic
mechanisms may be relevant [202, 250]. Another possible mechanism is a dif-
ference in mechanical properties of the large arteries, especially arterial sti-
ness, a structural and functional vascular component, which may be amenable
to more specic targeting of treatment.
e current gold-standard technique to assess arterial stiness is through
pulsewave velocity (PWV)measured along the carotid-femoral pathway, which
has been shown to have a powerful prognostic value for CVD, independent of
BP [55]. Additionally, pulse wave analysis, the assessment of local blood pres-
sure waves through applanation tonometry, can be used to assess local and cen-
tral augmentation index (AIx) and central systolic blood pressure (cSBP).e
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AIx is a measure of wave reections, while cSBP is the pressure faced by the
heart and may be more predictive of CVD than conventional brachial pressure
[121]. Pulse wave analysis is usually performed at the radial artery, and aortic
parameters are derived via the radial-to-aortic transfer function. However, this
transfer function has not been validated for use in people of African ancestry
[188]. Tonometer measurements at the common carotid artery can be used as
an alternative, as the carotid artery is an elastic, supercial artery very close to
the heart and carotid systolic pressure has been reported to be only on average
1.8 mmHg higher than aortic pressure [59].
Several studies have assessed the alleged ethnic dierence in mechanical
properties of the large arteries non-invasively. However, most of the available
data focused onAfrican-Americans [207, 218, 233, 235, 239, 242], African-Caribbeans
[71, 231, 251] or African-Europeans [187] rather than Africans living in sub-
Saharan Africa. To the author’s knowledge, the study by Shiburi et al. [188]
in South-Africa is the only study so far that measured PWV and pulse wave
analysis in sub-Saharan Africa. Whereas the burden of well-known communi-
cable diseases as malaria and HIV in sub-Saharan Africa is decreasing slowly,
the estimates and prognoses on the burden of hypertension are alarming. e
fact that cardiovascular diseases result in substantial mortality in economically
active age groups [27, 252], especially in urbanized regions [246] only adds to
this burden. e primary aim of this study was to measure arterial stiness,
aortic pressure and wave reections in an urban community sample in Nigeria,
one of the most densely populated SSA-countries. e results were compared
to corresponding values of a European population matched for age and gender.
Secondly, the accuracy of the transfer function (TF) to assess central AIx and
SBP was evaluated by comparing the TF-derived aortic parameters with AIx
and SBP obtained from carotid pulse wave analysis.
14.2 Methods
Study population
A total of 184 healthy, 1-2 year postnatal women (19-45 years) enrolled in the
Ibadan Child Growth and Vascular Health study (ICGVH [253]) were recruited
at the Adeoyo Maternity Hospital, Ibadan, an urban setting in the southwest of
Nigeria.
Measurements
Aer aminimum of 5minutes of supine rest, brachial BP wasmeasured with an
OmronMIT Elite HEM-7300-WE sphygmomanometer. Carotid-femoral pulse
wave velocity (PWV) was obtained in all women with the tono-Doppler device
described in chapter 11. Carotid and femoral ow waveforms were acquired se-
quentially using a handheld continuouswaveDoppler device (HuntleighHealth-
care, Cardi, UK). Transit time was calculated aer time-alignment of both
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ow waves via co-recorded ECG-signals. e distance between the supraster-
nal notch and the measurement location at the carotid artery was subtracted
from the distance between the suprasternal notch and the femoral measuring
location to obtain PWV as the ratio of distance and transit time [2].
Applanation tonometry was performed on the brachial, radial and carotid
artery using a Millar pressure sensor in a subset of 36 mothers.
Doppler and tonometry traces were captured at 100Hz using commercially
available acquisition hardware (National Instruments, Texas, USA) and dis-
played and stored using a custom-built hard- and soware platform developed
inMatlab (Mathworks, Natick, Massachusetts, USA), see also chapter 11. Radial
and carotid tonometry waves were calibrated with brachial diastolic (DBP) and
mean arterial pressure (MAP), the latter obtained through scaled brachial tono-
metric waveforms. Radial, carotid and synthesized aortic augmentation index
(AIx) and systolic blood pressure (SBP) were calculated using SphygmoCor-
soware (Atcor Medical, Sydney, Australia) as the ratio of the second and the
rst peak of the pressure wave expressed in percent. Augmented pressure (AP)
was calculated as the dierence between the second and the rst peak of the
pressure wave. In C-type waveforms with an inection point aer the peak
systolic pressure, the AP is negative, whereas it becomes positive for A-type
waveforms.
Comparison with Belgian population
e results from the Nigerian cohort are compared to a Belgian cohort, com-
posed of women included in two previous studies: the Asklepios study [94] and
a study on the vascular eects of migraine [132]. is allowed to cover the age
range of theNigerian population.eCaucasian populationwasmatched to the
Nigerian one for age: for every two Nigerian women, one Belgian control sub-
ject was included who diered less than two years in age with both Nigerians.
For the subset of 36 subjects with tonometry measurements, a separate match-
ing was performed: every Nigerian woman was matched to a Belgian woman
of the same age.
Statistics
Data are presented asmean (standard deviation). P-values lower than 0.05 were
considered as statistically signicant. To assess the determinants of PWV in
both populations, a stepwise forward multiple linear regression analysis was
performed including age, brachial MAP, body height, BMI and heart rate as
potential factors. Only the factors that were signicant in univariate analysis
were entered into multivariate analysis. All analyses were performed in PASW
Statistics 18 (IBM, Chicago, IL, USA).
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14.3 Results
Pulse wave velocity
Basic characteristics of the 184Nigerian and thematchedBelgian controlwomen
(aged 19-45 years) can be found in table 14.1.e Belgianswere on average taller,
marginally heavier but still had lower BMI and higher SBP and MAP but not
DBP. Average heart rate was lower than in theNigerianmothers. Pulse wave ve-
locity did not dier signicantly between populations; the dierence remained
insignicant aer adjustment for heart rate, BMI, height and SBP. Age, MAP
and SBP were all signicantly related to PWV in both cohorts aer univariate
regression analysis. However, multiple regression analysis revealed age and SBP
as the main determinants of PWV in the Nigerian cohort (R2=0.21, p<0.001),
whereas SBP was the only factor remaining signicant (R2=0.34, p<0.001) in
multiple regression analysis in the Belgian women. Figure 14.1 shows the evo-
lution of PWV with age for both ethnic groups.e increase in PWV with age
was slightly but not signicantly higher in Nigerian (0.7m/s per decade) than
in Belgian women (0.5 m/s per decade).
Table 14.1: Characteristics of Nigerian PWV cohort and its age- and gender-matched Caucasian
cohort.
Nigerians Belgians
Mean SD Mean SD p-value
N 184 92
Age (years) 30.6 5.1 30.7 5.9 NS
Height (cm) 159.1 5.2 167.2 6.6 <0.001
Weight (kg) 60.2 11.5 63.1 10.8 NS
BMI (kg/m2) 23.7 4.2 22.5 3.6 0.019
brachial SBP (mmHg) 111.7 12.0 115.1 13.0 0.035
brachial DBP (mmHg) 67.6 9.9 69.2 9.1 NS
brachial MAP (mmHg) 85.3 10.4 88.2 11.1 0.034
HR (bpm) 74.1 8.8 64.4 9.4 <0.001
PWV (m/s) 5.6 1.0 5.8 0.8 NS
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic
blood pressure; MAP, mean arterial pressure; HR, heart rate;
PWV, pulse wave velocity
Pulse wave analysis
In the subset of 36 subjects (aged 23-41 years) with tonometry measurements
and their matched Belgian controls (Table 2), only body height and heart rate
were signicantly dierent between the two groups. When looking at local sys-
tolic pressures, only radial SBP was signicantly lower in Nigerians than in Bel-
gians. Although synthesized aortic and carotid SBP did not dier signicantly
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Figure 14.1: Evolution of pulse wave velocity (PWV) with age for the Nigerian (black) and Bel-
gian (white) women. Trend lines show a slight but insignicant dierence between the Nigerian
(solid line) and Belgian cohort (dashed line).
across ethnicity, the dierence between both does (p<0.001). As for the wave
reection indices, synthesized aortic and carotid AIx and AP diered across
ethnicity, unlike radial AIx and AP. Aer adjustment for heart rate and height,
this dierence remained signicant for carotid AIx (p=0.03) and AP (p=0.02)
and borderline signicant for aortic AIx (p=0.06) and AP (p=0.07).e dier-
ence between carotid and aortic AIx did not dier signicantly between both
ethnic groups.
14.4 Discussion
is study is the rst to provide a direct comparison of arterial stiness and ar-
terial wave reections between Africans living in sub-Saharan Africa and age-
matched Belgians.e results of the present study suggest no ethnic dierences
in pulse wave velocity and central systolic pressure in young and middle aged
women, but we did nd a lower radial SBP and central AIx in Nigerian as com-
pared to Belgian women.
Our data can be compared to those of Shiburi et al. [188], who studied 108
apparently healthy, normotensive South-Africanwomen of comparable age, but
with a larger age range (33.5 (13.1) years). ey report an average PWV of 5.7
(1.5) m/s and a peripheral and aortic augmentation index of 78.0 (24.1) and 22.5
(15.5), respectively. While the PWV-values match very well, the peripheral AIx
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Table 14.2: Characteristics of Nigerian tonometry cohort and its age- and gender-matched Cau-
casian cohort.
Nigerians Belgians
Mean SD Mean SD p-value
N 36 36
Age (years) 30.3 4.9 30.3 4.9 NS
Height (cm) 159.4 6.5 167.2 7.2 <0.001
Weight (kg) 62.4 17.3 63.5 11.3 NS
BMI (kg/m2) 24.5 6.3 22.7 3.8 NS
brachial SBP (mmHg) 111.1 10.7 112.9 9.4 NS
brachial DBP (mmHg) 68.0 8.2 68.3 9.2 NS
brachial MAP (mmHg) 85.2 8.9 87.0 8.8 NS
HR (bpm) 77.7 9.1 65.4 11.5 <0.001
Local systolic pressure (mmHg)
Radial SBP 115.3 11.7 124.2 10.6 0.001
Aortic SBP 103.2 11.4 107.6 9.7 NS
Carotid SBP 110.1 12.1 109.3 10.0 NS
Carotid - aortic SBP 6.8 3.2 1.7 3.5 <0.001
Local augmented pressure (mmHg)
Radial AP -16.4 8.4 -20.0 11.6 NS
Aortic AP 2.3 2.6 5.5 6.7 0.009
Carotid AP -3.2 4.3 1.5 6.7 0.001
Carotid - aortic AP -5.3 3.3 -4.1 4.9 NS
Local augmentation index (%)
Radial AIx 66.6 14.3 64.3 19.1 NS
Aortic AIx 107.8 8.2 117.5 19.8 0.009
Carotid AIx 92.6 9.8 104.5 17.9 0.001
Carotid - aortic AIx -14.4 7.8 -13.0 15.5 NS
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood
pressure; MAP, mean arterial pressure; HR, heart rate ; AP, augmented
pressure; AIx, augmentation index
in the South-Africans is higher, probably because of a lower heart rate (67.6
(11.8) bpm). Central augmentation index cannot readily be compared, as an-
other denition is used by Shiburi et al. (AP/PP instead of P2/P1). Converting
our values to this alternative denition, aortic AIx becomes 6.8 (7.0), clearly
lower than the values of Shiburi et al. who also reported a lower heart rate (67.6
bpm).
In urbanized, westernized settings,most available data ondirect ethnic com-
parisons of arterial characteristics report a higher carotid-to-femoral PWV for
people of black African descent, aer correction for age and blood pressure.
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is was the case forAfrican-American student volunteers (n=25) [218], African-
Carribeans living in the UK (n=99, aged 40-64 years) [231], Brazilian black hy-
pertensive male military police soldiers (n=38, aged 19-47) [207] and African-
Carribeans living in the UK (n=46, aged 57-60 years) [71]. However, when
specic populations were compared, no dierence in carotid-to-femoral PWV
was found in patients on hemodialysis [242] and patients with type-2 diabetes
[230, 251]. All these studies suer from a relatively small sample size. In a more
representative sample from an ARIC sub-cohort [239], carotid artery stiness
was found to be higher in 268 African-Americans compared to 2459 European-
origin 45-64 year-olds aer adjustment for all vascular risk factors. Whether
higher BPs over prolonged periods lead to or are caused by a higher level of
aortic stiness remains uncertain. Our nding that arterial stiness does not
dier between black and white women is therefore in contradiction with cur-
rent literature. In the absence of other comparative studies directly comparing
sub-Saharan Africans to Caucasians, we can only speculate that the previously
reported ethnic dierences, reported in people of African descent living in de-
veloped countries, weremore a consequence of lifestyle and environmental fac-
tors.
Pulse wave analysis at the carotid artery can be used as an alternative for
aortic parameters obtained via the radial-to-aortic transfer function. In this
study, both approaches were followed as a way to implicitly assess the accu-
racy of the transfer function in Africans. In an invasive study by Van Bortel et
al., the dierence between carotid and invasively measured aortic pressure was
1.8 mmHg, which is in good agreement with the dierence between carotid
and TF-derived aortic pressure in the Caucasian cohort of this study: 1.7 (3.5)
mmHg. However, the dierence between the same two non-invasive estimates
of central pressure in the Nigerian cohort was much larger: 6.8 (3.2) mmHg.
Interestingly, Heernan et al. also reported a higher dierence between carotid
and TF-derived aortic SBP in African-American than in white students [218].
is might suggest that the transfer function used in the SphygmoCor device is
not as accurate when used in people of African descent.
An important point to consider in our study is the eect of ambient temper-
ature which was clearly dierent between the measurements in the Belgian and
Nigerian women. It has been reported that a 10○C increase in indoor tempera-
ture reduces brachial SBP by 2 to 5 mmHg [254, 255] as a result of vasodilatation
and reduced vascular resistance. As such, this might explain the lower brachial
MAP and SBP and the lower radial SBP in the Nigerian women, as well as the
lower aortic-to-radial pulse pressure amplication. e fact that PWV never-
theless remains constant can be explained by the fact that the carotid-to-femoral
pathwaymainly includes elastic arteries, which are less susceptible to vasoregu-
lation with increasing temperature. Assuming that AIx and AP reect to some
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extent the wave reections in the muscular arteries, the more vasodilated state
of the Nigerian women can also account for the lower aortic and carotid AIx
and AP observed in Nigerian women.
14.5 Limitations
A rst important limitation lies in the danger of extrapolation. e current
study comprises only a relatively small number of subjects in a limited age
range. Although no ethnic dierences in arterial stiness were found in this
population, these results cannot be readily extrapolated. e current ndings
merely indicate the need for larger-scale epidemiologic research on Africans
living in sub-Saharan Africa.
As opposed to studies on ethnic dierence in Western countries, any data
on Africans living in Africa cannot be compared to people of another ethnicity
who live in the same country. erefore, in this study, a comparison between
Nigerian and Belgian women was made. Although this may be statistically cor-
rect, this approach has important limitations. Even though both groups were
matched for age and gender, there are many other dierences between both
groups that cannot be quantied and thus not corrected for, such as the dier-
ences in lifestyle and environment.
14.6 Conclusion
In contrast to prior studies conducted in Western countries reporting ethnic
dierences in arterial stiness and wave reections between people of African
and European descent living in the same (Western) country, the present study
suggests no ethnic dierences in arterial stiness, wave reections or central
aortic pressure between young to middle aged Nigerian and Belgian women.
e observed dierence between carotid SBP and aortic SBP derived via the
radial-to-aortic transfer function in Nigerian women warrants the need for a
specic validation of the transfer function in people of African descent.
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Arterial pulse wave velocity in
Nigerian babies
15.1 Introduction
e burden of hypertension-related morbidity and mortality increases inex-
orably in developing countries, particularly in sub-Saharan Africa [256, 257].
e risk pattern of cardiovascular disease (CVD) is associatedwith a high preva-
lence of hypertension and growing rates of obesity and consequent diabetes,
especially in women. Maternal characteristics in pregnancy inuence neonatal
outcome but also early childhood blood pressure (BP) and vascular develop-
ment [258–260]. Furthermore, the etiology on risk factors for CVD in adults
may have its origin in utero and infancy [261, 262] and childhood risk factors
are predictive of sub-clinical and overt adult cardiovascular pathology [263,
264]. Higher BP in childhood predicts later hypertension but BP measurement
alone is an imprecise way of assessing early development of CVD risk. Aortic
pulse wave velocity (aPWV) is a powerful, independent predictor and marker
of both subclinical and overt CVD, over and above systolic and pulse pressure
[71, 264] probably because aPWVmore directlymeasures vascular distensibility
and overall pathology. Studies of arterial distensibility in infancy and childhood
are few [265, 266] and there are none to our knowledge in African children.
In this study, we address the early natural history of arterial distensibility by
measuring aPWV in a cohort of Nigerian children to examine the relationship
between maternal and neonatal characteristics (including malaria) and aPWV
at birth, around 3months and again at 12 months of age.e protocol, method-
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ology and equipment were similar to that in our previous study on infants in
Britain [267].
15.2 Methods
15.2.1 Participants
Healthy pregnant women aged 18 to 45 were recruited from a semi-urban com-
munity, Yemetu-Adeoyo, Ibadan in the relatively auent South West of Nige-
ria. HIV positive women were excluded. eir newborn babies were mea-
sured at three timepoints: at birth (1-3 days, baseline), at 3 months and at 1
year of age. Preterm deliveries (less than 36 weeks gestation), twins or babies
with known syndromes, metabolic defects, sexually transmitted infections, ma-
jor congenital abnormalities or severe birth trauma were excluded from the
study. Ethical approval for the study was obtained from the joint University of
Ibadan/University College Hospital ethical committee and from the University
of Manchester.
15.2.2 Measurements
Measurements on the mothers
At baseline, weight, height and blood pressure were measured in the mothers.
Seated BP was taken in a standard manner, 3 times at every visit during preg-
nancy aer >5minutes rest, with 1minute intervals, using a validatedDatascope
BPmonitor with appropriate sized cus.e mean value of the last two record-
ings was used in further analysis. Malaria was determined from thick smear
blood samples taken at delivery and up to 3 visits prior to delivery. Mothers
were classied as malaria-positive if they had a malaria positive smear in at
least one of the visits. Analysis was also done by parasite density count, and
four categories were distinguished: no, mild, moderate or severe malaria. e
last two are combined in further analysis.
Measurements on the babies
Measurements were carried out at birth and around 3 and 12months of age. BPs
were taken in triplicate using the Datascope BPmonitor with appropriate-sized
neonatal cus. Again the mean value of the last two recordings were analyzed.
Babies were weighed naked and length was measured from crown to heel on a
stadiometer. Skinfolds (triceps, biceps, subscapular, and suprailiac) were mea-
sured usingHoltain calipers on the le side of the body. All measurements were
obtained in duplicate, or in triplicate if disagreeing by >15%. Mean values of the
last two recordings were used in further analysis. All anthropometric measure-
ments were carried out by nurses who had dedicated training based on aWHO
manual. Inter-observer and within-observer error were minimized through 3
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monthly refresher training sessions where the standard operating procedures
and training videos were revisited to ensure standardization of techniques, us-
ing the same equipment for women and babies, throughout the study.
Aortic PWV measurement
Babies were in supine position for 2 to 5 minutes before aPWV measurement.
Two continuous wave 8MHz Doppler probes (Huntleigh Healthcare, Cardi,
UK) were used, one at the base of the neck to insonate the le subclavian artery
and the other peri-umbilically over the abdominal aorta above its bifurcation.
e probeswere each connected to aDoppler owvelocimeter (MD2,Huntleigh
Healthcare), with the output of the velocimeters taken to a custom-made am-
plier and analog-to-digital converter, sampling at a rate of 1kHz, and thence
to a laptop PC. Flow waveforms were generated, displayed and recorded in real
time (gure 15.1). aPWV is obtained as the ratio of travelled distance over tran-
sit time. e distance between the subclavian and abdominal sampling sites
was measured to the nearest 5 mm by a non-stretch tape measure, whereas the
transit time is the time delay between the foot of the subclavian wave and the
foot of the abdominal aortic wave [265] and was derived from the waveforms
with customwritten soware using amodication of the algorithm reported by
Kontis et al. [266].e soware allows to adjust a threshold value for optimal
foot detection aer which a histogram of the beat-to-beat varying transit times
is displayed.
Because of the circumstances in which this study is performed, the oen
restless babies as well as the lack of quality feedback given by the acquisition
soware, it can be expected that the quality of the ow recordings is not al-
ways high. erefore, a number of objective criteria was applied to lter out
those recordings of sucient quality for further analysis. Firstly, the histogram
of the individual transit times within each recording has to have a Gaussian
shape (normal distribution). Secondly, re-analysis of a recording with a dier-
ent threshold value for foot detection should not change the mean transit time
with more than 20%. As variations in transit time become relatively more im-
portant in short transit times, there is a cut-o point below which an accurate
assessment of the transit time is no longer possible. erefore, as a third cri-
teriumwe discarded all recordings with a mean transit time below 20ms. Since
the range of neonatal aPWV-values reported in literature (3 to 6 m/s, Koudsi
et al. [267]; 2 to 6.5 m/s, Gardiner et al. [268]) is well below our cut-o aPWV
(which is around 8 m/s for newborns, 9 m/s for babies of 3 months old and 10
m/s for 1 year old babies), the impact of this third criterium on the results is
limited.
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Figure 15.1: Schematic setup for aPWV measurement with Doppler probes at subclavian and
abdominal aortic artery. Panel A displays the measured arterial segment; panel B illustrates the
use of the probes on a baby; panel C shows the waveforms captured simultaneously from the
aortic arch and abdominal aorta and the time delay between the recordings [267].
15.2.3 Statistical analysis
Data are presented asmean (SD). Dierences in aPWVbetween cross-sectional
data were assessed using ANOVA, whereas a paired t-test was used in the longi-
tudinal aPWV-data.e inuence ofmaternalmalaria on childrens’ aPWVwas
assessed using ANOVA. All analyses were performed using PASW Statistics 18
(SPSS Inc., Chicago, US).
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15.3 Results
Out of the 246 babies with PWV-recordings at birth, 124 were retained aer
application of the quality criteria. Mean age of the mothers was 28.9 (5.1) years,
while mean gestational age was 39.3 (1.4) weeks. Mean maternal SBP/DBP was
103.7 (8.7)/60.2 (6.8) mmHg. At the age of three months, 77 of the 249 babies
with PWV-recordings were included, 18 of which also had PWV measured at
birth. At 12 months of age, 144 of the 267 babies with PWV-recordings were
included, 23 of which had PWV measured at 3 months and 40 babies also had
measurements at birth, also clear from gure 15.2. Data are presented as a com-
0 months
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66Group B Group A
12 months3 months
23
8136
0
Group C
Figure 15.2: Schematic overview of the number of cross-sectional and longitudinal aPWV-data
at 0, 3 and 12 months of age.
parison of cross-sectional measurements at the three timepoints and as three
subsets of longitudinal data. Table 15.1 shows the characteristics of the cross-
sectional data at birth, 3 and 12 months. e cross-sectional data show an in-
crease in aPWV during the rst 3 months of life with no signicant aPWV-
change during the next 9 months (le panel of gure 15.3). e longitudinal
data conrm this trend (right panel of gure 15.3) but no signicant correlations
were found between aPWV at any two timepoints in the longitudinal subsets
(R<0.15 for all cases).
e inuence of malaria on aPWVwas studied inmore detail. Comparison
of aPWV across maternal malaria status, expressed either as ‘yes/no’ or by de-
gree of parasite density (none, mild, moderate or severe), did not aect neonatal
aPWV as illustrated in Table 15.2.
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Table 15.1: Basic characteristics of the children measured at 0, 3 and 12 months.
0 months 3 months 12 months
N 124 77 144
Weight (kg) 3.0 (0.4) 5.8 (0.9) 8.5 (1.3)
Height (cm) 48.7 (2.3) 60.8 (2.9) 73.8 (2.9)
Subscapular skinfold (mm) 4.2 (0.9) 4.3 (0.8) 4.2 (0.8)
Triceps skinfold (mm) 4.2 (0.9) 4.3 (0.8) 4.1 (0.8)
Biceps skinfold (mm) 3.6 (0.7) 3.7 (0.7) 3.7 (0.8)
Suprailiac skinfold (mm) 4.4 (1.0) 4.4 (0.9) 4.4 (0.9)
SBP (mmHg) 71.6 (12.4) 89.1 (8.4) 88.5 (7.5)
DBP (mmHg) 36.1 (8.0) 48.0 (8.7) 64.5 (9.2)
HR (bpm) 126.2 (17.6) 128.0 (16.9) 112.3 (14.2)
PWV 4.5 (1.5) 5.6 (2.1) 5.7 (1.9)
SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate
PWV, pulse wave velocity
P<0.001
P<0.001 P=0.011
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Figure 15.3: Box-plot representation of the aPWV-data at birth, 3 months and 12 months. Le
panel: cross-sectional data; right panel: longitudinal data.
15.4 Discussion
By studying the arterial distensibility in young Nigerian children during their
rst year of life, this study is the rst to combine two relatively unexplored re-
search areas: the assessment of early cardiovascular risk development during
the rst year of life and the study of arterial distensibility in native Africans.
To the best of our knowledge, this study is the rst to report on the evo-
lution of aPWV during the rst year of life. Previously, Laogun et al. [269]
described the evolution of aPWV in British schoolchildren, where aPWV fell
progressively until the age of 10-12 to increase again aerwards. Although they
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Table 15.2: aPWV across maternal malaria status.
Malarial status
Age Positive Negative N
0 months 4.5 (1.3) 4.4 (1.6) 61/63
3 months 5.2 (1.9) 5.9 (2.2) 38/39
12 months 5.7 (2.1) 5.6 (1.8) 74/70
N denotes the number of malaria positive and
malaria negative babies, respectively
measured aPWV in babies of 3-7 days old, the next timepoint at which aPWV
was assessed was between the age of 2 and 3 years.erefore, the slight increase
in aPWV observed in the present study cannot readily be compared to these
data. Using the same methodology, Koudsi et al. assessed aPWV at birth in 148
British children, reporting a mean aPWV that was fairly similar to ours (4.6
m/s).
Both the cross-sectional and the longitudinal data report a signicant in-
crease in aPWV from0 to 3months or 12months. However, no correlation with
age in longitudinal aPWV-data was found. It is possible that the number of ba-
bies measured at two of the three timepoints was too small for the dierence
in aPWV to reach statistical signicance. Another interpretation could be that,
although on average aPWV increases during the rst three months of life, in-
dividual aPWV can uctuate considerably throughout the rst year of life.e
fact that aPWV in this study was not related to BP at any of the three timepoints
and therein clearly diers from aPWVmeasured at later life (where BP is a ma-
jor determinant of aPWV) might indicate that aPWV is determined by other
factors during the rst year of life than at later age. A similar phenomenon has
been described for the association between weight gain and SBP [270]: while
weight gain at 5 years was strongly related to SBP at the age of 22 years, the
weight gain at 1 year was not related to the SBP at 22 years.
Maternal malaria during pregnancy has been associated with adverse con-
sequences such as anaemia and low birth weight [271–273]. erefore, in a re-
gion where malaria is pandemic, we anticipated to nd a strong positive rela-
tion between malarial load in pregnancy and aPWV in early childhood. e
fact that no such relation was observed in the present study is surprising. One
can only speculate that this is related to the above mentioned hypothesis that,
during the rst year of life, aPWV is driven by dierent factors than at later age,
so the anticipated positive relation might still be observed during follow-up of
these children.
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15.5 Limitations
A major drawback of this study is the overall quality of the recordings, with
roughly only about 50% of all aPWV-recordings meeting the inclusion criteria.
is is probably due to the babies, who cannot stay calm easily for 5 minutes, in
particular when being confrontedwith twoDoppler probes touching their skin.
In addition, specic to the African setting, the lack of a reliable, continuous
electric power supply and the absence of a temperature-controlled room also
adds undesired variability to the measurements. Furthermore, the acquisition
interface did not provide any direct feedback on the quality of the recording,
which lead to many unintentional low-quality recordings.
erefore, three quality criteria were applied during post-processing to re-
tain only those recordings of sucient quality. Although these criteria were
dened ad-hoc and result from a trade-o between selecting high quality data
and retaining a statistically relevant amount of data, the observedmean value as
well as the range of aPWV-values is perfectly within the aPWV-values reported
in literature on neonates [267, 268].
15.6 Conclusion
Based on the assessment of aortic pulse wave velocity (aPWV) in Nigerian ba-
bies, the present study suggests that aortic stiness increases during the rst
three months of life by about 1 m/s, with no signicant change in the next 9
months. During the rst year of life, aPWV can uctuate considerably and is
unrelated to maternal malarial load.
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Conclusions
is nal chapter rst summarizes the main conclusions of each part, aer
which the current research is put into a broader perspective.
16.1 Validation and development of new methods
e analysis of wave reections and arterial stiness has increasingly gained at-
tention over the last 15-20 years and is now in the transition between clinical
research and clinical practice, as illustrated by the inclusion of pulse wave ve-
locity (PWV) as a marker of subclinical organ damage in the 2007 ESC/ESH
guidelines. e validation and development of new methods to quantify ar-
terial stiness and wave reections should be viewed against the background
of this anticipated introduction in clinical practice. Whereas research requires
the most accurate, complete characterization methods, a more pragmatic com-
promise between accuracy and time- and cost-eectiveness has to be made in
clinical practice. For this reason, a number of new methods and devices has
recently emerged, focusing specically on usability, lower prices and short ex-
amination times.
One suchmethod is the quantication of arterial stiness (transit time) and
wave reections (reection magnitude) by wave separation using a measured
pressure wave and an approximated triangular ow wave, thus bypassing the
oen expensive and time-consuming assessment of an aortic ow waveform
needed in the traditional approach of wave separation. We veried these ap-
proximation techniques and demonstrated that a triangular ow approxima-
tion yielded only moderate-to-poor agreement between the estimated and the
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reference transit time and reection magnitude. Approximating the ow by a
more physiological waveform signicantly improved the levels of agreement,
but considerable individual deviations still persist. One must therefore be cau-
tious when applying this technique clinically.
is highlights another important dierence between research and clini-
cal practice: whereas research is performed on study populations, clinical ap-
plication is on individuals. Measuring carotid blood pressure (a surrogate for
central aortic blood pressure) requires applanation tonometry recordings at the
brachial and the carotid artery. In obese patients, however, tonometry record-
ings are dicult to obtain, a problem that becomes increasingly important in
clinical practice, where each patient needs to be measurable. erefore, the
use of calibrated diameter distension waveforms could provide a more widely
applicable alternative for local arterial pressure assessment than applanation to-
nometry.is approach might be of particular use at the brachial artery, where
the feasibility of a reliable tonometric measurement has been questioned. We
demonstrated that a technique which makes use of distension waveforms at
both the brachial and carotid artery provides estimates of carotid pressure in
good agreement with the tonometer-based reference method. As such, further
development of cheap ultrasound devices, capable of providing diameter dis-
tension waveforms, may provide a clinically useful tool. Note that combining
tonometry and diameter distension waveforms performed poorer than use of a
single technique.
Another technique to assess central blood pressure which is clinically more
useful than the combined brachial-carotid tonometer approach, is the use of
radial tonometer waveforms, which are subsequently transformed into central
pressure via a transfer function. Not only does this method require a single
tonometer reading, the radial artery is also better suited for tonometry and ap-
plicable in virtually any subject with normal forearm vasculature. Drawback,
however, is the fact that the radial pressurewaveform requires calibration, based
on information measured at the brachial artery. Dierent calibration strategies
were tested. We demonstrated that, when the radial pressure is calibrated using
diastolic blood pressure and an estimate of themean arterial pressure (MAP), it
is advisable to use 40% of the brachial pulse pressure instead of the traditional
33% to assess MAP.
Another newly proposed method to quantify arterial stines, the Ambula-
tory Arterial Stiness Index (AASI), was critically evaluated using a previously
validated numerical model of the arterial circulation. We identied arterial
distensibility, vascular resistance and especially heart rate as the main deter-
minants of the AASI.e confounding eects of vascular resistance and heart
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rate seriously limit the use of AASI as a marker of arterial stiness. While our
model-generated data donot allow to exclude thatAASI is related to andpredic-
tive for cardiovascular disease, they do indicate that this is not due to its ability
to adequately capture and quantify arterial stiness. As such, we discourage the
further use of AASI as a marker of arterial stiness.
16.2 Validation and development of new devices
Along with the increased attention for the role of the large arteries in the devel-
opment of hypertension and concomitant cardiovascular diseases, the number
of devices to measure wave reections and arterial stiness has boosted.
e Arteriograph (Tensiomed, Budapest, Hungary) is a newly developed
device that claims to assess aortic PWV by means of a simple brachial cu.
To test the validity of the working principle of the Arteriograph, we used a
previously validated numerical model of the arterial tree to simulate pressures
and ows in the normal conguration and in a conguration with an occluded
brachial artery. A pronounced secondary peakwas indeed found in the brachial
pressure signal of the occluded model (in line with the working hypothesis of
the device), but the timing of this secondary peak was only related to the sti-
ness of the brachio-axillary arterial path and not to aortic stiness. Our data
therefore indicate that the method picks up wave reection phenomena con-
ned to the brachial and axillary arteries, and derived values of PWV rather
reect the stiness of the brachial and axillary arteries than the intended aortic
stiness. As such, our simulations invalidate the working principle of the Arte-
riograph. While these observations do not exclude a potential use of the device
in a clinical setting, we do object against the claim of the manufacturer that the
device measures aortic pulse wave velocity.
ere is increasing evidence that central systolic blood pressure (cSBP)may
be a better predictor of future cardiovascular events than brachial pressure.
However, the use of central pressures in daily clinical practice is currently ham-
pered by the fact that most measurement devices, although non-invasive, re-
quire a trained operator, introducing potential operator dependence. With the
recent development of automated andhence operator-independent devices such
as theOmronHEM-9000AI (OmronHealthcare, Kyoto, Japan), data collection
is facilitated, bringing central pressure a step closer to routine clinical prac-
tice. However, when using SphygmoCor and Omron HEM-9000AI as advo-
cated by their manufacturers in a population of black South Africans, the mean
dierence in cSBP predicted by both devices was as high as 18.8 (4.3) mmHg,
which is higher than the dierence between central and brachial pressure in
most cases. e main reason for this dierence in cSBP is to be sought in dif-
ferences between the two algorithms, rather than in dierences in measured
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waveforms. Our observations suggest that the ‘true’ central cSBP is to be sought
in between the Omron HEM-9000AI and SphygmoCor estimates, with Sphyg-
moCor probably providing the closest estimate.
As illustrated by the studies on Arteriograph and Omron HEM-9000AI,
these newly developed devices are not necessarily accurate.e few established
devices on the other hand are all rather expensive, which may pose an obstacle
for research in developing countries.erefore, we developed a low-cost device
to acquire ow and pressure waveforms and hence derive PWV and local blood
pressure. By combining dierent commercially available hardware components
and in-house available signal processing knowhow, we have developed an accu-
rate, low-cost device for the assessment of PWV and local pressure. Its mobility
and low cost make the Tono-Doppler device particularly suited for application
in remote settings and developing countries.
16.3 Arterial properties in people of African descent
People of African descent display a clearly dierent cardiovascular risk pro-
le than Caucasians. To date, the true mechanisms responsible for this ethnic
dierence remain largely unclear. Most of the research on ethnic dierences
between Africans and Caucasians is performed on Africans living in Western
countries such as the United States and the United Kingdom. Given the in-
creasing rates of cardiovascular disease in sub-Saharan Africa, more research
on Africans living in sub-Saharan Africa as a basis for policy and treatment
strategies is urgently needed. Against this background, two studies were un-
dertaken in Nigeria, the most populous country in sub-Saharan Africa.
Aortic stiness and arterial wave reections were assessed in young Nige-
rian women and compared to corresponding measurements in age-matched
Belgianwomen. In contrast to prior studies conducted inWestern countries, we
did not nd any ethnic dierences in arterial stiness, wave reections or cen-
tral aortic pressure between young to middle age Nigerian and Belgian women.
e observed dierence between carotid SBP and aortic SBP derived via the
radial-to-aortic transfer function in Nigerian women warrants the need for a
specic validation of the transfer function in people of African descent.
In a second study, the aortic stiness of 264 Nigerian babies, aged 0-1 year,
was asessed in an attempt to track early changes in arterial distensibility.e re-
sults from this study suggest that aortic stiness increases during the rst three
months of life, with no signicant change in the next 9 months. During the
rst year of life, PWV can uctuate considerably and is unrelated to maternal
malarial load.
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16.4 Perspectives
Since the inclusion of PWV in the 2007 ESC/ESH guidelines, the number of
devices and methods for the assessment of arterial stiness and wave reec-
tion has boosted. To date, no clear framework or regulatory mechanisms exist
to validate and ratify these newly developed methods and devices. e results
from the methodological research performed during this PhD illustrate that
most of these new methods and devices produce results that can dier consid-
erably from the gold-standard.is stresses the need for a better regulation for
the development of new devices and methods. In a rst step, a ‘reference cen-
tre’ performing a series of standardised comparativemeasurements with widely
accepted gold-standard devices and methods could provide some kind of qual-
ity label for new devices and methods. Within this perspective, the initiatives
undertaken by the Artery Society can only be welcomed.e society not only
coordinates several large multi-center studies to provide reference values for
new established parameters and markers (e.g. the reference values on arterial
stiness), it also publishes guidelines for the validation of new devices. Any-
how, up to date, the research eld is still quite polarized around ‘devices’. Given
that the overall purpose is to quantify physical properties of the arterial system,
it should ultimately not matter which device was used to measure these prop-
erties.
As for the research done in sub-Saharan Africa, the results from the cur-
rent studies did not identify ethnic dierences in arterial properties between
Africans and Caucasians, as oppposed to prior studies in Western countries. It
should, however, be mentioned that the sample size of the performed studies is
far too small to make any extrapolations and draw conclusions for dierences
between the Africans living in Africa and those living in Western countries.
Nevertheless, the performed research does stress the need for more large(r)-
scale epidemiological research into the mechanical properties of the large ar-
teries of people in sub-Saharan Africa. In this regard, the developed Tono-
Doppler device is a useful tool that can be used in further research. Subject
conditions are important when assessing arterial properties, as recognized in
the expert consensus document on arterial stiness listing a set of standard-
ised subject conditions. However, when comparing people from two settings,
markedly diering from each other in ambient temperature and humidity, it
is unclear whether one should use the same standardised conditions for both
groups. Applied to the African setting, the higher average temperature could
cause Africans to be more vasodilated, an eect that is no longer present when
measured under the standard temperature (22±1○C) mentioned in the expert
consensus document. erefore, a discussion should be held on the standard-
ization of tests and measurements, specically for the comparison of groups
from widely diering settings.
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